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Abstract 
 
Ehrlichia chaffeensis, an emerging tick-borne pathogen, causes human monocytic 
ehrlichiosis (HME).  The relationship between E. chaffeensis and its target cells in ticks and 
vertebrates is critical as the organism must persist in them.  We hypothesize that E. chaffeensis 
alters gene expression in support of adapting to dual hosts.  In support of testing this 
hypothesis, we developed an ORF-based microarray and performed global transcriptional 
analysis on the pathogen grown in macrophage and tick cells.  The analysis revealed the 
expression of about 30% of all the predicted E. chaffeensis genes, in macrophages or tick cell.  
Two-thirds of the transcribed genes are common for both host cell backgrounds.  About 20% of 
the commonly expressed genes also varied in expression levels which ranged from two to five 
fold.  Microarray data was verified by RT-PCR for a subset of randomly selected genes.  
Together, this is the first report describing the global host cell-specific gene expression patterns 
in E. chaffeensis.   
 
Differential gene expression may be an important adaptive mechanism used by E. 
chaffeensis for its continued survival in dual hosts.  To test this hypothesis, we established 
many basic protocols and tools needed for performing mutational analysis in E. chaffeensis.  
Four antibiotic selection markers; gentamicin, chloramphenicol, spectinomycin and rifampin, and 
two promoters constitutively expressed in E. chaffeensis, genes rpsL and tr, were identified.  
Two regions of the genome were also identified for performing initial mutational analysis.  
Several plasmid constructs were also made.  The optimal conditions for introducing these 
plasmids into host cell-free viable E. chaffeensis organisms were also established.  The 
molecular evaluation of several E. chaffeensis transformants using these plasmids suggested 
that the plasmids gained entry, but failed to get integrated into the genome or remain in the 
bacteria for longer periods of time.  
 
In summary, we demonstrated global host cell-specific differential gene expression in E. 
chaffeensis by employing microarray analysis.  Numerous host-specific expressed genes will be 
important for studies leading to effective methods of control.  We also established several basic 
protocols and tools needed for performing mutational analysis useful in evaluating the impact of 
the loss of expression of uniquely expressed genes. 
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Ehrlichia chaffeensis, an emerging tick-borne pathogen, causes human monocytic 
ehrlichiosis (HME).  The relationship between E. chaffeensis and its target cells in ticks and 
vertebrates is critical as the organism must persist in them.  We hypothesize that E. chaffeensis 
alters gene expression in support of adapting to dual hosts.  In support of testing this 
hypothesis, we developed an ORF-based microarray and performed global transcriptional 
analysis on the pathogen grown in macrophage and tick cells.  The analysis revealed the 
expression of about 30% of all the predicted E. chaffeensis genes, in macrophages or tick cell.  
Two-thirds of the transcribed genes are common for both host cell backgrounds.  About 20% of 
the commonly expressed genes also varied in expression levels which ranged from two to five 
fold.  Microarray data was verified by RT-PCR for a subset of randomly selected genes.  
Together, this is the first report describing the global host cell-specific gene expression patterns 
in E. chaffeensis.   
 
Differential gene expression may be an important adaptive mechanism used by E. 
chaffeensis for its continued survival in dual hosts.  To test this hypothesis, we established 
many basic protocols and tools needed for performing mutational analysis in E. chaffeensis.  
Four antibiotic selection markers; gentamicin, chloramphenicol, spectinomycin and rifampin, and 
two promoters constitutively expressed in E. chaffeensis, genes rpsL and tr, were identified.  
Two regions of the genome were also identified for performing initial mutational analysis.  
Several plasmid constructs were also made.  The optimal conditions for introducing these 
plasmids into host cell-free viable E. chaffeensis organisms were also established.  The 
molecular evaluation of several E. chaffeensis transformants using these plasmids suggested 
that the plasmids gained entry, but failed to get integrated into the genome or remain in the 
bacteria for longer periods of time.  
In summary, we demonstrated global host cell-specific differential gene expression in E. 
chaffeensis by employing microarray analysis.  Numerous host-specific expressed genes will be 
important for studies leading to effective methods of control.  We also established several basic 
protocols and tools needed for performing mutational analysis useful in evaluating the impact of 
the loss of expression of uniquely expressed genes.
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Vector-Borne Infections 
Vectors in General 
Living organisms that carry disease causing agents from one host to another are called 
vectors.  There are two types of vectors; mechanical and biological.   Mechanical vectors are 
defined as organisms that physically carry disease causing agents from one place to another, 
such as to carry a pathogen from a site where a pathogen may be present or from an infected 
host to another place.  Mechanical vectors do not support the development or replication of a 
pathogen.  The transfer of pathogens by mechanical vectors may lead to a disease in naïve 
animals and people.  For example, a housefly can serve as a mechanical vector for carrying 
bacteria from one place to another and contact of such bacteria by a host can lead to an 
infection or disease (41).  Inanimate objects such as gloves, clothing, equipment and shoes may 
also serve as vehicles to transfer infectious agents to animals or people (62).  However, 
inanimate objects are not considered as mechanical vectors, but are referred to as fomites (12).  
Biological vectors differ from mechanical vectors as they also serve as hosts for the pathogens 
they carry and aid in their development within them.  Many blood-sucking invertebrates are 
known to transmit infections to people and animals.  Biological vectors may or may not be 
affected by the presence of pathogens they harbor.  For example, Anopheles species 
mosquitoes, biological vectors for the malaria parasite, are not affected by the presence of 
Plasmodium parasites (27).  In contrary, the human body louse, a biological vector for a 
rickettisial pathogen, Rickettsia prowazeki, dies within two weeks after acquiring infection (81). 
 
Arthropods, a large group of invertebrates that belong to the phylum Arthropoda in the 
animal kingdom, are characterized by a rigid external skeleton, the presence of paired and 
jointed legs and a haemocoel.  The phylum arthropoda includes four subphyla; Trilobita, 
Crustacea, Chelicerata and Uniramia.  The subphylum Trilobita includes the mostly extinct 
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arthropods; Crustacea includes mostly aquatic arthropods; Chelicerata includes arthropods with 
six pairs of appendages, four pairs of which are legs; Uniramia, the largest subphyla includes 
arthropods with one pair of antennae and one or two pairs of maxillae.  Several of the 
arthropods have been identified as important vectors for transmitting disease causing agents.  
For example, the sand fly, Phlebotomus argentipes, is a transmitting vector for Leishmania 
donovani, the causative agent for visceral leishmaniasis in people (113).  Lice can transmit a 
variety of pathogens responsible for causing diseases in people.  Louse-borne infections in 
people include epidemic typhus, relapsing fever and trench fever (57).  Fleas are parasitic 
insects and transmit agents causing deadly diseases like plague (130).  The major vector-borne 
diseases in humans, and associated etiological agents and arthropod vectors are listed in Table 
1.1.  
 
Arthropod-borne infections in people are of major public health concern and are 
responsible for heavy mortalities and morbidity.  For example, arthropod-transmitted infectious 
agents causing malaria, dengue, yellow fever, plague, trypanosomiasis and leishmaniasis 
resulted in more human diseases and deaths in the 17th through early 20th centuries than all 
other causes combined (1).  Currently, Plasmodium species parasites transmitted by 
mosquitoes infect 350-500 million people each year resulting in more than one million deaths 
world wide (WHO).  Likewise, mosquitoes transmit several viruses which are responsible for 
serious infections in people and animals (55).  Aedes species mosquitoes transmit chikungunya 
virus to people and severe outbreaks of this viral infections have been reported in several parts 
of the world (48).  Eastern equine encephalitis (EEE) is a viral disease transmitted by Aedes, 
Coquillettidia, and Culex species mosquitoes (110).  EEE virus infects humans, horses, and 
several bird species and results in encephalitis (110).  Culex species mosquitoes can also 
transmit Japanese encephalitis virus and St. Louis encephalitis virus  
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Table 1.1:  Important vector-borne diseases of humans, and associated etiological 
agents and arthropod vectors (except tick vectors) 
Disease Pathogen/Parasite 
 
Arthropod Disease Vector 
 
 Viral diseases 
Dengue haemorrhagic  
Fever 
DEN-1, DEN-2, DEN-3, DEN-4 
flaviviruses 
 
Aedes aegypti mosquito 
Yellow fever Yellow fever flavivirus 
 
Aedes aegypti mosquito 
Encephalitis* Flavi-, alpha- and 
bunyaviruses 
 
Various mosquito and Ixodid 
tick species 
 
Bacterial diseases 
Epidemic Typhus Rickettsia prowazeki Mites 
Protozoal diseases 
Malaria Plasmodium falciparum 
Plasmodium vivax 
Plasmodium ovale 
Plasmodium malariae 
 
 
Anopheles species 
mosquitoes 
Leishmaniasis Leishmania spp Lutzomyia and Phlebotomus 
species Sandflies 
 
Trypanosomiasis Trypanosoma brucei 
gambiense 
Trypanosoma brucei 
rhodesiense 
 
Glossina spp. (tsetse fly) 
Chagas diseases Trypanosoma cruzi Triatomine spp. 
Filarial nematodes 
Lymphatic filariasis Brugia malayi, Brugia timori, 
Wuchereria bancrofti 
 
Anopheles, Culex, Aedes and 
Ochlerotatus mosquitoes 
Onchocerciasis Onchocerca volvulus Simulium species Blackflies 
 
 
*Including Japanese encephalitis, West Nile encephalitis, St. Louis encephalitis, La Crosse 
encephalitis and tick-borne encephalitis. 
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causing infections resulting in neurological problems in people (118).  West Nile Virus (WNV) is 
primarily transmitted by the bite of infected Culex species mosquitoes (16).  WNV infection can 
also result in a life threatening disease in people as well as in many other vertebrates 
(75,82,107).  Mosquitoes remain as the major arthropod vector and much of the mosquito-borne 
illnesses are centered in the tropical regions of the world, such as Africa, Asia and South 
America (108).  Although mosquito-born illnesses have been reported in animals and people in 
recent years in the USA, they are better controlled due to living conditions.  For example, WNV 
was first reported in New York in 1999 and rapidly spread to nearly all parts of the US and is 
responsible for several mortalities and morbidity (117).  The disease, however, is on the decline 
now which may be attributed to better measures of mosquito control (www.cdc.gov). 
 
 The arthropod vectors can also transmit pathogens to plants (51).  Arthropod-borne 
infections in plants can have significant impact on the economy.  For example, citrus triesteza 
virus, an aphid transmitted infection to plants, is reported to have killed several millions of citrus 
trees worldwide and is now considered to threaten an estimated $912 million in orange crops of 
central California (61).  Likewise, arthropod transmitted infections in animals also have 
significant economic impact.  Bluetongue is a viral infection transmitted by Culicoides species 
insects to cattle and sheep.  Bluetongue infections cause an estimated annual loss of $125 
million to the livestock industry in the US alone and $3 billion world-wide (47).  Several other 
arthropod transmitted diseases such as heart water fever, caused by Ehrlichia ruminantium; 
theileriosis, caused by Theileria parva; and babesiosis, caused by Babesia species cause heavy 
losses to the cattle industry world wide (10,11,63,73,93,98,150).  These pathogens are 
transmitted by ticks.  Ticks are the second most important arthropod vectors in transmitting 
infectious agents to people and animals (92,124,135). 
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Biology of Ticks 
 Tick is the common name of small arthropods that belong to the subphylum Chelicerata, 
class Arachnida and order Ixodida (119).  Ticks are the second most important group of 
arthropods that are reported to be acting as a vector for disease causing agents, mosquitoes 
being the first (119).  There are about 850 known species of ticks that have been identified 
(119).  The ticks are grouped into three families; Ixodidae, Argasidae and Nuttalliellidae based 
on morphological differences in body parts (Figure 1.1).  The family Ixodidae consists of 13 
genera and 650 species (Figure 1.1).  Ticks belonging to this family are called hard ticks 
because of the tough sclerotized plate on the dorsal body surface, termed scutum.  The 
Argasidae family includes 5 genera and approximately 170 species (Figure 1.1).  The ticks of 
this family lack the scutum and instead have a leathery cuticle and so are termed as soft ticks.  
The family Nuttalliellidae is represented by one species, Nuttalliela manaqua and has 
morphological features of both hard and soft ticks.  N. manaqua has a pseudoscutum which 
resembles a scutum but does not have the smooth appearance of the real scutum.  Ticks 
belonging to the families Ixodidae and Argasidae act as vectors to transmit infectious agents to 
animals and people (119). 
  
 The life cycle of the tick has four different life stages; egg, larva, nymph and adult 
(Figure 1.2) (119).  The life stages of the tick have significant morphological differences among 
them.  For example, larval ticks have six legs where are nymphal and adult ticks possesses 
eight legs.  Adult female ticks lay eggs following a blood meal and mating with a male.  The 
eggs hatch to become larvae.  The larvae obtain a blood meal from a smaller vertebrate host 
and molt to the nymphal stage.  Nymphs also acquire a blood meal and molt to become adults.  
Adult female ticks require a blood meal and mating with a male tick before it can lay eggs.  The 
total time needed to complete the life cycle may vary from less than a year to over three years 
depending on the climatic conditions, host availability and tick species.  The life cycle of  
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Figure 1.1. Classification of ticks.   
The ticks are grouped into three families; Ixodidae, Argasidae and Nuttalliellidae based on 
morphological differences in body parts.  The family Ixodidae consists of 13 genera and 650 
species.  Ticks belonging to this family are called hard ticks because of the tough sclerotized 
plate on the dorsal body surface, termed scutum.  The Argasidae family includes 5 genera and 
approximately 170 species.  The ticks of this family lack the scutum and instead have a leathery 
cuticle and so are termed soft ticks.  The family Nuttalliellidae is represented by one species, 
Nuttalliela manaqua and has morphological features of both hard and soft ticks. Ticks belonging 
to the families; Ixodidae and Argasidae act as vectors to transmit infectious agents to animals 
and people. 
ORDER IXODIDA
Ixodidae
(hard ticks)
Argasidae
(soft ticks)
Nuttalliellidae
(hard/soft ticks)
Argas (56 spp.)
3 Families
Ornithodoros (100 spp.)
Otobius (2 spp.)
Antricola (8 spp.)
Nothoaspis (1 sp.)
Ixodes (245 spp.)
Anomalphimalaya (3 spp.)
Haemophysalis (155 spp.)
Margaropus (3 spp.)
Boophilus (5 spp.)
Rhipicentor (2 spp.)
Rhipicephalus (70 spp.)
Cosmiomma (1 sp.)
Hyalomma (30 spp.)
Aponomma (24 spp.)
Amblyomma (102 spp.)
Nosomma (1 sp.)
Dermacentor (30 spp.)
Nuttalliella (1 sp.)Genera
 8 
soft ticks differ by having multiple nymphal stages and molts before they finally molt to adult 
stage.  So, the soft ticks may need to acquire several blood meals during the nymphal stage of 
its life cycle to finally molt to adults.  The total time to completion of the entire life cycle for soft 
ticks is much longer than that of hard ticks and also depends on the climate, host availability 
and tick species (119).   
 
 Ticks are ectoparasites and depend on a blood meal from various vertebrate animals 
including humans, wild and domestic mammals, birds and reptiles.  The ticks have evolved to 
have mouth parts that facilitate them to acquire a blood meal from vertebrate hosts (119).  The 
mouth parts of the ticks include a pair of palps, a pair of chelicerae and a hypostome.  All these 
mouth parts are mounted on a large cylindrical structure called the basis capituli (Figure 1.3).  
Chelicerae are the cutting organs used to penetrate the host’s skin and gain access to fluids.  
The palps have gustatory, mechanosensory and thermosensory functions and act as sensory 
organs to facilitate feeding (119).  The hypostome is a rod shaped structure and is a primary 
attachment organ of the host.  It enters into the host’s skin during feeding and has backward 
directed projections that prevent easy removal of the attached tick.  Though hard ticks and soft 
ticks have similar mouth parts, they differ in their feeding habits.  The hard ticks attach to the 
hosts for several days to few weeks and acquire the blood meal slowly.  The salivary glands of 
the hard ticks produce a cement-like substance which glues the feeding tick in place.  Soft ticks 
are fast feeders and they attach onto the host for few minutes to hours and acquire complete 
blood meals quickly.  The cuticle of the female hard ticks continues to grow to accommodate the 
large volume of the ingested blood.  This result in an increase in body size of several hundred 
times more than their unfed body weight.  In contrast, the cuticle of an adult soft tick can only 
expand but can not grow and so the fed tick weight can increase only up to 5-10 times more 
than their unfed body weight.  The meal size for nymphs and  
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Figure 1.2  Life cycle of hard ticks.   
The life cycle of the tick has four different life stages; egg, larva, nymph and adult.  Adult female 
ticks lay eggs upon blood meal and mating with a male.  The eggs hatch to become larvae.  The 
larvae obtain a blood meal from a smaller vertebrate host and molt to the nymphal stage.  
Nymphs also acquire a blood meal and molt to become adults. 
www.iassistdata.orgimagesticklifecycle.jpg 
 10 
Figure 1.3  Generalized mouthparts of a hard tick, based on a species of Ixodes.  
The mouth parts of the ticks include a pair of palps, a pair of chelicerae and a hypostome 
mounted on a large cylindrical structure called capitulum.  Chelicerae are the cutting organs 
used to penetrate the host’s skin and gain access to fluids.  The palps have gustatory, 
mechanosenseory and thermosensory functions and act as sensory organs to facilitate feeding.  
The hypostome is a rod shaped structure and is a primary attachment organ of the host.  It 
enters into the host’s skin during feeding and has backward directed projections that prevent 
easy removal of the attached tick. A, dorsal view; B, ventral view.  
http://www.entm.purdue.edu/publichealth/images/tick/tick02.gif 
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adults of argasid ticks, and Ixodid adult males is typically much smaller than that acquired by 
adult female Ixodid ticks (119). 
 
 Tick as an ectoparasite can impact the health of a vertebrate host.  For example they 
can suck large quantities of blood from a vertebrate host which may result in anemia.  Ticks 
may also provoke hypersensitivity reactions including anaphylaxis (9).  Some tick species 
secrete a neurotoxin from their salivary glands as they feed on the hosts; this may lead to 
paralysis followed by death (50).  This condition is commonly referred to as tick paralysis (50).  
Damage caused by infested ticks to the host is reported to facilitate infection of the host  with 
other infectious agents like Dermatophilus congeolensis (66,133). 
 
Ticks as transmitting vectors for pathogens: 
 
 The life span of the ticks is very long ranging from several months to years; they can 
survive for several months, without a blood meal, waiting for a suitable vertebrate host (119).  
Ticks have evolved strategies to survive while waiting for hosts; for example they can absorb 
moisture directly from the atmosphere by using hygroscopic substances secreted by the salivary 
glands.  This longevity and exceptional resistance to adverse conditions help ticks not only to 
perpetuate for several years, but also to carry the infectious agent in nature for long times.  
Ticks can lay large numbers of eggs.  For example, Amblyomma nuttalli is reported to lay more 
than 22,000 eggs in its life time.  The ability of laying large numbers of eggs is another survival 
feature for ticks to maintain their populations and spread effectively in nature.  Another 
important feature is the digestion process in ticks.  The blood acquired from the host is stored in 
the midgut of ticks and is digested slowly over several months to years.  The digestion process 
is primarily intracellular within midgut cells, i.e., digestive enzymes are not secreted into the 
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midgut thus providing the pathogens that may be present in the blood to escape into the tissues 
of the tick (119).  All these unique features allow the persistence of tick in nature, and also the 
pathogens they carry. 
 
 Ticks, during their life stages, can acquire pathogens during feeding on an infected 
vertebrate host.  The pathogens acquired during one stage of the life cycle, for example larva or 
nymph can be maintained in the subsequent life stages like nymph or adult; this phenomenon is 
called transstadial transmission.  Ehrlichia chaffeensis, a rickettsial pathogen is transstadially 
transmitted by Amblyomma americanum ticks (5,87).  If the pathogen acquired by the tick is 
transmitted to the future generations through the eggs, it is termed as transovarial transmission.  
Rickettsia rickettsii transmitted by ticks, is passed on from parent to offspring tick by transovarial 
transmission (74).  As ticks acquire blood meals from a variety of vertebrate hosts during their 
life cycle, they can transmit the infectious agents to different vertebrate hosts such as wild and 
domestic animals and people (77,92,119). 
 
 Ticks are known to transmit a variety of pathogens to vertebrate animals such as 
protozoa, bacteria including rickettsiae and viruses (40,92,119,124,127).  For example, 
protozoan parasites belonging to the genera Babesia and Theileria are transmitted by ticks 
(11,98).  The Babesia species parasites cause infections in several animals (mice, dogs, horses 
and cattle).  Theileria parva and Theileria annulata are responsible for the disease theileriosis in 
cattle (98).  Several bacterial pathogens transmitted by the ticks can significantly impact the 
health of animals.  Ixodes species ticks can transmit the Lyme disease agent, Borrelia 
burgdorferi, to dogs, horses and cats (128,132).  Similarly, Ehrlichia ruminantium, causative 
agent of Heart water fever in cattle, is transmitted by Amblyomma species ticks.  Anaplasma 
marginale, the causative agent of bovine anaplasmosis, is transmitted by ticks (151).  Tick 
borne infections are also responsible for economic losses to the animal industry (135).  A recent 
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estimate by International Livestock Research Institute suggests that ticks alone are responsible 
for 14-17 billion dollars of economic loss annually to the livestock industry worldwide (59).  In 
the cattle industry, tick transmitted infectious agents causing diseases, such as theileriosis, 
babesiosis, anaplasmosis, and Heart water fever results in the loss of several millions of dollars 
annually in sub-Saharan African countries (60).  The economically important infections 
transmitted by ticks to animals are listed in Table 1.2. 
 
 Ticks also harbor and transmit protozoan, bacterial and viral pathogens to people (135).  
For example, Ixodes dammini ticks transmit a protozoan parasite Babesia microti, the causative 
agent of human babesiosis to people in the USA (106).  Ixodes spp. ticks transmit lyme disease 
agent, Borrelia burgdorferi, to people (83).  Dermacenter and Haemophysalis species ticks can 
transmit the bacterial pathogen Francisella tularensis responsible for tularemia in people (49).  
Dermacentor species ticks are primarily responsible for transmitting Rickettsia rickettsii, the 
causative agent of Rocky mountain spotted fever in the USA (137).  Ticks belonging to genera 
Amblyomma and Ixodes transmit Ehrlichia and Anaplasma species pathogens responsible for 
Ehrlichiosis in people (2,5,7,15,30,31).  Ticks can also act as a vector for transmitting several 
viral agents (such as Tick-born encephalitis virus (TBEV) and other TBEV complex viruses 
belonging to Flavivridae) causing encephalitis and hemorrhagic fever in people in many parts of 
the world (76).  The important human pathogens and the tick vectors responsible for the 
infections are listed in Table 1.3. 
 
 In summary, ticks can transmit several disease causing agents to people.  Lyme 
disease agent is one of the few pathogens that is considered an important tick 
transmitted agent in USA.  Lyme disease has been reported from several parts of USA 
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with predominant number of cases from northeastern states.  Another important human 
disease, Rocky mountain spotted fever  
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Table 1.2  Economically important infections transmitted by ticks to animals 
Disease Etiological agent Tick species Distribution 
Bovine Babesiosis Babesia bovis 
Babesia bigemina 
Boophilus species World-wide 
Equine Babesiosis Babesia equi Dermacenter species World-wide 
Bovine Anaplasmosis Anaplasma marginale 
Anaplasma centrale 
Dermacenter species 
Rhipicephalus species 
Boophilus species 
World-wide 
Ovine and Caprine 
Anaplasmosis 
Anaplasma ovis Dermacenter species World-wide 
Theileriosis Theileria species  Amblyomma species 
Hyalomma species 
Dermacentor species 
Rhiphicephalus 
species 
Haemophysalis 
species 
World-wide 
Heart water disease in 
ruminants 
Ehrlichia ruminantium Ixodes species Sub-Saharan 
Africa, Asia and 
Caribbean 
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Table 1.3  Important tick transmitted etiological agents and the human disease  
Disease Etiological agent Tick species 
Rocky Mountain Spotted Fever Rickettsia rickettsii Dermacentor variabilis 
Dermacetor andersoni 
Tularemia Francisella tularensis Dermacentor variabilis  
Dermacetor andersoni 
Lyme disease Borrelia burgdorferi Ixodes scapularis 
Ixodes pacificus 
Human monocytic ehrlichiosis Ehrlichia chaffeensis Amblyomma americanum 
Human granulocytic ehrlichiosis Anaplasma 
phagocytophilum 
Ehrlichia ewingii 
Ixodes scapularis 
Ixodes pacificus 
Babesiosis Babesia microti Ixodes scapularis 
Relapsing fever Borrelia hermsi 
Borrelia turicatae 
Ornithodoros hermsi 
Ornithodoros turicatae 
Colorado tick fever Colorado tick fever virus Dermacenter andersoni 
Powassan virus encephalitis Powassan virus Ixodes species 
Tick-borne encephalitis Tick-borne encephalitis 
virus 
Ixodes species 
 
Haemorrhagic fever 
Several hemorrhagic fever 
viruses belonging to 
Flaviviridae,  
Ixodes species 
Haemophysalis species 
Dermacentor species 
Argas species 
Hyalomma species 
Rhipicephalus species 
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caused by a rickettsial pathogen was first reported in late 1800s and is still a concern in the 
USA.  Until 1980s, Rickettsia rickettsii, the RMSF agent, was the only known important 
rickettsial pathogen transmitted by ticks to people.  The discovery of human monocytic 
ehrlichiosis, human granulocytic anaplasmosis, and human ewingii ehrlichiosis has expanded 
the role of the tick as a vector. 
 
General introduction about Rickettsiales 
 
Rickettsiales belong to the class Alphaproteobacteria in the phylum Proteobacteria 
under the Kingdom Bacteria (32).  The order Rickettsiales includes several intracellular bacteria 
that cause fatal and chronic infections in people and many vertebrate animals (32).  Initial 
classification of Rickettsiales included several intracellular bacteria under this order.  With the 
recent studies based on the analysis of 16S rRNA, GroESL and several other surface protein 
gene sequences, this order has been reclassified to include two families Rickettsiaceae and 
Anaplasmataceae (32).  The family Rickettsiaceae includes obligate intracellular bacteria that 
grow in the cytoplasm of the eukaryotic host cells, whereas the Anaplasmataceae family has 
obligate intracellular bacteria that replicate in vacuoles derived from the host cell membrane 
(32).  There are two genera included in the Rickettsiaceae family; Rickettsia and Orientia.  The 
family Anaplasmataceae contains four genera; Anaplasma, Ehrlichia, Wolbachia and 
Neorickettsia (32). 
 
 Twenty five Rickettsia species and one Orientia species have been documented in the 
Rickettsiaceae family (32).  Morphologically the Rickettsia and Orientia species vary in shape 
from coccobacillary to short rods and measure 0.8-2.0 µm long and 0.3-0.5 µm wide (32).  The 
Rickettsia species are further subdivided into the spotted fever group and the typhus group.  
 18 
The spotted fever group organisms have the ability to polymerize actin in the host cytoplasm 
and enter into the host’s nucleus whereas the typhus group bacteria do not (54).  The spotted 
fever group organisms are mainly associated with arthropods such as ticks, mites and fleas 
(134).  These arthropods serve as biological vectors of transmission for pathogenic Rickettsia 
(91).  The typhus group pathogens are mainly transmitted to vertebrates from the infected feces 
of lice and fleas and by gaining entry into a host through mucous membranes or abraded skin 
(91).  Upon internalization into host cells, the Ricketssial pathogens escape from phagosomes 
by lysing the phagosomal membrane with phospholipase D and hemolysin C (101,139).  
Rickettsial pathogens are highly adapted to live in the host cell cytoplasm by acquiring ATP, 
nucleotides and amino acids from the host.  Orientia tsutsugamushi causes a life-threatening 
illness called scrub typhus in people (52).  O. tsutsugamushi differs from Rickettsia species both 
phenotypically, by not having peptidoglycans or lipopolysaccharides in the cell wall, and 
genotypically, by having only 90 % similarity in the 16S ribosomal gene sequences (125).  So, 
this pathogen was classified under a new genus (125).  This pathogen is maintained in nature in 
mites and is transmitted to humans by the larval mite during feeding (52).  These pathogens 
enter into host macrophages by phagocytosis, escape into the cytoplasm, and replicate by 
binary fission. 
 
The family Anaplasmataceae includes several important human and veterinary 
pathogens belonging to three genera; Anaplasma, Ehrlichia, Neorickettsia and non-pathogenic, 
symbiotic organisms belonging to the genus Wolbachia (32).  Morphologically the bacteria in 
this family vary from small rod, coccoid to pleomorphic forms ranging from 0.3-1.3 µm in size 
(32,102).  The primary target vertebrate host cells for Anaplamataceae organisms include 
erythrocytes, monocytes, macrophages, neutrophils, platelets and endothelical cells (32,102).  
The genera Anaplasma and Ehrlichia include several pathogenic organisms that cause 
infections in people and animals and are primarily transmitted by Ixodid ticks (32).  Several wild 
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and domestic animals like cervids, mice and rodents serve as reservoir hosts for these 
pathogens that serve to maintain them in nature (32).  The genera Ehrlichia and Anaplasma 
have similar cell tropisms and morphological appearance.  However, the sequence analysis of 
16S ribosomal protein genes revealed significant differences and so they were separated as two 
separate genera (32).  Three Neorickettsia species have been reported as pathogens causing 
diseases in animals and people.  They are Neorickettsia helminthoeca, Neorickettsia risticii and 
Neorickettsia sennetsu.  Vertebrate hosts like dogs, horses and humans acquire Neorickettsia 
by ingestion of insects or fish infested with infected trematodes or metacercaria (14,70,102).  
The Wolbachia species, non-pathogenic and symbiotic bacteria, reside in many invertebrates 
like insects, spiders, mites, ticks and filarial nematodes (such as Dirofilaria immitis, and 
Onchocerca volvulus) (122). 
 
Several rickettsial pathogens have been reported to cause infections in people and 
animals.  The oldest known tick transmitted rickettsial pathogen having significant impact in the 
USA is Rickettsia rickettsii, the causative agent of RMSF (137).  Several rickettsial pathogens 
belonging to the genera Anaplasma and Ehrlichia have also been identified as disease causing 
agents in animals and people (32).  Anaplasma marginale and Anaplasma centrale are the tick 
transmitted pathogens responsible for bovine anaplasmosis, an economically important disease.  
Ehrlichia ruminantium, another economically important tick-transmitted pathogen causes heart 
water disease in both domestic and wild ruminants.  This sub-Saharan African pathogen is also 
established in the some Caribbean islands posing a continuous threat to ruminants on the US 
mainland.  A pathogen that is highly homologous to E. ruminanitum has been identified recently 
from the ticks and goats of Georgia (68).  Ehrlichia canis, canine monocytic ehrlichiosis agent, is 
the oldest known rickettsia species having a wide spread distribution through out the world 
(except Austarlia).  Ehrlichia ewingii is another pathogen causing ehrlichiosis in dogs.  Ehrlichia 
equi and Ehrlichia phagocytophilum were reported as causative agents of diseases in animals in 
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Europe and USA, respectively.  Human granulocytic agent commonly referred to as HGE agent 
is causing infections in people.  These three pathogens were found to be identical, and more 
closely related to Anaplasma genus upon molecular analysis, and named Anaplasma 
phagocytophilum.  Ehrlichia and Anaplasma pathogens have been known for quite some time 
as animal pathogens only and their potential as human pathogens was not established until the 
first report in 1987 for Ehrlichia chaffeensis.  Anaplasma phagocytophilum was reported in 1990 
to cause infections in people and the disease was termed human granulocytic anaplasmosis 
(8,19).  Ehrlichia ewingii also was reported to be causing infections in people in 1998 and the 
disease is referred to as human ewingii ehrlichiosis (15).  In 1986, peculiar intracytoplasmic 
inclusion bodies were seen in the monocytes of a patient with an unknown illness and a history 
of tick bites (71).  They were initially identified as Ehrlichia canis organisms based on 
morphology and serological assays (3,24).  Later on, molecular characterization of these 
pathogens from human patients confirmed that this bacterium is significantly different and was 
formally named Ehrlichia chaffeensis in 1991 (3).  Subsequently, the transmitting vector 
(Amblyomma americanum tick) and the natural reservoir hosts (white tailed deer) were identified 
for this pathogen.  E. chaffeensis causes human monocytic ehrlichiosis (HME) in people.  HME 
infections are well documented in people and HME is considered as an emerging disease in the 
USA (136).  The newly identified diseases caused by Ehrlichia and Anaplasma pathogens can 
be severe and fatal in people and have significant impact on the health of people in the USA 
(32,87,102,105).  So, this led to the expansion of research on these pathogens. 
 
Ehrlichia chaffeensis as an emerging human pathogen 
 
Increased numbers of HME cases have been diagnosed in the USA since its first identification 
in 1986 (71).  The initial cases of HME were reported from the southeastern United States, 
where the A. americanum tick is most abundant (30,138).  However, in later years, the 
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infections were reported from all over the USA.  This is not due to the presence of tick vectors in 
all the states but due to infections acquired during travel to states with a known risk for E. 
chaffeensis exposure (58).  The incidence rate of HME is increasing continuously and in the 
year 2005 alone, about 471 cases in the US were reported to the CDC (33).  However, these 
numbers are likely to be an underestimate of the actual incidence as active surveillance studies 
revealed higher infections rates.  For example, a study conducted in Missouri revealed 0.02%-
0.06% infection rates and a similar study in Tennessee revealed an incidence rate of 0.3%-0.4% 
in the human population (33).  The numbers translate to approximately 25,000 cases in these 
two states.  A. americanum is present in several southern and Midwestern states (Figure 1.4).  
Assuming that the infection rates in these states are similar to Missouri and Tennessee, the 
likely incidence of HME in these areas is anticipated to be much higher than reported to CDC.  
 
E. chaffeensis pathogen is maintained in nature by transmission between white tailed 
deer (reservoir host) and A. americanum tick (vector) (Figure 1.5).  In addition to people, E. 
chaffeensis is also reported to be infective to several other vertebrate animals such as dogs, 
coyotes, deers, raccoons and other wild animals (29,145).  The wide spread distribution of this  
pathogen in other vertebrate hosts may also contribute to the maintenance of this pathogen in 
nature.  E. chaffeensis causes persistent infections in white tailed deer and tick vectors 
(transstadial transmission) (6,22,25,26,34,42,123,131,155).  Ticks acquire infection upon 
feeding on an infected animal during larval or nymphal stages.  The bacteria remain in the tick 
as it changes from larva to nymph or from nymph to adult.  Infected nymphs and adult ticks 
transmit E. chaffeensis to vertebrate hosts.  Humans are considered as accidental hosts for E. 
chaffeensis (87) (Figure 1.5). 
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Figure 1.4  Geographical distribution of Amblyomma americanum tick in the USA.   
The A. americanum tick is found in the regions that are colored in dark green in the map.  
http://www.cdc.gov/ncidod/dvrd/Ehrlichia/Natural_Hx/Natural_Hx.htm   
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Figure 1.5  Proposed life cycle for Ehrlichia chaffeensis.   
The life cycle of E. chaffeensis involves a vertebrate host and a tick vector.  The pathogen is 
maintained in nature by transmission between the A. americanum tick and white tailed deer 
(reservoir host).  Ticks acquire infection while feeding on an infected animal and maintain the 
infection through its life cycle stages.  Human beings and other vertebrate hosts are considered 
as accidental hosts and will acquire infection upon bite from an infected nymph or tick. 
http://www.cdc.gov/ncidod/dvrd/Ehrlichia/Natural_Hx/nathx1.htm#E.%20chaffeensis 
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People of all ages are likely to acquire E. chaffeensis infection from the bite of an 
infected tick (87).  However, severe illness is more common in people with compromised 
immunity resulting from various causes, such as HIV infection or immunosuppressive medical 
therapy (88).  Published reports also suggest that elderly people are at higher risk of developing 
a severe form of HME illness (88).  Clinical signs of the disease range from a mild viral-like 
illness to severe life threatening disease and usually begin within 7-10 days following the bite of 
a tick (33).  However as the disease progresses, multiple organs get involved and complicate 
the clinical course and result in the possibility of a life-threatening condition (87).  Analysis of the 
clinical signs in patients revealed many commonly reported clinical signs which include fever 
(97%), malaise (82%), headache (80%), nausea (64%), myalgia (57%) and arthralgias (41%).  
Studies also revealed that about 42% of the patients need hospitalization with 17% developing a 
life-threatening condition (33).  About 3% of the infections will result in mortality.  Neurological 
signs are also observed in 20% of the patients.  When disease progresses to a multisystemic 
condition, it results in acute renal failure, metabolic acidosis, respiratory failure, disseminated 
intravascular coagulopathy, hepatic failure, myocardial dysfunction and finally death (33). 
 
Diagnosis of HME is complicated because of the absence of a specific diagnostic clinical 
feature (33).  The tentative diagnosis is primarily based on the clinical findings combined with a 
history of tick bite.  Serum chemistry and blood panels may be helpful in arriving at a 
presumptive diagnosis.  Several other diagnostic approaches are available for the confirmatory 
diagnosis of the infection.  They include peripheral blood smear examination, clinical laboratory 
findings, serology based tests, PCR tests and isolation of the bacteria (4).  The examination of a 
stained peripheral blood smear of a patient is a routinely followed method.  Intracytoplasmic 
inclusion bodies are likely to be found in the monocytes of positive samples (33).  However, 
blood smear examination is a very insensitive method and inclusion bodies can be detected in 
less than 10% of the infected patients (33).  The most commonly found laboratory findings 
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include thrombocytopenia (71%), leucopenia (62%) and elevated liver enzymes alanine 
aminotranferease and aspartate aminotransferase (83%) (33).  The blood panel may show 
multilineage cytopenias in the course of the disease.  Hemorrhagic abnormalities are seen in 
some patients resulting in coagulopathies and even epistaxis (33).  The serological assays test 
for the presence of antibodies against E. chaffeensis.  The most commonly available serological 
test is indirect immunofluorescence assay (IFA).  The IFA test is performed on paired serum 
samples, collected within two to four week intervals, and the increase in the serum titers in the 
convalescent phase serum can be confirmatory to a clinical infection.  However, small 
percentages of patients do not develop antibodies to E. chaffeensis and so IFA negative does 
not necessarily mean that a patient is negative for infection.  The sensitivity of the 
immunological assay, ranges from 20 % to >90%, depending on the immune response from the 
host and the number of days since the acquisition of infection (33).  PCR assays are reported 
which tend to have higher sensitivity (up to 85%) than IFA.  However, these tests may only be 
available to clinicians practicing at or near a University hospital.  In vitro isolation of the 
pathogen from the clinical samples is another way of confirming the diagnosis of E. chaffeensis 
infection (18,46).  However, this technique requires substantial resources and time (6-8 weeks) 
and the sensitivity is highly variable (23).  This method is not routinely used in the clinical 
setting. 
 
If a tentative diagnosis is made for infection with E. chaffeensis, antibiotic therapy is 
initiated by the clinician without the need of a confirmatory diagnosis.  Empirical studies 
provided evidence that HME agent is highly susceptible to tetracyclines.  Doxycycline is 
preferred to other tetracyclines because of the relatively lower risk for adverse drug reactions 
and better patient tolerance in people.  Several in vitro studies confirmed the susceptibility of E. 
chaffeensis to doxycycline.  It is currently the drug of choice for E. chaffeensis treatment in all 
age groups of people including children.  Rifampin is another antibiotic that is effective against 
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E. chaffeensis infection.  Rifampin is prescribed to patients having contraindications to 
doxycycline, i.e., allergy or pregnancy.  Generally a course of 1-2 weeks of doxycycline or 
rifampin antibiotics is recommended for complete clearance of the pathogen.  Chloramphenicol 
is also shown to be inhibitory to the growth of E. chaffeensis.  However, it is not used in clinical 
setting because of the higher dose requirement of chloramphenicol. 
 
E. chaffeensis is an obligate intracellular bacterium that predominantly infects 
monocytes and macrophages in vertebrate hosts.  However, infections in other cell types such 
as lymphocytes, atypical lymphocytes, premyelocytes, metamyelocytes and band and 
segmented neutrophils are also reported (87).  The bacterium lacks pili or capsule and so may 
bind to the host cells by its outer membrane and internalized by phagocytosis (65).  This 
internalization may be receptor mediated or by an independent mechanism which remains to be 
established (104).  The internalized bacteria replicate in a vacuole rather than cleared by 
phagolysosomal degradation (104).  Because of its intracellular nature, E. chaffeensis may 
depend for nutrients and metabolites on the host cell cytoplasm (46).  This may be 
accomplished by proteins expressed on the cell surface (46).  The initial interactions between E. 
chaffeensis and its host are likely through the surface exposed proteins of the pathogen (46).  
Electron microscopic studies suggest that similar to Chlamydia species, E. chaffeensis has two 
morphologically distinct forms that are observed in the phagosomes (153).  Recent studies by 
Zhang et. al, suggest that the dense core bodies are the infectious forms that are found within 
the phagosomes and also are released outside, while the reticulate bodies are metabolically 
active, replicating cells that are only seen within the phagosomes of infected cells (153).  
Several studies have been performed to identify the outer membrane proteins of E. chaffeensis 
(28,46,148,149,152).  A glycoprotein outer membrane protein of about 120 kDa size termed 
gp120 is reported in E. chaffeensis (144,148,149).  This protein is mainly expressed in the 
dense core stages of E. chaffeensis.  The function of this protein is unknown, but recent studies 
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suggest that it is immunogenic and may be involved in the attachment and invasion of host 
cells.  Similarly, an immunodominant 28 kDa outer membrane protein has been reported to be 
expressed on the E. chaffeensis cell surface (21,85,99,100,147).  Multiple forms of this proteins 
are encoded from the p28-Omp multigene locus.  Recent studies also suggest that the p28-
Omp proteins are differentially expressed in a host cell-specific manner (21,85,99,100,147).  
Moreover, multiple post-translationally modified forms of the p28-Omp 19 and 14 have been 
reported in E. chaffeensis originating from vertebrate and tick cell backgrounds, respectively 
(114).  The biological significance of the protein products of the p28-Omp locus genes remains 
to be determined.  Several new proteins such as DO/DeqQ family serine proteases, GroEL, type 
IV secretion subunit (VirB9-1), a hypothetical protein and conserved proteins have also been 
reported recently as the surface expressed proteins in E. chaffeensis (46).  Though, studies to 
date did identify some surface expressed proteins of E. chaffeensis, much more remains to be 
understood about their function and role in pathogenicity.  Similarly, understanding the 
pathogenicity of E. chaffeensis requires the details of E. chaffeensis protein expression and 
molecular characterization of differentially expressed proteins relative to its growth in vertebrate 
and tick cells.  In addition, understanding the host response against the pathogen and the 
pathogen’s ability to survive by evading host clearance requires detailed investigations of the 
pathogen in vitro as well as in vivo using infection studies performed in vertebrate and tick 
hosts.  In vivo experiments using an animal model will be valuable in assessing host response 
to a pathogen and will provide insights about how Ehrlichia may evade the vertebrate immune 
system.  The pathogenicity of E. chaffeensis can be better studied with the availability of a 
suitable animal model that mimics infection observed in people.  Though white tailed deer 
(WTD) are considered a natural reservoir host, it is not suitable as an animal model because the 
clinical presentation in this host is not same as observed in people (22,26,36).  For example, 
people develop several clinical signs that are not observed in WTD when experimentally 
infected with E. chaffeensis in a laboratory.  Secondly, humans are considered accidental hosts 
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where infection is mostly short lived, with the exception of people with a compromised immune 
system.  Thus it is ideal to select an animal model that acquires infections with E. chaffeensis 
and the infection is cleared or persistent similar to that in immunocompetent and 
immunocompromised people.  Several laboratories have been using the mouse as a suitable 
model for understanding E. chaffeensis infections and host response (39,44,64,140).  E. 
chaffeensis in mice induces variable immune responses, depending on the genetic background 
and immunological status of the murine host (39,45,64,86,112,141). 
 
It is unclear what components of the immune system are responsible for either the 
clearing or persistence of E. chaffeensis infection in people.  It is also unclear what pathogen 
factors, if any, contribute to the pathogen’s persistence in a vertebrate host.  The role of innate 
(macrophage and cytokines), humoral and cell mediated responses have been evaluated using 
the mouse model.  The studies reported that macrophage activation and cell-mediated 
immunity, orchestrated by CD4+ T cells are critical for conferring rapid clearance of E. 
chaffeensis (44).  However, CD4+ T-cell help can be complemented by other types of helper T 
cells, because CD4 knockout mice also can cure an infection two weeks late compared to wild 
type.  The studies also showed that CD4+ T cells are not absolutely necessary for E. chaffeensis 
resistance, but the most effective host response is accomplished only with the CD4+ T cells 
(44).   
 
E. chaffeensis causes persistent infections in MHC-II-knockout mice compared to 
cleared infection in wild type mice suggesting the importance of MHC-II antigen expression for 
activating the helper T cells (45).  The presence of CD4+ T-cells was also demonstrated to be 
helpful in clearing the infection faster but not absolutely necessary to clear the infection, as 
CD4-knockout mice also cleared the infection, albeit slower.  When mice were treated with anti-
CD4 monoclonal antibody, the clearance of infection was delayed by about one week (121).  
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Therefore, it has been concluded that there is some redundancy in the immune responses that 
allows for host resistance in the absence of CD4+ T-cells.  An increase in the CD8+ T-cells is 
demonstrated in fatal HME infections and also in canine ehrlichiosis cases (53).  So, studies 
were investigated to understand the role of CD8+ T-cells in host responses.  Experiments 
revealed that CD8+ T-cells are also not required but help in clearing the infection faster (39).  
Toll-like receptor-4 (Tlr4) molecules contribute to the clearance of E. chaffeensis by a yet 
undefined mechanism (45,126).  Natural killer cells have been shown to not have a role in 
clearing E. chaffeensis infection in mice (44,45).  The role of CD4- and CD8- and γδ T-cells has 
not been studied and is not yet defined. 
 
Antibodies against E. chaffeensis are shown to confer transient protection against an 
experimental challenge infection (64,85,146).  Antibodies may act on E. chaffeensis when 
released from the infected cells and before entering another host cell.  Several reports have 
been published defining the role of antibody-mediated protection (85,146).  SCID mice show 
fatal infections with E. chaffeensis, but adoptive transfer of pathogen-specific immunoglobulins 
induces a transient protection and survival in these mice (17).  Other studies reported that the 
adaptive transfer of antibodies against an outer membrane protein resulted in significantly faster 
clearance of E. chaffeensis upon challenge compared to control groups in Balb/c mice (64,85).  
The mechanism of protection by antibodies is believed to be due to formation of immune 
complexes triggering microbicidal activities in infected macrophages leading to the elimination of 
bacteria.  Alternatively, it is also proposed that antibodies may opsonize bacteria upon release 
from infected cells resulting in clearing the pathogens.  However, antibodies alone not are 
sufficient to completely clear an E. chaffeensis infection as demonstrated in a SCID mice model 
where mice succumbed to infection when adaptive transfer of antibodies was withdrawn. 
 
 30 
Together the comprehensive immunological studies using mouse models demonstrated 
that host clearance against E. chaffeensis is complex and involves macrophage activation, 
cytokines, antibodies, helper T cells responses and possibly other members of the host immune 
system that are yet to be defined.  However, infection in the mouse model appear to be very 
similar to those observed in people who clear E. chaffeensis infection fairly rapidly as in the 
case of immunocompromised individuals.  It is entirely unknown how in a subset of people, E. 
chaffeensis infection results in serious disease which can be fatal.  One possible explanation for 
this could be the E. chaffeensis originating from tick cells may alter host response particularly in 
elderly people with compromised immune systems.  So, the important aspect for understanding 
persistent infections requires detailed knowledge about how the pathogen adapts itself to a tick 
host.  Secondly, infection resulting from Ehrlichia transferred from a tick host to a vertebrate 
such as a human may provide an opportunity for the bacteria to persist longer as a result of 
altered immunity caused by tick feeding.  Recent studies from our laboratory provided 
preliminary evidence that E. chaffeensis protein expression differs considerably when it is 
growing in a tick cell background compared to a macrophage environment (20,43,84,114,115).  
Tick-specific gene expression may be one of the possible means by which E. chaffeensis may 
adapt to vertebrate host and persistently evade host response. 
 
Differential clearance patterns of E. chaffeensis depending on the origin of bacteria have 
also been reported in murine hosts (43).  For example, mice infected with tick cell-derived E. 
chaffeensis exhibited higher rickettsemia and slower clearance compared to macrophage-
derived bacteria (43).  Mice inoculated with tick cell-derived E. chaffeensis produced 
significantly higher concentrations of IgG antibodies compared to mice challenged with 
macrophage-derived bacteria (43).  The differences observed may be because of the differential 
host-cell specific protein expression in E. chaffeensis.  Differential host cell-specific gene 
expression is reported to be playing a role in causing persistent infections in several other 
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closely related tick transmitted pathogens such as, Borrelia burgdorferi (115).  Differential host 
cell-specific protein expression has been reported from the p28-Omp gene locus of E. 
chaffeensis.  However, the transcriptional studies performed in E. chaffeensis so far were 
focused on a subset of genes such as, p28-Omp locus genes.  The mechanisms employed by 
E. chaffeensis in evading host cell responses can be better understood if we know all the host-
cell specifically expressed genes.  The role of the differentially expressed genes can be better 
studied if we can identify such genes.  In an effort to fill the gap of knowledge in this area, 
studies aimed at identifying the global transcriptional profiles of E. chaffeensis in vertebrate and 
tick host backgrounds will be valuable. 
 
To precisely map the role of such differentially expressed genes in the pathogenesis of 
E. chaffeensis, blocking the expression of such genes and then study the differences in the 
pathogenicity of the bacteria will also be important.  Silencing of the genes can be accomplished 
by several methods.  RNA interference (RNAi) approach, a novel technique that has gained 
considerable attention recently, is reported to silence the expression of a specific gene in 
eukaryotes (120,129).  However, this approach has not been described for use in prokaryotic 
organisms due to the lack of dicer system.  Another way is to block the function of a protein of 
interest by using antibodies raised against that particular protein.  However, this method may be 
feasible to block the surface expressed proteins, but may not be feasible for cytoplasmic 
proteins.  Moreover, such studies may also be difficult for intracellular bacteria such as E. 
chaffeensis.  This is further complicated in that E. chaffeensis has a complex life cycle in tick 
and vertebrate hosts.  The third method is to knockout or disrupt a specific gene of interest and 
study its impact on the growth and pathogenicity of the bacteria.  However, genetic manipulation 
systems are yet to be established for E. chaffeensis.  Therefore, studies aimed at developing a 
genetic manipulation system useful in creating targeted mutations in the genome of E. 
chaffeensis will be most valuable to understand the function of E. chaffeensis proteins. 
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In this chapter, I provided a detailed description summarizing the impact of arthropod 
vectors on animal and human health.  Ticks are the second largest group of arthropods 
responsible for vector-borne diseases.  Several tick species have been identified in recent times 
as the vectors for transmitting various rickettsial pathogens to animals and people.  HME, 
caused by E. chaffeensis, is an emerging tick-transmitted infection in USA.  An increased 
incidence of HME infections is reported from across the USA since its first report in 1986.  E. 
chaffeensis can persist and result in serious illness in immunocompromised and elderly people.  
The pathogen primarily infects monocytes/macrophages and evades the host clearance 
mechanisms to achieve persistent infections.  The pathogenic mechanisms employed by E. 
chaffeensis and the host responses in clearing the infection or causing the persistent infections 
is not well understood.  Recent studies also suggest that E. chaffeensis protein expression 
differs in a host cell-specific manner.  Furthermore, studies conducted using a mouse animal 
model suggested differential clearance patterns for E. chaffeensis originating from macrophage 
and tick cells.  Mice infected with tick cell-derived E. chaffeensis exhibited higher rickettsemia 
and slower clearance compared to macrophage-derived bacteria.  However, more remains to be 
understood with regard to the differentially expressed proteins and their role in the pathogen’s 
survival in vertebrate and tick host; also how will the differential expression of protein aid in the 
pathogen’s persistence in the vertebrate host. 
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CHAPTER 2 - Scope of the Thesis 
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E. chaffeensis is a tick-transmitted rickettsial pathogen and is the causative agent of 
human monocytic ehrlichiosis (HME).  E. chaffeensis infections in people can persist and result 
in serious illness with fatal outcome, particularly in immune compromised and elderly people.  
An increased incidence of HME pathogen infections is reported in the USA since its first 
identification in 1986.  An active surveillance study conducted in Missouri revealed 0.02%-
0.06% infection rates and a similar study in Tennessee revealed even a higher incidence rate of 
0.3%-0.4% in the human population.  On average, these numbers translate to approximately 
25,000 cases each year for these two states, suggesting that the true prevalence of the disease 
is much higher in the US for the regions where the E. chaffeensis transmitting tick (A. 
americanum) is more prevalent.  With a steady increase in reported cases as well as the much 
higher estimated HME case load, research focused on understanding the pathogenesis and 
molecular basis for persistent infections with E. chaffeensis is necessary.  It is also important to 
understand how the pathogen is able to adapt to dual host environments.  However, very little 
has been understood about the pathogenesis of E. chaffeensis.  For example, to date there are 
only a few outer surface proteins that have been identified and partially characterized.  The 
function of these limited number of identified membrane proteins and their role in the pathogen’s 
adaptability and survival is not known.  Immunological studies, primarily coming from three 
independent laboratories, revealed considerable understanding of the components of the host 
immune system responsible in clearing E. chaffeensis infection.  However, the mechanism by 
which the pathogen causes persistent infection and adapts to two different hosts, vertebrate and 
tick, remains largely unknown.  Recent studies suggest the role of differential protein expression 
by E. chaffeensis as one of the contributing factors in adapting the pathogen to different hosts 
and causing persistent infections in them.  However, the studies that described the host cell-
specific differential expression are limited primarily to characterizing a few outer membrane 
protein genes.  It is, therefore, unclear if the differential expression is limited to a subset of a few 
gene products or a common theme for many gene products.   
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Recent advancement in E. chaffeensis research includes the availability of the whole 
genome sequence of the pathogen and the establishment of suitable animal models of infection 
studies.  These tools can be further exploited to understand the pathogenesis of the bacteria.  
For example, the availability of whole genome sequence aids in functional genomics studies to 
map global gene expression pattern differences in the pathogen relative to its growth in 
vertebrate and tick cell environments, as well as to map differences in the pathogen during its 
replication (reticulate bodies) or in its infectious form (dense cored bodies).  Studies aimed at 
identifying the genes that are differentially expressed in different stages of the pathogen’s life 
cycle and in different host environments may provide important information helpful in devising 
better strategies for controlling pathogen infections.  Differentially expressed proteins serve as a 
good starting point for investigations focused on identifying genes that are important for the 
pathogen’s survival in vertebrate and tick host environments.  So, the significant gap of 
knowledge in this field can be filled by utilizing functional genome approaches, such as to 
assess the global gene expression differences by transcriptome analysis.  A microarray chip 
representing the open reading frames of the E. chaffeensis genome, if designed, will be 
valuable to evaluate the gene expression patterns of the pathogen in different life cycle stages.  
Microarray-based transcriptome analysis will also be valuable to validate numerous predicted 
genes identified by the whole genome sequence analysis.  One of primary goals of this research 
is to fill in this important gap of knowledge by developing an ORF-based whole genome 
microarray chip and then utilize it to map the gene expression patterns of E. chaffeensis in 
different host backgrounds. 
 
The importance of a gene expression to the pathogenicity of E. chaffeensis can be better 
understood if one is able to block the function of the protein made or by blocking the expression 
of such protein from the gene encoding it and then examine the impact of the loss of its function 
to the pathogen's survival and adaptability to dual host life cycle.  Several approaches can be 
 36 
used to achieve this goal; 1) prevent the protein expression by blocking the translation from an 
mRNA by using methods such as the RNA interference (RNAi) technology as demonstrated in 
eukaryotes, 2) inactivate the protein function by using drugs that specifically target a specific 
protein of interest and 3) by introducing mutations in a gene of interest so as to alter or block the 
expression from a gene.  Knockout or knockdown of an mRNA is somewhat challenging for 
bacterial pathogens, as RNAi technology is not described for any bacteria due to the lack of 
RNA dicer enzyme pathway in them.  Alternatively, a transcript may be blocked from being 
translated using an anti-sense oligonucleotide approach (35).  However, this is not practical for 
an intra-phagosomal pathogen, such as E. chaffeensis, as it is technically impossible to transfer 
sufficient quantities of antisense oligonucleotides to block gene expression of the pathogen from 
within a phagosome.  Similarly, inactivating a protein function using drugs targeted to a protein 
also requires the transfer of a specific drug to be accumulated in sufficient quantities within the 
pathogen that may be replicating in a phagosome.  This is also complicated by the additional 
research involved in designing and evaluating specific anti-protein analogues.  The third and 
more reasonable approach will be to create mutations within the E. chaffeensis genome to 
selectively inactivate a gene of interest.  Although this is the most desirable approach, the lack 
of established methods of genetic manipulations for E. chaffeensis or other closely related tick-
transmitted pathogens is a significant gap of knowledge in this field.  If established, a mutational 
analysis system will be most desirable to study the importance of many uniquely expressed 
genes of E. chaffeensis.  Although targeted mutational approaches have not been reported, 
recent studies reported transposon-based mutagenesis for another closely related tick-
transmitted pathogen, Anaplasma phagocytophilum.  The data described recently at two 
scientific meetings suggest that it is possible to transform Ehrlichia and Anaplasma species and 
targeted mutagenesis is likely to be achieved.  If established, the availability of a genetic 
manipulation system in creating mutations in a specific gene will be very valuable to study the 
role of proteins made from various genes to the pathogenicity of E. chaffeensis.  Therefore, the 
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second major goal of my research is to fill in this important gap of knowledge, i.e., evaluate the 
methods for establishing mutations in E. chaffeensis. 
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CHAPTER 3 - Open Reading Frame- Based Microarray 
Used in Evaluating Gene Expression Profiles of Ehrlichia 
chaffeensis Originating from Vertebrate and Tick cell 
Environments 
 39 
Abstract 
Ehrlichia chaffeensis is an emerging tick-borne rickettsial pathogen that causes 
infections in people and several vertebrate animals.  This is the causative agent of human 
monocytic ehrlichiosis.  The relationship between E. chaffeensis and its target cells, 
macrophages/monocytes in vertebrate hosts and tick cells, is critical as the organism must 
persist in them to complete its life cycle.  We hypothesize that E. chaffeensis employs host cell-
specific gene expression as a strategy for adapting to and surviving in dual hosts.  In To test this 
hypothesis, we developed a novel open reading frame (ORF)-based whole genome microarray 
and performed global transcriptional analysis using RNA from E. chaffeensis grown in 
macrophage and tick cells.  The analysis aided in the identification of about 30% of all the 
predicted E. chaffeensis genes (341-381) as expressed independent of its growth in 
macrophages and tick cells.  About two-thirds of the transcribed genes identified by microarray 
analysis are common for both host cell backgrounds.  Nearly 20% of the commonly expressed 
genes also varied in their expression levels which ranged from two to four fold.  Proteins 
encoding commonly expressed genes include those involved in DNA metabolism, energy 
metabolism, protein synthesis, transcription, transport and cellular processes.  In addition, a 
significant portion of the commonly expressed genes (60 out of 263 ORFs) included those 
coding for proteins with unknown function (hypothetical proteins).  Host cell-specific expressed 
transcripts also have a similar ratio of genes coding for hypothetical proteins and those with 
defined function.  Microarray data was verified by RT-PCR for a subset of randomly selected 
genes from non-expressed, commonly expressed and differentially expressed pools.  Together 
the comprehensive transcriptional analysis represents the first report describing the global host 
cell-specific gene expression patterns in E. chaffeensis. 
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Introduction 
E. chaffeensis causes persistent infections in both vertebrate and tick hosts 
(6,22,25,26,34,42,123,131,151,155).  It is critical to understand how this pathogen remains in 
dual hosts for extended periods of time.  There may be many ways by which the organism may 
persist.  The strategies may include altering the host response, varying the expressed antigens 
relative to time post-infection, and differential host-specific protein expression (43,114,115,131).  
As ticks are heterothermic and vertebrate hosts are homeothermic, E. chaffeensis may also 
have evolved to express unique antigens in response to their host environments.  Several 
studies reported the role of differential gene expression as an important adaptive mechanism in 
causing persistent infections by many tick-borne pathogens.  For example, Lyme disease agent, 
Borrelia burgdorferi, is reported to express outer surface protein A in its tick host and outer 
surface protein C in the vertebrate host under in vivo conditions (109).  This differential 
expression in B. burgdorferi is shown to be important for the colonization and adaptation to 
different hosts (89,90).  Host cell-specific differential expression for a subset of E. chaffeensis 
proteins has also been reported recently (114,115).  Recent studies also demonstrated that 
clearance by the murine host is delayed for E. chaffeensis grown in tick cells as compared to 
those grown in vertebrate host cells (43).  Together, these results suggest that unique protein 
expression in E. chaffeensis grown in tick host provides an opportunity for the pathogen to 
evade clearance from a vertebrate host.  Much of the fundamental knowledge about the host-
specificity and how it contributes to the pathogen’s persistence can be understood by surveying 
the host-specific differences in the gene expression by transcriptome and proteome analysis.   
 
A limited number of studies have been carried out on E. chaffeensis in an effort to 
examine the contributions of expressed genes in support of persistent infection (43,154).  
Previous transcriptional analyses from our laboratory demonstrated the differential expression of 
the genes coding for p28 outer membrane proteins, termed p28-Omp genes, from E. 
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chaffeensis grown in mammalian host cells and tick cells under in vitro conditions (114,115).  
Several in vitro and in vivo studies from other laboratories also demonstrated the differential 
expression of outer membrane protein genes in vertebrate and tick host backgrounds 
(20,84,131).  Our recent proteome analysis also confirmed the findings from the transcriptional 
studies (111).  Much of the research until now is focused on few genes, mostly encoding outer 
membrane proteins (21,85,99,100,131,144,147-149).  A significant gap of knowledge exists in 
understanding the pathogenic mechanisms employed by E. chaffeensis and the strategies it 
uses to evade host clearance.  Comparative analysis of gene expression at the global level from 
E. chaffeensis cultivated in vertebrate and tick environments will yield significant more novel 
information to answer questions about the intracellular survival of this important human 
pathogen.  Recent advances in the rickettsial field include the availability of the whole genome 
sequence of E. chaffeensis (56).  However, only limited numbers of genes have been 
characterized at the molecular level (144,147,148).  The availability of whole genome sequence 
greatly aids in mapping the global transcriptional profiles of E. chaffeensis.  Such data will be 
valuable in defining the mechanisms employed by the pathogen for its continued survival in 
vertebrate and tick hosts as well as to map the molecular basis for pathogenesis.   
 
In this study, we designed an ORF-based whole genome microarray chip of E. 
chaffeensis and utilized it to assess global transcriptional differences in the bacteria growing in 
vertebrate and tick cell environments.  This is the first functional genome study reporting the 
transcriptional analysis of E. chaffeensis.  This study aided in the identification of numerous host 
specifically expressed genes in E. chaffeensis.  Findings from our study will be important to 
further enhance our understanding of E. chaffeensis pathogenesis and help in devising better 
control strategies. 
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Materials and Methods 
In vitro cultivation of E. chaffeensis in macrophage and tick cell lines:  E. chaffeensis 
Arkansas isolate was cultivated at 37°C in the canine macrophage cell line, DH82, as described 
previously.  Arkansas isolate was also cultivated in the tick cell line, ISE6, but at 34°C in the 
absence of CO2 as described by Munderloh et al. (79).  
 
Designing the microarray chip:  We obtained the unannotated complete genome sequence of 
E. chaffeensis from The Institute of Genome Research, TIGR (www.tigr.org) and carefully 
analyzed it for the presence of open reading frames (ORFs) that contain 95 or longer amino 
acids with the aid of the Artemis genome sequence analysis program (Welcome Trust Sanger 
Institute, Cambridge, UK).  (Note:  An annotated genome sequence was not available at the 
time when we initiated this study).  A total of 1,234 ORFs were identified and used in designing 
the array.  Two probes, of about 45 nucleotides long, specific for each ORF were designed.  
Similarly, three probes targeting the variable regions in each ORF were designed for all 22 
genes in the p28-Omp gene locus.  Specific probes targeting several house keeping genes 
were also designed representing human, canine, murine, and tick hosts.  The house keeping 
genes used as a control are: 18S rRNA genes from homosepians, mouse (Mus musculus), 
Rhiphicephalus sanguinius ticks and dog (Canis familiaris); beta actin gene from Ixodes 
scapularis, homosepians, mouse and dog; GAPDH gene from mouse, dog and homosepians; 
16S mitochondrial rRNA gene from I. scapularis and A. americanum.  Positive controls with 
perfectly matched and mismatched oligonucleotides were also included in the array.  In array 
design, we opted to use an oligonucleotide-based in situ synthesized microarray.  The 
advantage of an in situ synthesized oligonucleotide microarray is that it can be highly specific 
and minimizes non-specific hybridization signals resulting from a false priming of the targets and 
probes.  We also reasoned that the inclusion of the probes in triplicate and distributing them 
randomly throughout the microarray chip will aid in accurate detection of the expressed 
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transcripts.  This is specifically to rule out the false negatives.  Several blank wells were 
included to serve as background controls.  The microarray chips were custom manufactured 
from Xeotron Corporation (now affiliated with Invitrogen, Carlsbad, CA).  The chip is prepared 
using DMT-protected phosphoramidite nucleoside monomers in the presence of photo-
generated acid. 
 
RNA isolation, labeling and hybridization:  E. chaffeensis was grown in either DH82 cells or 
ISE6 cells to about 100% infectivity and allowed to undergo ~100% lysis (culture is evaluated 
microscopically by Hema 3 polychromatic staining of the cytospin slides).  About 30 ml of E. 
chaffeensis infected culture is centrifuged at 1,200 g for 10 min at 4°C to pellet the host cell 
debris and the supernatant containing host cell-free E. chaffeensis is filtered by passing through 
5 and 3 µ filters.  The filtrate is centrifuged at 15,000 g for 15 min at 4°C to pellet the E. 
chaffeensis organisms.  The cell pellet is resuspended in 1 ml of Tri-reagent and total RNA is 
extracted by following the protocols described by the manufacturer (Sigma-Aldrich, St. Louis, 
MO).  The final purified RNA pellet is dissolved in 100 µl of nuclease free water and subjected to 
column purification, by passing through RNeasy mini elute columns (Qiagen Corporation, 
Valencia, CA), to remove residual genomic DNA that may be present in the preparations.  The 
RNA is eluted from the column into a final volume of 10 µl of nuclease free water.  An outline of 
the protocol for isolating host cell-free E. chaffeensis RNA is shown in Figure 3.1.  The 
concentration of E. chaffeensis RNA was assessed by using a ND-1000 Spectrophotometer 
(Nano Drop Technologies, Wilmington, DE).  The integrity and purity of RNA samples was 
assessed by using an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo  
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Figure 3.1  Outline of protocol for isolating host cell-free E. chaffeensis RNA.   
The host cells infected with E. chaffeensis were harvested when the infectivity was about 100% 
and the bacteria were separated from the host cell debris by filtration and differential 
centrifugation.  RNA was isolated from host cell-free E. chaffeensis by Tri-reagent method and 
contaminating DNA was removed by using a column based purification technique. 
 
 
Ehrlichia chaffeensis in Host cells
(Infectivity-100% and ~100% lysis)
Host cell-free E. chaffeensis is collected
E. chaffeensis RNA used for microarray
Centrifugation at 1,200 g for 10 min at 4°C to pellet cell debris
Supernatant is filtered through 5 and 3 micron filters 
Filtrate is pelleted at 15,000 g for 15 min at 4°C
Pellet is resuspended in 1 ml of Tri-reagent 
Total RNA isolated as per the manufacturer’s protocol
RNA subjected to column purification to remove contaminating DNA
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Figure 3.2  Purified E. chaffeensis RNA (Ech) resolved on a Bioanalyzer chip.   
RNA from E. coli (Ec) and macrophage cultures were also isolated and analyzed to compare the 
resolved rRNA bands of all three species (Ech rRNA bands were identified with arrow heads).  
Lane M represents molecular markers. 
M       Ec Ech DH82
4.0
1.0
2.0
Kb
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Alto, CA) (Figure 3.2).  About 4 µg of RNA was reverse transcribed using superscript II 
(Invitrogen Corporation, Carlsbad, CA) in the presence of random hexamers, chip control 
spikes, and amino allyl modified dUTPs (Sigma-Aldrich, St. Louis, MO).  The amino allyl-labeled 
targets were then coupled to aliquots of ester linked Cy3 or Cy5 dyes (GE Healthcare, 
Piscataway, NJ).  The labeled targets were used to hybridize the microarray chips for 18 h at 
35°C in a M-2 microfluidic station and washed as outlined in the Xeotron specifications 
(Invitrogen, Carlsbad, CA).  Arrays were scanned to visualize the labeled wells using a GenePix 
4000B scanner (Molecular Devices Corporation, Union City, CA).  The RNA labeling, chip 
hybridization and initial output data analysis were performed at the Vanderbilt University 
Microarray Shared Resource Facility (Nashville, TN).  An outline of the microarray protocol is 
shown in Figure 3.3. 
 
Data analysis:  The data from the GenePix scanner were analyzed using the software, Gene 
Traffic (Stratagene, La Jolla, CA) and MS Excel (Microsoft, Redmond, WA).  We performed 
three independent experiments using three different batches of RNA each isolated from E. 
chaffeensis growing in either macrophage or tick cell environments.  Our chip design included 
various internal controls, the presence of several empty wells and hybridization and labeling 
controls with both mismatch and perfect match oligonucleotides.  Any fluorescence detected in 
the negative control wells is considered background fluorescence and is subtracted from the 
total fluorescence measured from all wells.  The averages of the fluorescence intensity values of 
all the probes representing an ORF were calculated separately for each hybridization.  The 
average fluorescence values were compared with the other two hybridizations performed using 
E. chaffeensis RNA derived from the same host cell background and the total average values 
from all three hybridizations were calculated for each ORF.  This analysis resulted in the 
generation of the average normalized fluorescence intensity values, from the three experiments 
using E. chaffeensis RNA derived from DH82 host cell background, for each ORF. 
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Figure 3.3  Microarray protocol.   
E. chaffeensis RNA was reverse transcribed and labeled with Cy3 or Cy5 fluorescent 
dyes.  The labeled cDNA was then hybridized to a microarray chip, followed by washing 
to remove unbound molecules and the chip is scanned in a Genepix 4000 B scanner 
and the data were analyzed.
Reverse transcription and labeling 
by using cy3 or cy5 dyes 
Scanning of the microarray 
chip
E. chaffeensis RNA
Data analysis
Hybridization of labeled cDNA
on a microarray chip
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Similar analysis was performed using the data generated from the three hybridizations 
performed using ISE6 cell-derived E. chaffeensis RNA.   
 
A threshold fluorescence value was determined, for each hybridization, based on the 
fluorescence measured in the control wells which contained mismatched and unrelated probes.  
The ORFs whose average fluorescence is more than the determined threshold fluorescence are 
identified as expressed in E. chaffeensis.  The ORFs that were found to be expressed in both 
cell backgrounds were further analyzed.  The ratio of the fluorescence intensity values for each 
ORF between macrophage and tick cell hybridizations was calculated.  The ORFs with the ratio 
values between 0.5 and 2.0 were considered as expressed at the same level.  All the ORFs with 
ratios greater than 2.0 and less than 0.5 were considered as expressed at higher or lower levels 
in the RNA obtained from E. chaffeensis grown in either macropahges or tick cells. 
 
RT-PCR analysis:  The gene expression data obtained from the microarrray experiments was 
validated by analyzing the transcriptional profiles for a subset of genes using a semi- 
quantitative RT-PCR assay.  A subset of genes representing the commonly expressed genes, 
macrophage- and tick cell- specific expressed genes and genes that are found to be 
transcriptionally inactive or too low to be detected by microarray analysis were selected.  
Forward and reverse primers were designed for the selected genes for use in the RT-PCR 
analysis.  RNA was isolated from 5 ml cultures of E. chaffeensis grown in macrophage or tick 
cells at different time points post infection (ranging from 6 h to 120 h) by using Tri-reagent 
method as per the manufacturer’s protocols.  The final RNA pellet is dissolved in 100 µl of 
nuclease free water and stored at -80°C.  About 10 µl of the RNAs were treated with 
RQ1DNase to remove any contaminating genomic DNA as per the manufacturer’s protocols.  
The amount of RNA used in the RT-PCR analysis was normalized by assessing the RNA 
concentration by real time RT-PCR targeted to 16S rRNA gene.  Equal amounts of RNA were 
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used as templates in subsequent experiments.  RT-PCR was performed by adding the forward 
and reverse primers under optimized conditions identified for each gene as described in 
Chapter 5.  A semi-quantitative RT-PCR was performed by terminating the reaction at different 
PCR cycles.  About 5 µl of PCR products are resolved on an agarose gel and the presence or 
absence of amplicons was evaluated by using ethidium bromide stained DNA gels as described 
in Chapter 5. 
Results 
ORF-based whole genome microarray chip for E. chaffeensis:  We obtained the 
unannotated complete genome sequence of E. chaffeensis from TIGR.  The genome sequence 
was carefully analyzed for the presence of open reading frames (ORFs) that contain 95 or 
longer amino acids in a row by using Artemis genome sequence analysis program (Welcome 
Trust Sanger institute, Cambridge, UK).  Our analysis identified 1,234 ORFs.  Two probes were 
designed targeting specific regions for each identified ORF.  The length of each probe is about 
45 nucleotides long.  Similarly, three probes targeting the variable regions in the ORF of each 
gene were designed for all 22 genes in the p28-Omp gene locus of E. chaffeensis.  The probes 
were in situ synthesized by randomly placing them throughout the microarray chip in triplicate.  
In addition, we incorporated probes for one or more housekeeping genes to represent dog, 
human, white tailed deer and tick host of E. chaffeensis.  Positive controls with perfectly 
matched and mismatched oligonucleotides were also synthesized in the array chips.  Several 
blank wells were left to serve as background controls. 
 
Global gene expression analysis of E. chaffeensis:  Six independent experiments were 
performed (three each) by using RNA isolated from E. chaffeensis grown in macrophages or tick 
cell environment.  RNA from E. chaffeensis grown in tick cells or macrophages was isolated 
three times independently using three different culture flasks.  To evaluate the reproducibility of 
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the data from microarray analysis, we performed self to self hybridization of the E. chaffeensis 
RNA isolated from macrophage and tick cells.  The data obtained from one experiment in Cy3 
and Cy5 channels is presented in the Figure 3.4 (panels A, B and C).  The log fluorescence 
between the two dyes used in the experiment was plotted against each which shows good 
correlation between the signals observed in Cy3 and Cy5 channels (Figure 3.4, panel D). 
 
To assess global gene expression differences in E. chaffeensis, the data from three 
independent experiments were analyzed carefully.  The averages of fluorescence intensity 
values for all the probes representing an ORF were calculated and compared between the 
hybridizations performed using RNA from E. chaffeensis grown in macrophage and tick cells.  
with the macrophage and tick cells.  The analysis using the data from three different 
experiments revealed that average fluorescence values for probes representing about 381 
ORFs were above the background fluorescence in RNA derived from macrophage grown E. 
chaffeensis.  Similar analysis revealed that average fluorescence values for probes representing 
about 341 ORFs were above the background fluorescence in RNA derived from tick cell grown 
E. chaffeensis.  We examined the expression profiles of the transcripts from the RNA 
polymerase complex in macrophage and tick cell derived E. chaffeensis RNA (Figure 3.5).  The 
expression levels for all transcripts are within two fold for E. chaffeensis grown in both cell 
backgrounds.  These results suggest that microarray data are valid since all subunits of RNA 
polymerase had very similar ratios of expression levels in both host cell backgrounds. 
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Figure 3.4  E. chaffeensis microarray.   
Whole genome microarray was prepared and evaluated using RNA isolated from macrophage 
and tick cell grown E. chaffeensis.  Panel A contains the image of a chip scanned for Cy5 
labeling and panel B contains the image of a chip scanned for Cy3 labeling.  Panel C contains 
an image representing the ratio between the Cy5 and Cy3 labeling for the same chip.  Panel D 
represents the correlation data for self to self hybridization. 
A
B
C
D
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Figure 3.5  Expression of genes of the RNA polymerase complex in E. chaffeensis 
grown in macrophage and tick cells.   
The expression genes coding the RNA polymerase complex was analyzed by using RNA 
derived from E. chaffeensis grown in macrophage and tick cells.  The ratios of the expression 
(average of three independent experiments) between macrophage and tick cell derived E. 
chaffeensis along with error bars is plotted on Y-axis. 
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Figure 3.6.  Transcriptional analysis of the E. chaffeensis genome.   
RNA was isolated from E. chaffeensis grown in tick and macrophage cell environments and 
used in the microarray gene expression analysis.  The microarray data for three independent 
experiments were evaluated to identify expression pattern in E. chaffeensis originating from 
macrophages and tick cells.  The analysis revealed a total of 381 and 341 genes were 
expressed in E. chaffeensis growing in macrophages and tick cells, respectively.  Two hundred 
and sixty three genes are commonly expressed in both cell backgrounds and about 118 and 78 
are found to be uniquely expressed in E. chaffeensis growing in macrophages and tick cells, 
respectively. 
Tick cell
(341)
Macrophage 
(381)
263118 78
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The ORFs that were found to have signals above the background fluorescence in macrophage 
and tick cell-derived E. chaffeensis RNA were compared to identify the commonly expressed 
and host-specifically expressed transcripts.  This analysis revealed that 263 ORFs have 
fluorescence above the background in both macrophage and tick cell derived E. chaffeensis 
RNA (Figure 3.6 and 3.7).  About 118 ORFs were found to have fluorescence above 
background in macrophage derived E. chaffeensis RNA.  Similarly, 78 ORFs were found to 
have fluorescence above background in tick cell derived E. chaffeensis RNA (Figure 3.7).  We 
further compared the average fluorescence intensity values for the 263 genes that were found 
to be positive in both cell backgrounds.  About 80% of the ORFs have fluorescence values 
within two fold difference between macrophage and tick cell derived E. chaffeensis RNA.  About 
8 ORFs have average fluorescence values more than two fold greater in macrophage derived E. 
chaffeensis RNA compared the tick cell derived E. chaffeensis RNA.  This analysis also 
revealed that 47 ORFs have average fluorescence values more than two fold greater in tick cell 
derived E. chaffeensis RNA compared to the macrophage derived E. chaffeensis RNA (Figure 
3.7) 
 
The major portion of ORFs that have fluorescence above background in both cell 
environments included those coding for DNA metabolism, energy metabolism, protein synthesis, 
transcription, transport and cellular processes (Table 3.1 and 3.2).  Several ORFs coding for 
hypothetical proteins are also found to have fluorescence values above background. The 
majority of the transcripts belonging to uniquely expressed groups include those coding for cell 
envelope, hypothetical and genes with unknown function.  In addition, transcripts made from 
cofactor and vitamin biosysnthesis and protein fate genes were among the uniquely expressed 
group, contributing to about 20% of the group. 
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Figure 3.7  Gene expression analysis of E. chaffeensis.   
Microarray data were evaluated to identify differences in the levels of transcripts in commonly 
expressed genes.  Transcripts from which greater than 2 fold differences were observed were 
considered as expressed at high or low in either macrophage or tick cell backgrounds.  The data 
from this analysis revealed that about 80% of the genes that are common to E. chaffeensis 
grown in both cell backgrounds are expressed at equal levels and included several coding for 
hypothetical proteins.  The genes that are expressed at high or low levels in the common list of 
genes also include some coding for hypothetical proteins.  Similarly, the host cell-specifically 
expressed genes also contained several coding for hypothetical, membrane proteins and 
proteins of unknown function. 
Equal levels
208 (80%)
Higher in Macrophages
8 (3%)
Higher in Tick cells
47 (17%)
Hypothetical proteins: 43 Hypothetical proteins: 3
Macrophage-specific   = 118  
Hypothetical             =   37
Membrane proteins =   13
Tick cell-specific           =  78  
Hypothetical = 17 
Membrane proteins  =     2 
Common to Both (263) 
Hypothetical proteins: 14
Unique genes
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Table 3.1  E. chaffeensis transcripts grouped based on functional identity. 
Functional Group 
Genome 
(total number) 
Macrophage 
(unique or higher 
levels 
Tick cell 
(unique or 
higher 
levels) 
Common 
Disrupted reading 
frame 
7 0 0 0 
Mobile and 
extrachromosomal 
4 0 0 0 
Amino acid 
biosynthesis 
24 4 2 4 
Co-factor and vitamin 
biosynthesis 
65 10 7 7 
Cellular processes 43 3 4 7 
Central intermediary 
metabolism 
3 1 0 2 
DNA metabolism 46 2 3 10 
Energy metabolism 88 7 7 40 
Phospholipid 
metabolism 
22 4 2 4 
Protein fate 75 10 10 10 
Protein synthesis 111 9 20 36 
Nucleotide 
biosynthesis 
38 4 5 4 
Regulatory functions 17 1 2 3 
Signal transduction 5 0 0 1 
Transcription 23 3 2 9 
Transport 40 3 1 10 
Cell envelope 49 13 2 16 
Hypothetical 425 40 31 43 
Unknown function 85 12 15 13 
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Table 3.2  The transcriptional analysis of E. chaffeensis.   
The genes that were found to be expressed by microarray analysis are grouped based on their 
functional identity.  The average fluorescence (along with standard error) detected in the 
microarray chips is presented in the table.  Macrophage, average fluorescence measured from 
the chips hybridized with macrophage-derived E. chaffeensis RNA; tick cells, average 
fluorescence measured from the chips hybridized with tick cell-derived E. chaffeensis RNA; 
white background, commonly expressed; yellow background, tick cell-specifically expressed; 
green background, macrophage-specifically expressed. (Table continued into pages 60-70). 
 
No. Gene ID Gene Name Macrophage Tick cell 
    Amino acid biosynthesis     
1 ECH_0058 
2,3,4,5-tetrahydropyridine-2-carboxylate N-
succinyltransferase  14585±222 26275±256 
2 ECH_0594 acetylglutamate kinase  0 4690±2418 
3 ECH_0676 arginine biosynthesis bifunctional protein ArgJ  17140±9817 23742±11405 
4 ECH_0680 argininosuccinate synthase  1676±2607 0 
5 ECH_0016 aspartate-semialdehyde dehydrogenase  10931±9397 0 
6 ECH_0443 dihydrodipicolinate reductase  6276±2541 9131±2645 
7 ECH_0089 glutamine synthetase, type I  1958±1732 0 
8 ECH_1017 N-acetyl-gamma-glutamyl-phosphate reductase  1388±13 0 
9 ECH_0311 serine hydroxymethyltransferase  10751±3209 18718±9489 
10 ECH_0144 succinyl-diaminopimelate desuccinylase  0 1722±2192 
    Biosynthesis of co-factors and vitamins     
1 ECH_0156 
2C-methyl-D-erythritol 2,4-cyclodiphosphate 
synthase  976±152 0 
2 ECH_0157 
2-C-methyl-D-erythritol 4-phosphate 
cytidylyltransferase  796±2041 0 
3 ECH_0134 3,4-dihydroxy-2-butanone 4-phosphate synthase  8425±2326 13477±9449 
4 ECH_0757 4-diphosphocytidyl-2C-methyl-D-erythritol kinase  8611±2546 10005±6722 
5 ECH_0783 6,7-dimethyl-8-ribityllumazine synthase  0 3476±85 
6 ECH_0950 8-amino-7-oxononanoate synthase  1167±427 0 
7 ECH_0666 
adenosylmethionine-8-amino-7-oxononanoate 
aminotransferase  1091±445 0 
8 ECH_0873 Coq7 family protein  6278±1141 5815±3846 
9 ECH_0629 cysteine desulfurase  2867±2701 0 
10 ECH_0381 dihydropteroate synthase  0 2305±398 
11 ECH_0702 folylpolyglutamate synthase  10400±2645 5964±2742 
12 ECH_0125 glutamate--cysteine ligase  6690±1121 9056±6577 
13 ECH_0822 glutamine-dependent NAD(+) synthetase  2035±190 0 
14 ECH_0651 GTP cyclohydrolase I  5538±6224 0 
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15 ECH_0689 
iron-sulfur cluster assembly accessory 
protein_0689 28916±10414 39554±13924 
16 ECH_0806 
nicotinate (nicotinamide) nucleotide 
adenylyltransferase  0 3973±294 
17 ECH_0701 porphobilinogen deaminase  2604±1419 0 
18 ECH_1004 protoheme IX farnesyltransferase  0 3041±321 
19 ECH_0225 putative ATP-NAD kinase  1067±501 0 
20 ECH_0455 putative geranyltranstransferase  2211±998 0 
21 ECH_0931 pyridoxamine 5'-phosphate oxidase  0 4599±3499 
22 ECH_0798 thiamin biosynthesis protein ThiC  0 4178±2626 
23 ECH_0206 thiamin biosynthesis ThiG  0 6161±2180 
24 ECH_0893 thiamine-phosphate pyrophosphorylase  12289±3797 18787±12629 
   Cell envelope, Surface structures     
1 ECH_0039 120 kDa immunodominant surface protein  0 20243±17672 
2 ECH_0645 immunogenic protein  6634±2164 19133±10687 
3 ECH_0462 OmpA family protein  0 5504±3750 
4 ECH_0482 putative lipoprotein_0482 19875±1872 18691±3571 
5 ECH_0558 putative lipoprotein_0558 19235±1376 17992±8388 
6 ECH_0625 putative lipoprotein_0625 6024±8070 7087±9837 
7 ECH_0929 putative lipoprotein_0929 18443±7934 25927±8367 
8 ECH_0188 putative surface protein  7102±1136 7000±3066 
9 ECH_0170 variable length PCR target protein  27673±10111 15239±8623 
    Cellular processes     
1 ECH_0734 antioxidant, AhpC/Tsa family_0734 0 2048±181 
2 ECH_1090 cell division protein FtsA  18113±1365 11914±3591 
3 ECH_1153 cell division protein FtsZ  7794±2390 14658±6312 
4 ECH_1156 chromosome partitioning ATPase, ParA family  10805±11191 0 
5 ECH_0648 dimethyladenosine transferase  0 7942±3953 
6 ECH_0031 hemolysin  5751±3094 0 
7 ECH_0890 putative cell division protein FtsK  6342±1402 6062±3316 
8 ECH_0337 putative cell division protein FtsQ  8193±2350 8178±5211 
9 ECH_0143 putative competence protein F  0 8013±3680 
10 ECH_0335 putative osmotically inducible protein  6137±1347 5898±3519 
11 ECH_0871 putative twitching motility protein PilT  6774±1638 8889±3696 
12 ECH_0042 type IV secretion system protein VirB10  6689±1275 16441±9341 
13 ECH_0041 type IV secretion system protein VirB11  1120±211 0 
14 ECH_0497 type IV secretion system protein, VirB6 family  13597±2986 13064±4826 
    
Central intermediary metabolism, Amino 
sugars     
1 ECH_0541 
5-formyltetrahydrofolate cyclo-ligase family 
protein  9845±2821 8827±3278 
2 ECH_1014 inorganic pyrophosphatase  7490±1641 8523±47391 
3 ECH_0018 S-adenosylmethionine synthetase  3031±1615 0 
    DNA metabolism     
1 ECH_0809 chromosomal replication initiator protein DnaA  13008±6457 6543±3616 
2 ECH_0028 crossover junction endodeoxyribonuclease RuvC  0 5880±5105 
3 ECH_0858 DNA gyrase, A subunit  6749±6457 7111±3616 
4 ECH_0620 DNA gyrase, B subunit  6405±1261 12269±6063 
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5 ECH_0080 DNA polymerase I  3095±474 0 
6 ECH_1009 DNA polymerase III, beta subunit  12272±6823 14543±9547 
7 ECH_0761 DNA primase  26580±12101 21736±11143 
8 ECH_0750 DNA topoisomerase I  0 7629±3304 
9 ECH_0857 endonuclease III  10311±195 7697±5276 
10 ECH_1109 recA protein  7267±2472 14770±9667 
11 ECH_0843 recR 6111±1355 10473±4782 
12 ECH_0451 replicative DNA helicase  6249±1261 13822±6063 
13 ECH_0082 ribulose-phosphate 3-epimerase  16641±5056 15040±10469 
14 ECH_0173 tyrosine recombinase XerD  6172±1310 16923±8077 
15 ECH_0074 uracil-DNA glycosylase, family 4  1273±444 0 
     
     
  Energy metabolism   
1 ECH_0097 fructose- biphosphate aldolase, class I  1132±176 0 
2 ECH_1031 aconitate hydratase 1  21169±12766 19023±9817 
3 ECH_0138 aminomethyl transferase family protein  2631±545 0 
4 ECH_1089 ATP synthase F0, B chain  940±711 0 
5 ECH_1088 ATP synthase F0, B' subunit  6932±1262 5746±23722 
6 ECH_0132 ATP synthase F1, alpha subunit  7578±3179 9833±1958 
7 ECH_0573 ATP synthase F1, beta subunit  10965±4382 18508±6889 
8 ECH_0131 ATP synthase F1, delta subunit  10182±3952 24845±11051 
9 ECH_0574 ATP synthase F1, epsilon subunit  6871±1617 5651±2240 
10 ECH_0652 ATP synthase F1, gamma subunit  8819±4161 17029±8420 
11 ECH_0124 citrate synthase I  9193±2971 11655±9158 
12 ECH_1068 C-type cytochrome family protein  0 3079±916 
13 ECH_1055 cytochrome c oxidase assembly protein CtaG  0 4311±1953 
14 ECH_1003 cytochrome c oxidase, subunit I  8859±1821 7703±2766 
15 ECH_1002 cytochrome c oxidase, subunit II  11471±4471 18134±8904 
16 ECH_0029 cytochrome c oxidase, subunit III  7549±2361 16452±5468 
17 ECH_0327 cytochrome C, membrane-bound  6047±1622 10906±6229 
18 ECH_0789 cytochrome c-type biogenesis protein CcmE  8479±2590 13161±10459 
19 ECH_0137 cytochrome c-type biogenesis protein CcmF  13705±5675 39329±16690 
20 ECH_0509 dihydrolipoamide dehydrogenase  6638±1222 8029±2167 
21 ECH_0992 dihydrolipoamide dehydrogenase  8804±2774 5608±4228 
22 ECH_0368 dioxygenase family protein  0 13871±5209 
23 ECH_0544 enolase  1371±498 0 
24 ECH_0038 ferredoxin A  0 5285±2893 
25 ECH_0376 fumarate hydratase, class II  9302±3088 7685±3565 
26 ECH_0175 malate dehydrogenase  6163±1091 10876±6991 
27 ECH_0641 malate dehydrogenase, NAD-dependent  9176±3202 30728±10644 
28 ECH_0786 NADH dehydrogenase I, A subunit  7373±195 6139±5276 
29 ECH_0787 NADH dehydrogenase I, B subunit  27209±8291 30484±2252 
30 ECH_0788 NADH dehydrogenase I, C subunit  6700±1786 9985±3487 
31 ECH_0548 NADH dehydrogenase I, F subunit  9130±2135 5774±2527 
32 ECH_0618 NADH dehydrogenase I, G subunit  1022±4444 16698±5546 
33 ECH_0617 NADH dehydrogenase I, H subunit  1475±669 0 
34 ECH_0552 NADH dehydrogenase I, J subunit  2474±774 13427±4787 
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35 ECH_0554 NADH dehydrogenase I, L subunit  18090±10362 14902±10414 
36 ECH_0555 NADH dehydrogenase I, M subunit  12805±8341 1138±3572 
37 ECH_0556 NADH dehydrogenase I, N subunit  8616±4025 1322±4624 
38 ECH_0474 
NADH-ubiquinone/plastoquinone oxidoreductase 
family protein_0474 7747±3077 11203±7588 
39 ECH_0667 
proline dehydrogenase/delta-1-pyrroline-5-
carboxylate dehydrogenase  2146±71 0 
40 ECH_0487 propionyl-CoA carboxylase, alpha subunit  6696±1976 6026±1207 
41 ECH_0599 propionyl-CoA carboxylase, beta subunit  18937±8071 11061±6516 
42 ECH_1079 putative cytochrome c oxidase, subunit I  13917±5405 17289±6709 
43 ECH_0442 putative flavin reductase  27094±7391 24636±13633 
44 ECH_0179 putative NADH dehydrogenase I, N subunit  26806±15317 32773±17222 
45 ECH_0385 quinone oxidoreductase  8494±2111 16318±9090 
46 ECH_0638 ribose 5-phosphate isomerase B  13091±5958 21188±9633 
47 ECH_0316 
succinate dehydrogenase and fumarate reductase 
iron-sulfur protein  0 4394±474 
48 ECH_0918 
succinate dehydrogenase, cytochrome b556 
subunit  21495±9984 49282±11686 
49 ECH_0315 succinate dehydrogenase, flavoprotein subunit  10646±3085 17691±8636 
50 ECH_0979 succinyl-CoA synthetase, beta subunit  7278±1444 5904±3174 
51 ECH_0646 triosephosphate isomerase  11413±4523 43251±11480 
52 ECH_0521 ubiquinol-cytochrome c reductase, cytochrome b  10504±4392 15120±8207 
53 ECH_0522 ubiquinol-cytochrome c reductase, cytochrome c1  1567±0555 0 
54 ECH_0520 
ubiquinol-cytochrome c reductase, iron-sulfur 
subunit  10447±3086 15872±10451 
    Fatty acid and phospholipid metabolism     
1 ECH_0072 
1-acyl-sn-glycerol-3-phosphate acyltransferase 
family protein  1254±124 0 
2 ECH_1078 
CDP-diacylglycerol--glycerol-3-phosphate 3-
phosphatidyltransferase  0 2818±864 
3 ECH_0811 enoyl-(acyl-carrier-protein) reductase  12947±5815 17174±7513 
4 ECH_0447 fatty acid/phospholipid synthesis protein PlsX  10387±2705 16352±10471 
5 ECH_0741 holo-(acyl-carrier-protein) synthase  904±183 0 
6 ECH_0227 malonyl CoA-acyl carrier protein transacylase  37771±12533 38221±13635 
7 ECH_0905 phosphatidylglycerophosphatase A  2264±66 0 
8 ECH_0780 
putative CDP-diacylglycerol--serine O-
phosphatidyltransferase  11866±2528 20735±13714 
9 ECH_0269 putative phosphatidate cytidylyltransferase  10557±4037 26537±14874 
10 ECH_0875 putative phosphatidylglycerophosphatase A  2323±530 0 
    Hypothetical     
1 ECH_1155 conserved hypothetical protein TIGR00043  4001±442 0 
2 ECH_0009 hypothetical protein ECH_0009  40583±11987 43890±10865 
3 ECH_0010 hypothetical protein ECH_0010  11740±2881 27477±17486 
4 ECH_0021 hypothetical protein ECH_0021  7127±5719 0 
5 ECH_0049 hypothetical protein ECH_0049  7056±2080 16520±10443 
6 ECH_0079 hypothetical protein ECH_0079  7408±1312 9287±4179 
7 ECH_0084 hypothetical protein ECH_0084  32835±15835 29558±17989 
8 ECH_0087 hypothetical protein ECH_0087  2106±267 0 
9 ECH_0106 hypothetical protein ECH_0106  349±1200 0 
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10 ECH_0113 hypothetical protein ECH_0113  2031±77 0 
11 ECH_0114 hypothetical protein ECH_0114  1114±1730 0 
12 ECH_0115 hypothetical protein ECH_0115  9178±7485 0 
13 ECH_0116 hypothetical protein ECH_0116  1397±443 0 
14 ECH_0119 hypothetical protein ECH_0119  7171±3417 0 
15 ECH_0120 hypothetical protein ECH_0120  5590±5643 0 
16 ECH_0122 hypothetical protein ECH_0122  0 11154±8844 
17 ECH_0147 hypothetical protein ECH_0147  607±1173 0 
18 ECH_0148 hypothetical protein ECH_0148  0 884±953 
19 ECH_0158 hypothetical protein ECH_0158  0 6836±6320 
20 ECH_0159 hypothetical protein ECH_0159  7059±1377 18569±12432 
21 ECH_0166 hypothetical protein ECH_0166  31639±12975 15097±9975 
22 ECH_0176 hypothetical protein ECH_0176  6651±1084 13798±11048 
23 ECH_0199 hypothetical protein ECH_0199  0 4183±860 
24 ECH_0230 hypothetical protein ECH_0230  23963±10542 17911±8518 
25 ECH_0237 hypothetical protein ECH_0237  7683±2227 9200±4350 
26 ECH_0240 hypothetical protein ECH_0240  7230±1856 15400±9368 
27 ECH_0243 hypothetical protein ECH_0243  12420±4984 10544±7220 
28 ECH_0246 hypothetical protein ECH_0246  29273±3192 19278±7579 
29 ECH_0247 hypothetical protein ECH_0247  1226±564 0 
30 ECH_0252 hypothetical protein ECH_0252  2541±1588 0 
31 ECH_0253 hypothetical protein ECH_0253  2952±1580 0 
32 ECH_0257 hypothetical protein ECH_0257  2121±789 0 
33 ECH_0270 hypothetical protein ECH_0270  6378±2501 10728±9233 
34 ECH_0272 hypothetical protein ECH_0272  6402±1784 18481±7960 
35 ECH_0275 hypothetical protein ECH_0275  2437±4662 0 
36 ECH_0278 hypothetical protein ECH_0278  0 5708±5490 
37 ECH_0284 hypothetical protein ECH_0284  1036±47 0 
38 ECH_0285 hypothetical protein ECH_0285  35406±8415 47265±8745 
39 ECH_0288 hypothetical protein ECH_0288  1059±230 0 
40 ECH_0289 hypothetical protein ECH_0289  27256±6273 33043±6540 
41 ECH_0292 hypothetical protein ECH_0292  11744±3050 13042±4524 
42 ECH_0329 hypothetical protein ECH_0329  486±311 0 
43 ECH_0343 hypothetical protein ECH_0343  0 19260±7614 
44 ECH_0348 hypothetical protein ECH_0348  17090±6425 12034±6990 
45 ECH_0377 hypothetical protein ECH_0377  13267±5425 18589±8799 
46 ECH_0388 hypothetical protein ECH_0388  6796±2332 15329±8944 
47 ECH_0391 hypothetical protein ECH_0391  11871±7668 6040±2879 
48 ECH_0439 hypothetical protein ECH_0439  6129±2369 5691±3393 
49 ECH_0454 hypothetical protein ECH_0454  0 2820±340 
50 ECH_0477 hypothetical protein ECH_0477  0 9085±9671 
51 ECH_0519 hypothetical protein ECH_0519  1065±46 0 
52 ECH_0523 hypothetical protein ECH_0523  13334±7206 12420±8758 
53 ECH_0526 hypothetical protein ECH_0526  6008±1383 11345±3955 
54 ECH_0531 hypothetical protein ECH_0531  0 10478±3649 
55 ECH_0549 hypothetical protein ECH_0549  0 5913±2760 
56 ECH_0570 hypothetical protein ECH_0570  896±193 0 
57 ECH_0576 hypothetical protein ECH_0576  8099±2855 5748±1693 
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58 ECH_0578 hypothetical protein ECH_0578  0 3420±246 
59 ECH_0587 hypothetical protein ECH_0587  6342±1529 7850±684 
60 ECH_0588 hypothetical protein ECH_0588  1406±780 0 
61 ECH_0593 hypothetical protein ECH_0593  25753±5943 9366±5683 
62 ECH_0601 hypothetical protein ECH_0601  25991±7596 17903±8857 
63 ECH_0609 hypothetical protein ECH_0609  1120±397 0 
64 ECH_0611 hypothetical protein ECH_0611  0 1149±510 
65 ECH_0612 hypothetical protein ECH_0612  10088±1013 6526±1317 
66 ECH_0627 hypothetical protein ECH_0627  26088±7844 22160±8935 
67 ECH_0635 hypothetical protein ECH_0635  0 9693±2366 
68 ECH_0640 hypothetical protein ECH_0640  7089±1926 6913±4453 
69 ECH_0663 hypothetical protein ECH_0663  0 4393±1318 
70 ECH_0664 hypothetical protein ECH_0664  10258±2272 6114±3408    
71 ECH_0670 hypothetical protein ECH_0670  2689±2631 0 
72 ECH_0681 hypothetical protein ECH_0681  1464±1578 0 
73 ECH_0695 hypothetical protein ECH_0695  15672±6329 54738±7002 
74 ECH_0697 hypothetical protein ECH_0697  1254±1286 0 
75 ECH_0700 hypothetical protein ECH_0700  20170±10683 0 
76 ECH_0706 hypothetical protein ECH_0706  2689±2910 0 
77 ECH_0707 hypothetical protein ECH_0707  20146±6161 13719±9514 
78 ECH_0708 hypothetical protein ECH_0708  25131±10546 18037±12619 
79 ECH_0709 hypothetical protein ECH_0709  2967±3198 0 
80 ECH_0715 hypothetical protein ECH_0715  7158±1002 8093±5437 
81 ECH_0720 hypothetical protein ECH_0720  9571±2991 14618±6965 
82 ECH_0722 hypothetical protein ECH_0722  10284±4469 23110±12660 
83 ECH_0725 hypothetical protein ECH_0725  6844±1861 7024±4290 
84 ECH_0739 hypothetical protein ECH_0739  872±174 0 
85 ECH_0744 hypothetical protein ECH_0744  7639±1394 7023±3104 
86 ECH_0753 hypothetical protein ECH_0753  0 3289±2029 
87 ECH_0778 hypothetical protein ECH_0778  6426±674 5817±802 
88 ECH_0825 hypothetical protein ECH_0825  6287±1379 6578±3540 
89 ECH_0836 hypothetical protein ECH_0835  1519±458 0 
90 ECH_0838 hypothetical protein ECH_0838  7304±1713 21640±8392 
91 ECH_0854 hypothetical protein ECH_0854  20187±11633 21651±12771 
92 ECH_0865 hypothetical protein ECH_0865  18895±7729 24018±3082 
93 ECH_0878 hypothetical protein ECH_0878  20321±13794 62034±2745 
94 ECH_0888 hypothetical protein ECH_0888  11266±3500 15265±5015 
95 ECH_0910 hypothetical protein ECH_0910  958±90 0 
96 ECH_0916 hypothetical protein ECH_0916  6431±1521 13466±8962 
97 ECH_0943 hypothetical protein ECH_0943  6096±1778 29838±3493 
98 ECH_0947 hypothetical protein ECH_0947  1807±321 0 
99 ECH_1023 hypothetical protein ECH_1023  0 3592±4832 
100 ECH_1036 hypothetical protein ECH_1036  36759±11902 42291±18552 
101 ECH_1037 hypothetical protein ECH_1037  1992±447 0 
102 ECH_1042 hypothetical protein ECH_1042  18621±8263 15202±9949 
103 ECH_1043 hypothetical protein ECH_1043  13569±4546 17071±9467 
104 ECH_1044 hypothetical protein ECH_1044  16056±6897 12384±6417 
105 ECH_1047 hypothetical protein ECH_1047  7307±1725 22524±12578 
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106 ECH_1059 hypothetical protein ECH_1059  35733±6155 11690±7864 
107 ECH_1104 hypothetical protein ECH_1104  26672±7330 14927±2857 
108 ECH_1105 hypothetical protein ECH_1105  2994±1977 0 
109 ECH_1122 hypothetical protein ECH_1122  14385±8526 7239±4306 
110 ECH_1128 hypothetical protein ECH_1128  3259±1451 0 
111 ECH_1147 hypothetical protein ECH_1147  2008±124 0 
112 ECH_1148 hypothetical protein ECH_1148  0 23080±7366 
113 ECH_1152 hypothetical protein ECH_1152  8004±1732 9183±4028 
114 ECH_1154 hypothetical protein ECH_1154  23060±6972 30716±3219 
    Protein fate     
1 ECH_0178 apolipoprotein N-acyltransferase  1972±1744 0 
2 ECH_0367 
ATP-dependent Clp protease, ATP-binding 
subunit ClpB  0 5760±4376 
3 ECH_0900 
ATP-dependent Clp protease, ATP-binding 
subunit ClpX  6935±2012 9672±6565 
4 ECH_0901 
ATP-dependent Clp protease, proteolytic subunit 
ClpP  0 2764±1769 
5 ECH_0899 ATP-dependent protease La  0 6330±4465 
6 ECH_0471 chaperone protein DnaK  10406±3035 20485±8463 
7 ECH_0853 chaperone protein HtpG  8188±2893 13495±7381 
8 ECH_0364 chaperonin, 10 kDa  9390±4362 26007±15986 
9 ECH_0365 chaperonin, 60 kd  9422±4248 30179±16991 
10 ECH_0369 cytosol aminopeptidase  0 4660±2880 
11 ECH_0997 heat shock protein HslVU, ATPase subunit HslU  623±602 0 
12 ECH_1050 hflK protein  6625±2122 10222±2928 
13 ECH_1064 methionine aminopeptidase, type I  2427±1007 0 
14 ECH_1057 peptidase, M16 family_1057 0 2144±406 
15 ECH_0073 peptide deformylase  0 10925±7688 
16 ECH_0428 preprotein translocase, SecY subunit  9663±3751 15073±5955 
17 ECH_1008 preprotein translocase, YajC subunit  7756±2245 13695±8125 
18 ECH_1101 prolipoprotein diacylglyceryl transferase  15659±4605 8962±6984 
19 ECH_1106 protein-export membrane protein SecD  6833±2444 7784±3611 
20 ECH_0095 protein-export membrane protein SecF  1353±152 0 
21 ECH_0233 protein-export protein SecB  7573±2368 11882±6887 
22 ECH_0295 putative heme exporter protein CcmA  0 2489±609 
23 ECH_0065 putative heme exporter protein CcmB  3147±1594 0 
24 ECH_0939 putative polypeptide deformylase  0 6887±2033 
25 ECH_0731 rotamase family protein  3260±2873 0 
26 ECH_0690 signal peptidase I  9623±2156 12559±6323 
27 ECH_1060 signal peptidase II 1863±831 0 
28 ECH_0401 signal peptide peptidase SppA  1119±66 0 
29 ECH_1111 signal recognition particle-docking protein FtsY  923±14 0 
30 ECH_0970 
type I secretion membrane fusion protein, HlyD 
family  938±525 0 
    Protein synthesis     
1 ECH_0484 50S ribosomal protein L28  19097±8276 17734±11315 
2 ECH_0981 alanyl-tRNA synthetase  15335±7512 5570±3514 
3 ECH_0876 ankyrin repeat protein_0876 33212±2532 16034±9888 
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4 ECH_0768 cysteinyl-tRNA synthetase  0 3366±811 
5 ECH_1025 glutamyl-tRNA(Gln) amidotransferase subunit C  1340±854 0 
6 ECH_0813 glutamyl-tRNA(Gln) amidotransferase, B subunit  19842±8461 12162±9513 
7 ECH_0023 glycyl-tRNA synthetase, alpha subunit  10942±2505 11879±5164 
8 ECH_0897 methionyl-tRNA formyltransferase  0 7647±5427 
9 ECH_0705 
peptide chain release factor 2, programmed 
frameshift  8438±2221 5660±2051 
10 ECH_0434 phenylalanyl-tRNA synthetase, beta subunit  11820±3341 15898±8551 
11 ECH_0309 putative ribosomal protein S18  9409±2702 9160±4692 
12 ECH_0142 
ribosomal 5S rRNA E-loop binding protein 
Ctc/L25/TL5  6428±1531 18118±4764 
13 ECH_0955 ribosomal protein L1  15507±7473 20744±10069 
14 ECH_0954 ribosomal protein L10  9513±1589 23207±5177 
15 ECH_0956 ribosomal protein L11  12232±5326 13557±7448 
16 ECH_1019 ribosomal protein L13  24258±10783 48180±8737 
17 ECH_0419 ribosomal protein L14  11294±5797 32810±17650 
18 ECH_0427 ribosomal protein L15  0 4200±3213 
19 ECH_0416 ribosomal protein L16  19829±9657 32357±14963 
20 ECH_0433 ribosomal protein L17  0 3309±388 
21 ECH_0425 ribosomal protein L18  15384±3245 28710±4561 
22 ECH_0412 ribosomal protein L2  15438±5958 38819±9633 
23 ECH_0197 ribosomal protein L20  0 4167±1430 
24 ECH_0545 ribosomal protein L21  0 6816±6166 
25 ECH_0414 ribosomal protein L22  17444±3568 29391±5246 
26 ECH_0411 ribosomal protein L23  16136±9969 23295±11881 
27 ECH_0420 ribosomal protein L24  9229±4645 32032±14932 
28 ECH_0409 ribosomal protein L3  12490±5013 31580±10182 
29 ECH_0226 ribosomal protein L31  1037±603 0 
30 ECH_0410 ribosomal protein L4  6187±2164 12076±5513 
31 ECH_0421 ribosomal protein L5  20320±9871 38531±12592 
32 ECH_0424 ribosomal protein L6  7705±2821 22597±13242 
33 ECH_0953 ribosomal protein L7/L12  9505±4176 14829±11237 
34 ECH_0408 ribosomal protein S10  6630±1607 11505±5726 
35 ECH_0431 ribosomal protein S11  10486±2694 10915±3472 
36 ECH_0963 ribosomal protein S12  9178±2042 12828±5562 
37 ECH_0430 ribosomal protein S13  15470±5095 20410±11539 
38 ECH_0422 ribosomal protein S14p  7126±2433 13505±7791 
39 ECH_0727 ribosomal protein S15  14839±7032 29271±10993 
40 ECH_0192 ribosomal protein S16  17304±6993 30720±11758 
41 ECH_0418 ribosomal protein S17  688±224 0 
42 ECH_0071 ribosomal protein S20  10540±1402 16500±3868 
43 ECH_0978 ribosomal protein S21  16993±7116 27793±13025 
44 ECH_0415 ribosomal protein S3  0 4475±3555 
45 ECH_0912 ribosomal protein S4  6910±2779 13483±7518 
46 ECH_0426 ribosomal protein S5  14525±8711 34310±12854 
47 ECH_0308 ribosomal protein S6  14497±6138 31409±13525 
48 ECH_0962 ribosomal protein S7  13823±6621 33109±14454 
49 ECH_0423 ribosomal protein S8  21262±8817 19555±9263 
50 ECH_0267 ribosome recycling factor  0 3591±127 
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51 ECH_222 rRNA-23S ribosomal RNA 28995±5452 7405±3567 
52 ECH_0135 SsrA-binding protein  12820±5268 23030±7573 
53 ECH_0961 translation elongation factor G  18364±10271 23102±13480 
54 ECH_0777 translation elongation factor P  20773±7396 17389±7019 
55 ECH_0515 translation elongation factor Ts  10283±2973 12930±7618 
56 ECH_0960 translation elongation factor Tu-1 14381±5266 26824±11598 
57 ECH_0407 translation elongation factor Tu-2 15483±3404 29885±11883 
58 ECH_0563 translation initiation factor IF-2  6933±2130 10815±4977 
59 ECH_0007 translation initiation factor IF-3  6101±1539 7432±3924 
60 ECH_0872 
tRNA (5-methylaminomethyl-2-thiouridylate)-
methyltransferase  0 8742±5397 
61 ECH_0003 tRNA (guanine-N1)-methyltransferase 10284±3809 21381±6433 
62 ECH_0060 tRNA modification GTPase TrmE  2260±1758 0 
63 ECH_0622 tRNA pseudouridine synthase A  15330±5331 17561±5119 
64 ECH_0091 tyrosyl-tRNA synthetase  5597±2580 0 
65 ECH_0136 valyl-tRNA synthetase  1893±78 0 
    
Purines, pyrimidines, nucleosides, and 
nucleotides     
1 ECH_0429 adenylate kinase  8029±3071 8113±5209 
2 ECH_0461 adenylosuccinate synthetase  12942±3995 6778±1157 
3 ECH_0378 carbamoyl-phosphate synthase, large subunit  999±400 0 
4 ECH_0171 CTP synthase  0 4146±473 
5 ECH_0940 dihydroorotate dehydrogenase  6685±1815 7785±5075 
6 ECH_0123 GMP synthase  1239±1334 0 
7 ECH_0224 inosine-5'-monophosphate dehydrogenase  1360±895 0 
8 ECH_1117 nucleoside diphosphate kinase  12291±4526 35611±7546 
9 ECH_1108 orotate phosphoribosyltransferase  0 3589±310 
10 ECH_0792 orotidine 5'-phosphate decarboxylase  0 3596±1290 
11 ECH_0160 
phosphoribosylaminoimidazole carboxylase, 
catalytic subunit  1388±559 0 
12 ECH_0766 
ribonucleoside-diphosphate reductase, beta 
subunit  0 3564±1017 
13 ECH_0266 uridylate kinase  7344±1614 11205±7634 
    Regulatory functions     
1 ECH_1012 DNA-binding response regulator  14676±5456 14502±6524 
2 ECH_0162 integration host factor, alpha subunit  0 3018±314 
3 ECH_1118 putative transcriptional regulator  6379±2911 6327±1372 
4 ECH_0885 sensor histidine kinase  1975±282 0 
5 ECH_0152 tldD protein  11680±4221 7494±5307 
6 ECH_0163 transcriptional regulator, MerR family  0 5585±4178 
    Signal transduction     
1 ECH_0339 putative nitrogen regulation protein NtrX  6052±1079 6981±4508 
    Transcription     
1 ECH_0002 16S rRNA processing protein RimM  14502±9045 6231±341 
2 ECH_0432 DNA-directed RNA polymerase, alpha subunit  8952±2297 12644±4321 
3 ECH_0952 DNA-directed RNA polymerase, beta subunit  15522±2024 8043±6063 
4 ECH_0951 DNA-directed RNA polymerase, beta' subunit  7572±869 9733±10139 
5 ECH_0796 DNA-directed RNA polymerase, omega subunit  10626±3201 33946±5290 
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6 ECH_0562 N utilization substance protein A  13500±2875 14080±7363 
7 ECH_1116 
polyA polymerase/tRNA nucleotidyltransferase 
family protein  6640±1917 6645±5069 
8 ECH_0726 polyribonucleotide nucleotidyltransferase  16520±6182 20490±10075 
9 ECH_0263 ribonuclease HI  10647±3313 22073±9193 
10 ECH_0564 ribosome-binding factor A  0 4680±2093 
11 ECH_0760 RNA polymerase sigma factor RpoD  8536±1243 10249±1382 
12 ECH_0957 transcription antitermination protein NusG  6636±2452 9616±5072 
13 ECH_0133 transcription elongation factor GreA  25325±12916 9729±5252 
14 ECH_0200 transcription termination factor Rho  11521±301 12451±9987 
    Transport and binding proteins     
1 ECH_0085 ABC transporter, ATP-binding protein_0085 16937±9826 17852±12839 
2 ECH_0845 ABC transporter, ATP-binding protein_0845 6401±1690 5951±2966 
3 ECH_0972 ABC transporter, permease protein  17687±9424 17565±9325 
4 ECH_0313 ABC transporter, permease/ATP-binding protein  0 4223±5608 
5 ECH_0067 
cation diffusion facilitator transporter family 
protein  29322±5605 35117±12550 
6 ECH_0510 efflux transporter, RND family, MFP subunit  3182±3037 0 
7 ECH_0193 major facilitator family transporter_0193 13598±1390 17413±1593 
8 ECH_0816 major facilitator family transporter_0816 8332±1375 6396±4316 
9 ECH_0818 major facilitator family transporter_0818 6160±2451 5605±1954 
10 ECH_0466 
monovalent cation/proton antiporter, MrpF/PhaF 
subunit family  7724±2150 9531±5292 
11 ECH_0469 Na(+)/H(+) antiporter subunit C  2122±212 0 
12 ECH_0189 putative iron-binding protein  6523±1375 10904±4676 
13 ECH_0438 sodium:alanine symporter family protein_0438 2811±3802 0 
14 ECH_0383 type I secretion system ATPase  12416±3440 17916±10981 
    Unknown function     
1 ECH_1011 3'-5' exonuclease family protein  26552±13641 30331±17334 
2 ECH_0653 ankyrin repeat protein_0653 28725±15864 41517±6870 
3 ECH_0684 ankyrin repeat protein_0684 7719±15890 13230±13193 
4 ECH_1033 apaG protein  0 3667±668 
5 ECH_1084 AraM protein  0 7121±5372 
6 ECH_0473 aromatic-rich protein family  10289±4111 5839±3782 
7 ECH_0392 ATPase, AFG1 family  2183±3179 0 
8 ECH_0307 CvpA family protein  6799±1369 19710±10078 
9 ECH_0312 cyaY protein  9925±4254 20683±8847 
10 ECH_1114 dehydrogenase, isocitrate/isopropylmalate family  0 3586±88 
11 ECH_0374 
DNA / pantothenate metabolism flavoprotein 
family protein  1438±533 0 
12 ECH_0201 dnaJ domain protein  252±72 0 
13 ECH_0012 Es1 family protein  0 6577±10291 
14 ECH_0724 GTP-binding protein LepA  7192±4831 0 
15 ECH_0693 GTP-binding protein TypA  0 2844±692 
16 ECH_0332 
HAD-superfamily hydrolase, subfamily IA, variant 
1  8864±4638 11690±3858 
17 ECH_1066 hexapeptide transferase family protein  12811±6131 23108±13039 
18 ECH_0793 hydrolase, TatD family  0 8760±3980 
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19 ECH_0355 M23/M37 peptidase domain protein  0 3068±719 
20 ECH_0985 metallo-beta-lactamase family protein  0 2211±546 
21 ECH_0184 NADH:ubiquinone oxidoreductase family protein  1108±3349 0 
22 ECH_0202 NifU domain protein  7078±2290 9107±5800 
23 ECH_0366 
oxidoreductase, short-chain 
dehydrogenase/reductase family_0366 0 13095±6401 
24 ECH_1083 pentapeptide repeat protein  2822±965 0 
25 ECH_0008 P-loop hydrolase family protein  20242±6760 41903±8397 
26 ECH_0061 putative flavoprotein  2505±4794 0 
27 ECH_0644 
putative metalloendopeptidase, glycoprotease 
family  19672±8239 17295±11414 
28 ECH_0211 putative methyltransferase  10908±4457 9812±7036 
29 ECH_0063 
putative NADH-ubiquinone oxidoreductase, 
homolog  6610±1617 7610±5224 
30 ECH_0896 rhodanese domain protein  0 1160±3375 
31 ECH_0577 RmuC family protein  148±799 0 
32 ECH_0628 rrf2/aminotransferase, class V family protein  0 497±1384 
33 ECH_0390  SPFH domain /band 7 family protein  714±352 0 
34 ECH_0802 Sua5/YciO/YrdC/YwlC family protein  2176±3051 0 
35 ECH_0210 surA domain protein  0 3157±358 
36 ECH_1081 SURF1 family protein  13118±5810 15728±8851 
37 ECH_0746 
topoisomerase DNA-binding C4 zinc finger 
domain protein  1749±1563 0 
38 ECH_1069  TPR repeat protein  4500±1973 0 
39 ECH_0891 YGGT family protein  11157±4128 8623±2477 
40 ECH_0751 YjeF family protein  7360±1398 7678±4485 
 
 
Analysis of the p28 outer membrane protein genes (p28-Omp) expression in different 
host backgrounds under in vitro conditions:  The p28-Omp is a multigene locus that codes 
for 22 tandemly arranged outer membrane protein genes.  The expression of these 22 genes 
was assessed by analyzing the microarray data independent from the rest of the analysis.  This 
group of genes contained different sets of probes that were designed targeting to three variable 
regions in each ORF.  The threshold fluorescence values for these genes were carefully 
selected to examine the expression (Figure 3.8).  Nine genes of the p28-Omp locus were found 
to have fluorescence values above background in tick cell-derived E. chaffeensis with the 
highest signals from the probes representing gene 14.  In macrophage cell-derived E. 
chaffeensis, the fluorescence values for all the probes representing the 22 p28-Omp genes 
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were above the background with highest fluorescence values from the probes of gene 19 
(Figure 3.8).  A cartoon depicting the E. chaffeensis p28-Omp locus and the microarray data for 
one set of variable region 1 probes from a chip hybridized with the labeled cDNA of macrophage 
and tick cell-derived E. chaffeensis RNA is represented in the Figure 3.9. 
 
Figure 3.8  Transcription from the p28-Omp locus of E. chaffeensis grown in 
macrophage (A) and tick cells (B).   
The average fluorescence measured (from three independent experiments) in all the spots is 
plotted on the Y-axis and the corresponding gene is represented on the X-axis.  (Error bars 
represent the standard deviation) 
 69 
Figure 3.9  Transcription from p28-Omp locus of E. chaffeensis grown in macrophage 
and tick cells. 
A, a cartoon depicting the E. chaffeensis p28-Omp locus; B, microarray wells for one set of 
variable region 1 probes from a chip hybridized with  the macrophage-derived E. chaffeensis 
RNA; C, similar to B except that RNA was derived from tick cell grown E. chaffeensis 
 
 
 
RT-PCR analysis to confirm the expression results from the microarray experiments:  To 
validate the gene expression data obtained from the microarrray experiments, a semi-
quantitative RT-PCR was performed for a subset of genes representing the commonly 
expressed, macrophage and tick cell-specifically expressed and non-expressed groups (Table 
3.3).  The RT-PCR data is shown in Figure 3.10.  The genes from the commonly expressed lists 
were positive and equal levels of RT-PCR products were detected from reactions that contained 
RNAs derived from E. chaffeensis grown in both macrophage and tick cell environments as 
templates.  The genes that contained higher fluorescence intensity values in E. chaffeensis 
RNA derived macrophages showed more RT-PCR products when RNA of macrophage grown 
E. chaffeensis was used as template.  Similarly, the genes having higher fluorescence values 
when tick cell derived E. chaffeensis RNA was used also showed more RT-PCR products when 
tick cell derived RNA is used as a template.  The ORFs having fluorescence intensity values 
1 2 3 4 5 6 7 8 9 10 11 12 13 15 16 17 19 20 2114 181’
A well with a perfect 
match probe (+ve control)Blank well
A well with a miss match
probe (-ve control)
A)
B)
C)
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below the background tested negative by RT-PCR when both macrophage and tick cell derived 
E. chaffeensis RNA is used as a template. 
 
Figure 3.10  Semi-quantitative RT-PCR for validating the microarray data.  
The gene expression data obtained from the microarray experiments were confirmed by 
analyzing the transcriptional profiles for a subset of genes using semi-quantitative RT-PCR 
approach.  A subset of genes representing the commonly expressed, macrophage- and tick-
specific and non-expressed groups were selected. RNA isolated from E. chaffeensis grown in 
DH82 and tick cell lines at different time points post infection was used for this analysis.  A 
semi-quantitative RT-PCR was performed where the amplification was terminated at different 
PCR cycles and equal volumes of the PCR products are resolved on an agarose gel and 
stained by ethidium bromide.  The analysis was also performed on RNA isolated at different 
time points after infection in vertebrate and tick cell cultures.  h, hours post infection; M, 
macrophage-derived E. chaffeensis RNA; T, tick cell-derived E. chaffeensis RNA; +, reaction 
positive control; -, reaction negative control. 
COMMONLY EXPRESSED
EXPRESSED HIGH IN TICK CELLS
120 kDa immunodominant surface protein 
Iron-sulfur cluster assembly accessory protein
Ribosomal protein S8 
NON EXPRESSED
Hypothetical protein ECH_0661
Hypothetical protein ECH_0276
6 h          24 h       120 h
EXPRESSED HIGH IN MACROPHAGES
+    - M   T      M    T     M    T  
Aspartate-semialdehyde dehydrogenase
6 h          24 h       120 h
Hypothetical protein ECH_0126
+    - M   T      M    T     M    T  
Hypothetical protein ECH_0700
Hypothetical protein ECH_0021
Hypothetical protein ECH_1148 
Hypothetical protein ECH_0343
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Table 3.3  Table showing the genes that were selected for RT-PCR analysis and the 
sequences of primers used in the assay.   
A subset of genes representing the commonly expressed genes, macrophage- and tick- specific 
genes and non-expressed groups were selected for further analysis.  The forward and reverse 
primers were designed targeting these selected genes for use in the RT-PCR analysis. 
Gene name Forward primer Reverse primer Expressed in 
Aspartate-semialdehyde dehydrogenase 
(ECH_0016)  
GATACAAATACTGGAACCCTAAC TCAATCCAGAAGACATAGC Macrophage 
Hypothetical protein (ECH_0700) TGTTTGCCTACTACACTTTC GTAAGAAAAAAGTGATAGTAC Macrophage 
Hypothetical protein (ECH_0021) GGAATTAGATTTGCTTTTG AATACAGAATAAGTTAGCGAATC Macrophage 
iron-sulfur cluster assembly accessory protein 
(ECH_0689) 
GTACAAATACTTTACCTAACTTCC CGAATTGTGCATGAGTTTCTAAG common 
Ribosomal protein S8 (ECH_0423) TATGAATAAGGTAATAGTAG CATAATTCCTTTAGATGTA common 
Hypothetical protein (ECH_0276)  CTAGAAAGTTCTATGCTGTG CATTGTCTGTATATCCTGCTTC not expressed 
Hypothetical protein (ECH_0661) ATTTATCCAGTTGTTCAGAAAG GGATAAGAACACCGTAATAAC not expressed 
Hypothetical protein (ECH_0126) GGTAGAATCAGGAGATAACT GTACAATATAATGCTACAAC not expressed 
120 kDa immunodominant surface protein  
(ECH_0039) 
CGTTATAAAGGAGGAAGATAAAG CCATACATATACATTTCATAC tick 
Hypothetical protein (ECH_1148)  CACATATCTCAAAGTGACG CTACCTTCTTCAGCAGGAG tick 
Hypothetical protein (ECH_0343) AGGATCTGTAGGAGCAATAG GCTTCAATAACTTAAAC Tick 
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Discussion 
 In this study we have evaluated the possibility of designing an open reading frame based 
whole genome microarray chip for E. chaffeensis.  At the time we initiated this study, the 
annotated genome sequence was not published and so we opted to identify the ORFs in the 
whole genome sequence of E. chaffeensis.  The unannotated complete genome sequence of E. 
chaffeensis available at the TIGR website was downloaded and analyzed by using Artemis 
genome sequence analysis program.  Our analysis revealed 1,234 ORFs which is slightly higher 
than the reported ORFs in the annotated sequence of E. chaffeensis (56).  We do not anticipate 
this as a problem as we may have identified more ORFs than the actual reported ORFs.  Upon 
careful evaluation we realized that some ORFs that were identified by the annotated genome 
were not identified by our Artemis sequence analysis.  A total of 848 ORFs of the annotated E. 
chaffeensis genome were included in our analysis.  Our initial analysis of examining the data of 
the self to self hybridization of the RNA from all six chips (three each from a specific host cell 
derived E. chaffeensis RNA) between Cy3 and Cy5 channels gave a good correlation 
suggesting the validity of the data for further analysis. 
 
 To further insure that the data is interpretable, we selected the RNA polymerase 
complex for further evaluation.  We reasoned that the expression from all the subunits of RNA 
polymerase complex should be present as they are needed for the formation of the RNA 
polymerase complex.  Moreover, as RNA polymerase is needed to initiate the expression of 
genes, it is anticipated that the expression from the subunits remain similar in both host cell 
backgrounds.  Our analysis indeed showed that the expression levels of RNA polymerase 
subunits remained similar in E. chaffeensis grown in both macrophages and tick cell 
environments.  These observations further authenticate the microarray data.  These analyses 
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suggest that the microarray data represent a true reflection of the expression levels in E. 
chaffeensis. 
 The evaluation of fluorescence intensity signals from E. chaffeensis RNA identified about 
381 ORFs having signals above the background in E. chaffeensis grown in macrophages and 
341 ORFs having signals above the background in E. chaffeensis grown in tick cell 
environments.  Assuming that higher fluorescence signals represent expression, these numbers 
represent the expressed transcripts from E. chaffeensis in these host cell backgrounds.  The 
average number of expressed genes in E.chaffeensis in both macrophage and tick host cell 
backgrounds remained very similar.  In fact, these numbers are very similar to our estimated 
number of expressed genes based on the identified protein spots on the 2D resolved gels (114).  
Based on evaluation of the expression levels, the expressed genes from the microarray data are 
grouped into three main categories; the commonly expressed, macrophage- specifically and tick 
cell-specifically expressed groups.  The commonly expressed group may represent the genes 
that are required for the survival of E. chaffeensis.  Further evaluation of these commonly 
expressed genes also revealed three subgroups within them; the subgroup where the 
expression levels remained at the same level, subgroups of the genes that contained higher 
signals in either macrophage or tick cell derived E. chaffeensis RNA.  The groups that are 
uniquely expressed and subgroups having high or low levels of transcription in a host cell 
specific manner may represent important sets of proteins needed for the pathogen for its 
adaptation to macrophage and tick environments. 
 
 A major portion of commonly expressed transcripts belongs to categories such as DNA 
metabolism, energy metabolism, protein synthesis, transcription, transport and cellular 
processes.  These categories of transcripts represent those involved in metabolic pathways 
needed for normal physiological homeostasis of an organism.  The majority of the transcripts 
belonging to the uniquely expressed groups include genes coding for cell envelope, hypothetical 
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and proteins of unknown function.  In addition, transcripts made from cofactor and vitamin 
biosynthesis and protein fate genes were among the uniquely expressed group contributing to 
about 20% of the group.  It is not surprising to see uniquely expressed transcripts belonging to 
the above mentioned categories.  For example, the cell envelope is the contact for the pathogen 
to its host environment.  If it were to change its gene expression in support of its survival in 
different host background, it is likely that the proteins on the cell surface would be altered.  
Although, it is not clear what the function the hypothetical proteins and genes coding for proteins 
of unknown function may have, they may represent Ehrlichia specific proteins that may be 
involved in the pathogen’s adaptation to different host environments.  Possibly, it may be using 
its unique proteins in support of protein catabolism such as those encoded by protein fate 
genes.  E. chaffeensis growth in tick cells require a more complex media which includes several 
minerals, co-factors and vitamins as bacteria may depend differently for its requirement in 
different host cells (80).  Our microarray data, in fact suggest differential expression in genes 
encoding for various proteins involved in co-factor and vitamin biosynthesis. 
 
 We were stringent in setting the threshold levels to call a gene expressed.  Thus, the 
genes for which the positive fluorescence signals were identified may represent true expression 
in E. chaffeensis.  There may be genes that are expressed at low levels that might have been 
considered as non-expression because of our high stringency.  For example, if we drop the 
threshold values by 1000 units, we saw about 200 more genes expressed from E. chaffeensis.  
This group of genes may represent truly non-expressed genes or genes that are expressed at 
very low levels.  Careful examination of these genes is needed to further validate their 
expression status.   
 
 We have validated the microarray data on a subset of genes using semi-quantitative RT-
PCR assay.  It is important to validate the data from microarray by another independent method.  
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In support of this, we performed semi-quantitative RT-PCR analysis for randomly chosen genes 
representing the non-expressed, commonly and host cell-specifically expressed groups.  The 
analysis was also performed using RNA isolated from cultures collected at different time points 
post infection (6 h to 120 h).  Our RT-PCR analysis showed similar expression patterns as 
identified by microarray analysis for the genes studied.  The genes that were identified as non-
expressed were tested negative by RT-PCR.  Similarly, the genes that were identified as 
commonly expressed had similar levels of expression as judged by RT-PCR.  Likewise, RT-
PCR analysis also supported the differential expression observed in microarray. 
The availability of whole genome sequence data is a significant advancement in the field 
of E. chaffeensis.  However, the data can not be used without knowing the significance and 
expression of the genes identified in E. chaffeensis.  This is the first study that took advantage 
of the whole genome sequence in assessing the expression of genes in E. chaffeensis.  This 
study also represents the first set of experiments that validated the expression from many 
hypothetical protein genes of E. chaffeensis.  We have identified 114 genes coding for 
hypothetical proteins to be expressed in E. chaffeensis.  Until now, the studies have only 
characterized a few genes (21,85,99,100,144,148).  The previously reported data is very limited 
considering the importance of E. chaffeensis for human health.  This current study represents 
the first and most comprehensive analysis of transcription from E. chaffeensis genome.  The 
comprehensive transcriptional analysis also represents the first report describing the global host 
cell-specific gene expression patterns in E. chaffeensis.  The data will be very valuable to 
enhance our understanding of E. chaffeensis pathogenesis and ultimately will help in devising 
better control strategies. 
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CHAPTER 4 - Evaluation of Methods for Establishing 
Mutations in E. chaffeensis 
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Abstract 
Differential gene expression may be an important adaptation mechanism used by E. 
chaffeensis in support of its continued survival in dual hosts.  One of the ways this hypothesis 
can be tested is by performing mutational analysis that aid in altering the expression from the 
differentially expressed genes and to assess their impact on the pathogen’s growth in vertebrate 
and tick cells.  However, the methods for introducing mutations in this pathogen have not yet 
been documented.  In this study, we established many basic protocols and tools needed for 
performing mutational analysis in E. chaffeensis.  These include the identification of appropriate 
antibiotic selection markers, choice of genes to create mutations and the selection of 
constitutively active Ehrlichia promoters useful in preparing the transformation constructs and 
conditions for transformation.  Our analysis aided in the identification of four antibiotics; 
gentamicin, chloramphenicol, spectinomycin and rifampin that are inhibitory to E. chaffeensis 
growth.  Resistance genes against these four antibiotics are available to serve as suitable 
markers for monitoring mutations in E. chaffeensis.  The promoters of two constitutively 
expressing E. chaffeensis genes; 30S ribosomal S12 protein (rpsL) and putative transcriptional 
regulator (tr) were also identified to aid in driving the expression of antibiotic selection markers.  
We selected the p28-Omp 15 gene because protein expression from this gene is low in both in 
tick cell and macrophage environments.   Similarly, a hypothetical protein gene, Ech_0126, was 
selected for creating mutations as our RNA analysis revealed no evidence for its expression in 
either tick cell or macrophage environments.  We selected these genes as initial targets for 
mutational analysis; we reasoned that mutations within these genes do not impact E. 
chaffeensis growth.  Several plasmid constructs were made that contained antibiotic selection 
markers and p28-Omp 15 or Ech_0126 gene segments for use in homologous recombination 
experiments.  The optimal conditions for introducing these plasmids into host cell-free viable E. 
chaffeensis organisms were also established.  The molecular evaluation of several 
transformants of E. chaffeensis suggested that the plasmids gained entry, but failed to get 
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integrated into the genome or remain in the bacteria for longer periods of time.  These results 
suggest that the pathogen may not support the replication of plasmids or integration of foreign 
DNA in its genome.  This hypothesis may be justified because; 1) E. chaffeensis and other 
closely related species do not harbor plasmids, and 2) although E. chaffeensis genome contains 
many genes that encode for recombinase like proteins, few appeared to be expressed.  
Alternatively, additional strategies or modifications to our current protocols may be needed to 
continue our efforts to introduce mutations in E. chaffeensis. 
 
Introduction 
E. chaffeensis is the causative agent of HME and it results in persistent infections in both 
vertebrate and tick hosts (6,22,25,26,34,42,87,123,131,151,155).  It is not clear how this 
pathogen is able to adapt to dual hosts and continue to survive for long periods of time.  One of 
the probable mechanisms is by inducing changes in the gene expression in a host cell-specific 
manner (43).  Recent studies from our laboratory suggest that the pathogen indeed expresses 
many proteins in a host cell-specific manner (114,115).  This is further confirmed by global gene 
expression analysis performed as a part of my Ph.D. dissertation research (discussed in 
Chapter 3).  Whole genome microarray analysis identified host cell-specific gene expression 
from numerous genes of E. chaffeensis.  Recent studies from our laboratory also suggest that 
E. chaffeensis originating from tick cells is able to survive longer in a vertebrate host compared 
to the pathogen originating from macrophages (43).  Together, these data suggest that variation 
of gene expression in E. chaffeensis grown in tick cells may aid the pathogen in conferring 
resistance to host clearance.  However, this hypothesis remains to be supported by providing 
experimental evidence. 
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This role of differential gene expression can be best understood if one is able to control 
or alter host cell-specific differential expression and then assess its impact on the pathogen’s 
clearance by a vertebrate host.  The availability of a genetic manipulation system to create 
targeted mutations in a gene of E. chaffeensis will be valuable to understand the importance of 
differential expression for the pathogen’s dual host adaptation and pathogenicity.  Alternatively, 
the protein expression may also be inhibited by blocking the translation from an mRNA or by 
inactivating the protein function using drugs that specifically target to a protein of interest.  
Knockout or knockdown of an mRNA is somewhat challenging for a bacterial pathogen, as the 
RNAi pathway described for eukaryotes is not reported for prokaryotes (120,129).  Alternatively, 
a transcript may be blocked from being translated using an anti-sense oligonucleotide approach 
(35).  However, this may be more challenging for an intra-phagosomal pathogen, such as E. 
chaffeensis.  Similarly, inactivating a protein function using a drug is also challenging.  
Moreover, this is further complicated by the additional research involved in designing and 
evaluating specific anti-protein analogues.  Thus, the more reasonable approach would be to 
create mutations within the E. chaffeensis genome to selectively inactivate a gene of interest. 
 
E. chaffeensis is a Gram-negative organism; thus existing methods of introducing DNA 
into Gram-negative bacteria are likely to be effective.  Although, transformation in E. chaffeensis 
is complicated, as it is an obligate intracellular pathogen, recent data on Rickettsia and 
Anaplasma species suggest that it is an achievable task (37,95,97,143).  For example, several 
studies on R. prowazekii, R. monacensis and A. phagocytophilum documented the introduction 
of mutations using a transposon-based random mutational approach (37,78,94).  Targeted 
mutation has also been reported by Rachek et al for R. prowazeki (95,97)  More over, data 
reported from two unpublished meeting proceedings on A. marginale and E. muris suggested 
that it is possible to create targeted mutations in Ehrlichia species (38,69). 
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In this study we established many basic protocols and tools needed for performing 
mutational analysis in E. chaffeensis.  They include the identification of appropriate antibiotic 
selection markers, choice of genes to create mutations and the selection of constitutively active 
Ehrlichia promoters useful in preparing the transformation constructs and conditions for 
transformation.  In addition, numerous transformation experiments have been performed to 
introduce mutations in E. chaffeensis.  The experimental outcome is described in this chapter. 
 
Materials and Methods 
In vitro cultivation of E. chaffeensis in macrophage and tick cell lines:  E. chaffeensis 
Arkansas isolate was cultivated at 37°C in the canine macrophage cell line, DH82, as described 
previously (114).  The Arkansas isolate was also cultivated in the tick cell line, ISE6, using 
medium designed for its growth and maintenance at 34°C in the absence of CO2 as described 
by Munderloh et al. (1999).  The ISE6 cell line is derived from the embryos of the Ixodes 
scapularis tick (114).  Another tick cell line, AAE2, derived form the embryos of A. americanum 
ticks, is also used to grow E. chaffeensis (115).  The medium and the growth conditions for 
AAE2 cell line are same as those for ISE6 (115). 
 
Purification of E. chaffeensis:  E. chaffeensis was cultivated in either macrophage or tick 
cells.  The cells are harvested when the infectivity reached 80-90 % of nearly 100% confluent 
flask.  Infection was assessed by microscopic examination of polychromatic stained cytospin 
slides.  About 25 ml of infected culture was collected into a tube and centrifuged at 15,000 g for 
15 min.  The supernatant was discarded and the pellet resuspended in 10 ml of 0.25 M ice cold 
sucrose solution.  The cells were lysed by adding 1 mm diameter glass beads into the tube and 
vortexing for 30 sec two times.  Alternately, cells were lysed by passing through a 27½ gauge 
needle five times or by sonicating at a setting of 6.5 for 30 sec each for two times.  The lysed 
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cell suspension is transferred into a new tube free of glass beads and centrifuged at 100 g for 
10 min.  The supernatant is transferred into a new tube and centrifuged at 15,000 g for 15 min 
to spin down cell-free Ehrlichia.  At the end of centrifugation, supernatant was discarded and the 
cell-free Ehrlichia pellet resuspended in 10 ml of 0.25 M ice cold sucrose.  The centrifugation 
step is repeated one more time and the final Ehrlichia pellet is suspended in a small volume of 
0.25 M sucrose solution. 
 
Antibiotic sensitivity assays:  The sensitivity of E. chaffeensis to different antibiotics was 
evaluated as described (13).  Briefly, E. chaffeensis was cultivated in T75 flasks having 100% 
confluent DH82 cells.  When the infectivity reached approximately 50 %, 0.5 ml culture per each 
well was transferred to all wells in a 24 well plate.  Spectinomycin, rifampin, chloramphenicol, 
kanamycin, ampicillin and gentamicin were tested for their ability to inhibit E. chaffeensis 
growth.  Antibiotic solutions were prepared by dissolving the powder in appropriate solvents as 
suggested by the manufacturer (Sigma Aldrich Corporation, St. Louis, MO).  The negative 
control included the culture wells with no antibiotic added, or just solvent is added.  Positive 
control wells contained tetracycline at 1 µg/ml final concentration.  The concentrations of the 
antibiotics tested were as follows: specitnomycin at 10, 50, 100, 150 and 200 µg/ml; rifampin at 
0.1, 0.2 and 0.5 µg/ml; gentamicin at 2.5, 10, 20, 40, 80 and 120 µg/ml; chloramphenicol at 1, 2, 
4 and10 µg/ml; ampicillin at 1 and 20 µg/ml; kanamycin at 1 and 10 µg/ml.  Different dilutions of 
antibiotics, including controls, were tested in triplicate wells and the experiments were repeated 
three independent times.  Media along with freshly prepared antibiotics dilutions were replaced 
every 3 days.  The infectivity of the DH82 cells was also monitored every 3 days for up to 12 
days by microscopic evaluation of polychromatic stained cytospin culture slides.  The inhibitory 
rates were assessed relative to control wells that received no antibiotics.  Relative inhibition was 
also assessed by using tetracycline as a positive control.  Average values of infected cell 
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numbers for triplicate wells were plotted against no antibiotics controls to determine the 
antibiotic sensitivity for each drug tested.   
 
Identification of the antibiotic sensitivity genes:  Rifampin, chloramphenicol, spectinomycin 
and gentamicin were identified as inhibitory to E. chaffeensis.  To assess their use in our study, 
genes that conferred resistance to all four antibiotics were identified.  The use of the rifampin 
resistant gene, arr2, has been described by Qin et al (94).  The plasmid containing the rifampin 
resistance gene, pMW1409, was obtained from Dr. David Wood.  The arr2 gene along with the 
R. prowazeki rpsL  promoter was amplified by PCR using gene specific primers.  The use of 
spectinomycin resistance gene has been described by Felsheim et al (37).  The plasmid 
containing the spectinomycin resistance gene was obtained from Dr. Uli Munderloh.  The open 
reading frame of the spectinomycin was PCR amplified by 
using specific primers.  The resistance genes for chloramphenicol and gentamicin were 
obtained from plasmid pDEST10 (Invitrogen Technologies, Carlsbad, CA) by following a similar 
strategy as described for rifampin.  The primers used to amplify the antibiotic resistance genes 
are listed in Table 4.1.  
 
Selection of genes in the E. chaffeensis as targets for homologous recombination:  To 
identify an appropriate target in the E. chaffeensis genome for homologous recombination 
experiments, the expression patterns of various E. chaffeensis genes were analyzed.  
Specifically, microarray data were examined to identify genes that are low in expression or that 
lack expressed transcripts in both vertebrate and tick cell backgrounds.  Our microarray data 
analysis aided in the identification of many such genes.  We chose two genes in particular, i.e., 
p28-Omp 15 gene and ECH_0126.  More detailed information about the selection is provided in 
the results section.  The microarray data suggested that the p28-Omp 15 gene is expressed at 
low levels in E. chaffeensis growing in macrophages and tick cells.  Another gene ECH_0126 
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was also selected as microarray analysis revealed that the transcripts for this gene are not 
detectable in both macrophage and tick cell backgrounds.  To verify the absence of expression 
from Ech_0126 gene, RT-PCR analysis was performed by using specific primers targeted to the 
coding region of the Ech_0126 gene.  The reaction was carried out in a 25 µl volume containing 
E. chaffeensis RNA as template and by following the optimal reaction conditions as described in 
Chapter 5.  The reaction included a negative control tube where nuclease free water is added in 
place of RNA and a positive control tube where genomic DNA is added as the template in a 
PCR reaction. 
 
 Selection of constitutively active E. chaffeensis promoters:  To drive the expression of 
antibiotic resistance genes, promoters at are constitutively active in both tick and vertebrate host 
backgrounds need to be selected.  Our global transcriptional analysis (Chapter 3) identified 
several genes that appear to be constitutively expressed in E. chaffeensis derived from 
macrophage and tick cell backgrounds.  Although our microarray analysis aided in the 
identification of many genes, which seemed to be constitutively expressed, we chose the 
promoters of the tr and rpsL genes as our choice because homologues of these promoters from 
closely related rickettsials, such as Rickettsia prowazeki and Anaplasma phagocytophilum have 
been utilized in mutational analysis experiments.  The activity of these promoters was further 
verified by performing RT-PCR analysis.  Primers specific for tr and rpsL genes coding regions 
were designed and used in the RT-PCR analysis to map transcription of these genes.  RNAs 
isolated from E. chaffeensis originating from macrophage or tick cells were used as templates in 
RT-PCR analysis.  The reaction also included a negative control that contained no template and 
a positive control having E. chaffeensis genomic DNA as the template, but by performing PCR 
reaction.  The reaction was carried out in a 25 µl volume containing E. chaffeensis RNA as 
template and following the optimal conditions for the reaction as described in Chapter 5. 
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Table 4.1  The list of primers and sequences used in the preparation of plasmid constructs.   
Primer Sequence 
Primes used in the Gene 15 construct 
RRG190-Gene 15-for 1 CCTTCTAGTTTTATTTATTTG 
RRG191-Gene 15 for 2 CTTTCTGAACCAGTACAAG 
RRG192-Gene 15 rev TTCTCCAGAAGCTGTTG 
RRG433-Gene 15-5’-for GTCAAGCTTCAAAGACTACTTATGTATTATAG 
RRG434-Gene 15-5’-rev GTCGGATCCCAAACCATACAACGCGACAG 
RRG435-Gene 15-3’-for GTCACTAGTCTACTCTTAAAGCGTTTGC 
RRG436-Gene 15-3’-rev GTCTCTAGACAAATTAACAGTAGTAAACC 
Primes used in the ECH_0126 gene construct 
Ech_0126-5’-for GTCAAGCTTCATCATCAAAATTACATTCC 
Ech_0126-5’-rev GTCGGATCCGGTAGAATCAGGAGATAACTC 
Ech_0126-3’-for GTCACTAGTGATTTATGTGTATCTGTCGCAG 
Ech_0126-3’-rev GTCTCTAGAGCACTGTATTTCTATCTCTAC 
Primes used to obtain antibiotic resistance genes and promoters 
Rifampin-for ATGGTAAAAGATTGGATTCC 
Rifampin-rev GTCTAGAGGATCCTTAATCTTC 
Gentamicin-for ATGGGATCGGCCATTGAAC 
Gentamicin-rev TCAGAAGAACTCGTCAAG 
CAT-for ATGGAGAAAAAAATCACTGG 
CAT-rev TTACGCCCCGCCCTGCCA 
Spectinomycin-for ATGTTACGCAGCAGCAACG 
Spectinomycin-rev TTATTTGCCGACTACCTTGGTG 
Ech-rpsl-for TAGATTATTTTGAAAGGAAG 
Ech-rpsl-rev TAGATTATTTTGAAAGGAAG 
Ech-Tr-for AATACATCCCCCCTTACC 
Ech-Tr-rev CCAGTGATTT TTTTCTCCAT 
Tr-ORF-for ACGTTGAAGTAAGAGATATAATG 
Tr-ORF-rev CGATAGCAAAATAGATAGCAAAG 
Rpsl-ORF-for CAATTAGTCCGCAAACCGC 
Rpsl-ORF-rev TAAGCTATAACCTCACTACC 
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Preparation of plasmid constructs for use in homologous recombination experiments:  
Several constructs were prepared targeting the two genes, p28-Omp 15 and Ech_0126, of E. 
chaffeensis.  The generation of constructs involved several molecular cloning techniques such 
as PCR, sequencing, restriction enzyme digestion and ligation.  All the basic molecular biology 
protocols are described in Chapter 5 and the schematic outline of the plasmid constructs is 
described below for genes p28-Omp 15 and Ech_0126.  
 
Construction of plasmids targeting the p28-Omp 15 gene:  An approximately 1.4 kb 
segment of the p28-Omp 15 gene containing the entire ORF and parts of flanking regions was 
amplified by PCR.  The PCR reaction was performed using a proof reading DNA polymerase, E. 
chaffeensis genomic DNA as template and the primers RRG 190 and RRG 192 under 
appropriate conditions as outlined in Chapter 5 (Figure 4.1 and Table 4.1).  The PCR product is 
referred to as 15C.  Another segment of gene 15 that lacked 5’ flanking region and part of 5’ 
ORF segment was also PCR amplified using the primers RRG 191 and RRG 192 for use in 
construct preparation; this PCR product is termed 15P.  The plasmid BlueScript SK+ (pBS) was 
chosen to use as a backbone to insert the gene 15 fragments.  The restriction enzyme sites for 
EcoR I and Hind III restriction enzymes were deleted from pBS by employing molecular 
methods.  This was accomplished by digesting with one restriction enzyme at a time and then 
performing a fillin reaction using T4 DNA polymerase followed by blunt end ligation.  Plasmids 
that lost the enzyme site were selected by transforming the ligation products into competent E. 
coli cells.  Further plasmid DNA analysis was performed as described in Chapter 5.  This 
strategy aided in generating a pBS vector lacking EcoR I and Hind III restriction sites; which is 
referred to as pBS#.  The PCR products 15C and 15P were inserted into the EcoR V site of the 
pBS# by blunt end ligation and transformation into E. coli cells.  The resulting plasmids 
containing 15C and 15P are termed pBS-15C and pBS-15P, respectively.  A schematic 
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representation detailing the steps involved in the generation of plasmid constructs is shown in 
Figure 4.2. 
 
The plasmids pBS-15C and pBS-15P were then used to insert a gene cassette, Rparr-2, 
containing a rifampin resistance gene driven by the R. prowazeki rpsL  promoter (conveniently 
referred to as RP for illustration).  The Rparr-2 cassette was obtained from the plasmid 
pMW1409 by PCR using the primers, forward primer Rparr-2 and reverse primer DW416.  
RPwas inserted into the Sma I site of pBS-15C and pBS-15P plasmids by blunt  
 
Figure 4.1.  A cartoon representing the E. chaffeensis genomic region of the p28-Omp 
locus selected for mutational analysis.   
The forward primers (RRG 190 and RRG 191) and reverse primer (RRG 192) used in the 
preparation of the construct and approximate size of the PCR products are represented in the 
Figure.  Arrowhead direction is to represent the orientation of each gene. 
1375 bp
1100 bp
RRG 190 RRG 191 RRG 192
Gene 14 Gene 15 Gene 16
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Figure 4.2  The schematic representation of the plasmid constructs prepared for use in 
the homologous recombination experiments targeting the p28-Omp 15 gene.   
A partial or complete segment of p28-Omp 15 gene was amplified and inserted into the EcoR V 
site of the pBS plasmid.  A segment (RP) containing the rifampin resistance gene along with R. 
prowazeki rpsL  promoter was amplified from pMW1409 (obtained from Dr. Wood) and inserted 
at the Sma I or EcoR I site of pBS containing gene 15 segment. 15C, p28-Omp 15 gene 
complete segment plus flanking sequences; 15P, p28-Omp 15 gene partial segment plus 3’ 
flanking sequence; RP, rifampin gene with promoter; pBS 
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end ligation and transformation into E. coli cells.  The newly generated constructs having the 
rifampin cassette in the Sma I site of pBS-15C and pBS-15P plasmids are termed pBS-15C-RP 
and pBS-15P-RP, respectively.  In support of generation of another construct, RP is inserted 
into the EcoR I site of pBS-15P.  To facilitate ligation of RP (blunt ended fragment) into the 
EcoR I site of pBS-15P, the plasmid was digested with EcoR I and a fillin reaction was 
performed using T4DNA polymerase to create blunt ends.  Subsequently, the blunt-ended linear 
plasmid was used in the ligation reaction to insert the RP segment.  This strategy aided in 
insertion of RP into the blunt-ended EcoR I site of pBS-15P and the resulting plasmid is termed 
pBS-15PD-RP.  The integrity of the plasmids, particularly the presence of inserts at appropriate 
locations and the presence of accurate sequences was verified by plasmid DNA sequence 
analysis as outlined in Chapter 5. 
 
Three additional recombination plasmids targeted to disrupt the p28-Omp 15 were also 
gene prepared for use in homologous recombination experiments.  These constructs contained 
the resistance genes for chloramphenicol, spectinomycin and gentamicin.  Two segments of the 
p28-Omp 15 gene spanning the 5’ and 3’ regions of the ORF were amplified by PCR technique.  
The 5’ end segment was amplified using the primers RRG 433 and RRG 434.  The primers are 
designed to contain Hind III and BamH I restriction sites at the 5’ and 3’ ends of the PCR 
product, respectively.  The 3’ end fragment was amplified using the primers RRG 435 and RRG 
436; these primers are designed to contain Xba I and Spe I restriction sites at the 5’ and 3’ ends 
of the PCR product, respectively.  These inserts were directionally cloned into pBS using 
molecular techniques such as restriction enzyme digestion, ligation and transformation as 
described in Chapter 5.  The resulting plasmid was termed pBS-15D.  The E. chaffeensis tr 
promoter was PCR amplified by using genomic DNA as the template and the primers Ech-tr-for 
and Ech-tr-rev.  The PCR products were cloned into the plasmid Blue topo cloning vector and 
the resultant plasmid is termed as pBT-tr.  The antibiotic resistance gene products for 
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gentamicin and chloramphenicol were amplified from the pDEST 10 vector by performing PCR 
using specific primers (Table 4.1).  Similarly, the spectinomycin resistance gene is also PCR 
amplified by using the specific primers (Table 4.1).  The antibiotic resistance gene products 
were inserted into the pBT-tr such that the antibiotic resitance genes are in frame with the tr 
promoter.  The activity of the tr promoter was verified in E. coli cells by selecting the 
transformed organisms in media containing appropriate antibiotics.  The antibiotic resistance 
gene cassette containing tr promoter driving the expression from gentamicin, chloramphenicol 
and spectinomycin resistance genes was released from the pBT-tr vector by restriction enzyme 
digestion and cloned into BamH I and Spe I sites of the pBS-15D by using molecular techniques 
as described in Chapter 5.  A cartoon depicting the plasmid structure is shown in Figure 4.3. 
 
Construction of plasmids targeting the Ech_0126 gene coding for a hypothetical protein:  
A segment of the Ech_0126 gene, from the 5’ end of the open reading frame, is amplified by 
PCR using the primers Ech_0126-5’-for and Ech_0126-5’-rev and E. chaffeensis genomic DNA 
as template and is termed 126-5’.  The primers were designed to contain Hind III and BamH I 
restriction sites at the 5’ and 3’ ends of the PCR product, respectively.  The 126-5’ was digested 
with BamH I and Hind III and is ligated into similarly digested pBS vector.  The resulting plasmid 
containing 126-5’ fragment in pBS was termed pBS-126-5’.  The plasmid pBS-126-5’ was 
linearized by digestion with Hind III and BamH I.  The rpsL  gene promoter of E. chaffeensis is 
PCR amplified using genomic DNA as the template and the PCR product is cloned into pBT; the 
resultant plasmid is termed pBT-rpsl.  The antibiotic resistance genes for chloramphenicol and 
rifampin were also amplified by PCR as described in previous section and inserted into the pBT-
rpsl  such that the resistance genes are in frame with the rpsl  promoter.  The resultant plasmids 
were termed as pBT-rp-CAT and pBT-rp-RIF.  The plasmids pBT-rp-CAT and pBT-rp-RIF were 
digested with  
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Figure 4.3  Schematic representation of the plasmid constructed for use in homologous 
recombination experiments to disrupt the coding sequence of the p28-Omp gene 15.   
The 5’ and 3’ end segments of the p28-Omp 15 gene were generated by PCR and inserted into 
the pBS.  A cassette containing the E. chaffeensis tr gene promoter driving the expression of an 
antibiotic resistance gene is engineered in between the inserted gene 15 segments.  AMP, 
ampicllin resistance gene; Gene15-5, 5’ segment of the gene 15 ORF, Gene 15-3, 3’ segment 
of the gene 15 ORF; Ech-TR-pr, E. chaffeensis transcriptional regulator gene promoter; AB-
CDS, antibiotic resistance gene coding sequence; CHL, chloramphenicol acetyl transferase 
gene; RIF, rifampin resistance gene; SPEC, spectinomycin resistance gene.
pBS-15D-AB
AMP
AB-CDS
CHL or RIF or SPEC
Gene15-5’
Gene15-3’
Ech-TR-pr
Bam HI
HindIII
Spe I
Xba I 
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BamH I and Spe I restriction sites to release a cassette that contains the E. chaffeensis rpsL 
promoter driving the chloramphenicol or rifampin resistance genes, respectively.  The released 
fragments were gel-isolated and cloned into the BamH I and Spe I site of pBS-126-5’.  The 
resulting plasmids are termed as pBS-126-5’-rp-CAT and pBS-126-5’-rp-RIF, respectively. 
 
Another segment of the ECH_0126 gene is amplified from the 3’ end of the open reading 
frame using the primers Ech_0126-3’-for and Ech_0126-3’-rev RRG 560; the product was 
termed 126-3’.  The forward primer is designed to contain a Spe I site at the 5’ end of the PCR 
product and the 126-3’ fragment itself has a Spe I site at the 3’ end in the ECH_0126 gene 
sequence.  The 126-3’ and pBS-126-5’-rp-CAT and pBS-126-5’-rp-RIF were digested with Spe I 
restriction enzyme.  The vector was dephosphorylated and used in ligation reactions.  The Spe I 
digested 126-3’ fragment is inserted into the Spe I site of pBS-126-5’-rp-CAT and pBS-126-5’-
rp-RiF vectors and the resulting vectors were termed pBS-126-CAT and pBS-126-RIF, 
respectively.  The proper orientation of the 126-3’ segment was verified by sequencing analysis.  
A cartoon showing the final plasmid along with the inserted fragments is depicted in Figure 4.4. 
 
Preparation of plasmid DNA and electroporation conditions for E. chaffeensis:  The final 
plasmid constructs were transformed into a dam-/dcm- mutant strain of E. coli.  This strain is 
methyltransferase deficient and suitable for growth of plasmids free of dam and dcm 
methylation.  Plasmid DNA was isolated from 200 ml of E. coli culture by using endofree maxi 
prep Plasmid DNA isolation kit as per the manufacturer’s protocols.  The final plasmid DNA is 
eluted into 100 µl of nuclease free water.  This plasmid DNA was methylated by using host-cell 
free extracts of E. chaffeensis as described by Feldschein, et al. (37).  Following methylation, 
the plasmid DNAs were purified by ethanol precipitation and the integrity of the plasmid DNA 
was  
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Figure 4.4  Schematic representation of the plasmid constructed for use in homologous 
recombination experiments designed to disrupt the coding sequence of the Ech_0126 
gene.  The 5’ and 3’ end segments of the Ech_0126 gene were generated by PCR and inserted 
into pBS.  A cassette containing the E. chaffeensis rpsL gene promoter driving the expression of 
an antibiotic resistance gene was engineered in between the inserted Ech_0126 gene 
segments.  AMP, ampicllin resistance gene; Ech_0126-5’, 5’ segment of the Ech_0126 gene, 
Ech_0126-3’, 3’ segment of the Ech_0126 gene; Ech-rpsL-pr, E. chaffeensis rpsl gene 
promoter; AB-CDS, antibiotic resistance gene coding sequence; CHL, chloramphenicol acetyl 
transferase gene; RIF, rifampin resistance gene. 
pBS-126-AB
AMP
AB-CDS
CHL or RIF
Ech_0126-5’
Ech_0126-3’
Ech-rpsl-pr
BamH I
Hind III
Spe I
Spe I
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assessed by resolving on a DNA agarose gel.  Typically, about 1 µg of plasmid DNA was added 
per each electroporation reaction containing 100 µl of purified cell-free E. chaffeensis (described 
above) and mixed gently by slow pipetting and carefully transferred to a prechilled 1 mm gap, 
100 µl capacity electroporation cuvette (Eppendorff Corporation, Westbuty, NY).  The 
electroporation cuvette is incubated on ice for 5 min and subjected to electric shock in an 
eppendorff 2510 electroporator (Eppendorff Corporation, Westbuty, NY).  The settings used for 
electroporation are 5 µF, 5 milliseconds and voltages ranging from 1000-2500 V.  The controls 
included in the study were E. chaffeensis organisms that were electroporated or not 
electroporated in the absence of plasmid DNA.  Immediately following electroporation, the 
contents were transferred to a flask containing a confluent layer of host cells (macrophages or 
tick cells). 
 
Southern blotting technique to assess the internalization of plasmids:  To evaluate the 
validity of our electroporation conditions the presence of internalized plasmid DNA was 
assessed by using Southern blotting method (72).  Briefly, E. chaffeensis was subjected to 
electroporation in the presence of 1 µg of pBS-15C-RP plasmid DNA, but at different voltage 
settings, ranging from 1000 V to 2000 V.  The analysis also included a control electroporation 
reaction that contained plasmid DNA and E. chaffeensis but not subjected to electroporation.  
Immediately after electroporation, the contents of the cuvette were transferred to an eppendoff 
tube and centrifuged at 14,000 g for 6 min at 4°C.  The supernatant was discarded and the 
pellet suspended in 0.5 ml of 0.25 M sucrose solution and centrifuged at 14,000 g for 6 min at 
4°C.  The supernatant was discarded and the pellet suspended in 85 µl of 1X DNAse buffer 
followed by the addition of 15 µl of DNAse (Promega Corporation) and incubated at 37°C for 1 
h.  The DNAse digestion was stopped by adding 4 µl of 0.5 M EDTA and incubation at 65°C for 
10 min.  Subsequently, 2.5 µl of Proteinase-K (10 mg/ml) was added and tube is incubated at 
37°C for 4 h.  E. chaffeensis organisms were disrupted by adding 2 µl of 10X SDS buffer and 
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incubated at room temperature for 5 min.  Total DNA from these cultures was isolated by using 
phenol/chloroform extraction method and the final pellet was dissolved in 9 µl of TE buffer.   
 
To the isolated DNA, 2 µl of 10 X EcoR I restriction enzyme digestion buffer and 10 units 
of EcoR I enzyme were added and digested at 37°C for 2 h in a 20 µl reaction.  The digested 
products were then resolved on a 0.9 % agarose gel run at 40 V for 6 hours and the resolved 
DNA was transferred to a nylon membrane (72).  Digestion controls, included 0.5 µg of E. 
chaffeensis gDNA and 50 ng of pBS-15C-RP plasmid DNA, were also a part of the resolved gel.  
The nylon membrane was probed with 32P labeled probes for the 16S rDNA and the rifampin 
resistance gene.  The random primer labeling technique was used to synthesize radioactive 
probes, with PCR products of 16S rDNA gene and rifampin resistance gene segments as 
templates as per the manufacturer’s instructions (Random Primer labeling kit, Stratagene 
Corporation, La Jolla, CA).  After 14 h of incubation at 65°C, the membrane was washed once 
with 6X SSC, 0.1% SDS followed by two washes at 2X SSC, 0.1% SDS and a final wash at 
0.1X SSC, 0.1% SDS.  The nylon membrane was then exposed to an X-ray film at -70°C using 
an intensifying screen.  The X-ray film was developed and presence of plasmid DNA within E. 
chaffeensis was assessed from the autoradiograph. 
 
Methods for monitoring transformants:  The culture media from flasks containing 
electroporated E. chaffeensis and from control flasks was changed once every 3-4 days.  
Appropriate antibiotics were added after 24-72 h post transformation at a concentration 
inhibitory to E. chaffeensis growth (Figure 4.5).  The presence of genetically modified E. 
chaffeensis was assessed in cultures growing in the presence of an antibiotic by evaluating the 
growth or lack of growth by microscopic analysis of polychromatic stained culture slides.   
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Figure 4.5  Outline of transformation protocol.   
The E. chaffeensis organisms were electroporated in the presence of plasmid DNA.  The 
electroporated E. chaffeensis were inoculated into T25 flasks containing macrophages or tick 
cells.  Depending on the plasmid used, appropriate antibiotics at inhibitory concentrations were 
added at days 1-3 post transformation and the media was replaced once every 3 days along 
with fresh antibiotics.  Infectivity was monitored by microscopic evaluation of culture slides once 
every 3 days.
Day 1-3
Appropriate
antibiotics
added 
Once every 3 days
media is replaced with 
fresh antibiotics and 
culture monitored by 
microscopy
E. chaffeensis +
plasmid DNA
Electroporation
Day 0
5 ml Host cells
+
Electroporated
E. chaffeensis
 96 
Any cultures that appeared to be positive were further evaluated by molecular techniques.  
Genomic DNA and total RNA were isolated from the putatively transformed E. chaffeensis 
organisms.  RNA was used in RT-PCR analysis to look for the presence of the transcripts for 
the 16S rRNA gene.  PCR analysis was performed, with genomic DNA as template, using 
primers spanning the expected insertion regions or with primers targeted to the antibiotic 
resistance gene or in combination of both. 
Results 
Sensitivity of E. chaffeensis to various antibiotics:  To identify suitable selection markers for 
use in the transformation experiments, the sensitivity of E. chaffeensis to various antibiotics was 
evaluated.  Ampicillin, chloramphenicol, gentamicin, rifampin, spectinomycin and kanamycin 
antibiotics were evaluated for their potential to be used as selection markers.  The percentage 
of E. chaffeensis infected cells in the wells that received antibiotic treatment was compared with 
the control wells that did not contain the antibiotics to estimate the relative growth inhibitory 
effect of the antibiotics (Figure 4.6).  In the control wells that did not receive the antibiotics, the 
E. chaffeensis infected host cells increased from 50% to about 75% by day 3.  By day 7, nearly 
all the host cells were found to be infected (100%).  The proportion of infected cells decreased 
from 50% to less than 10% in the wells that contained rifampin at concentrations of 0.1 µg/ml or 
higher by day 3 post antibiotic addition.  E. chaffeensis infected host cells were undetectable by 
day 7 or later in the presence of rifampin at concentrations of 0.1 mg/ml or higher.  The wells 
that contained gentamicin at concentrations of 80 µg/ml or 120 µg/ml showed a decrease in the 
proportion of infected cells by day 3 from 50% to about 5% and no E. chaffeensis organisms 
were detectable by day 7 until day 12.  Gentamicin at lower concentrations, 20 and 40 µg/ml, 
was partially inhibitory to E. chaffeensis growth while at 2.5 and 10 µg/ml concentrations, the 
drug had no effect.   Spectinomycin at concentrations of 50 µg/ml or higher is also completely 
inhibitory to E. chaffeensis. 
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Figure 4.6  Antibiotic sensitivity of E. chaffeensis. 
 Briefly, E. chaffeensis was cultivated in T75 flasks having 100% confluent DH82 cells and when 
the infectivity reached about 50 %, approximately 0.5 ml culture per each well was transferred to 
a 24 well plate.  Rifampin, chloramphenicol, ampicillin, kanamycin, spectinomycin and 
gentamicin various concentrations were added to the wells and their effect on E. chaffeensis 
growth was evaluated (Panel A-E).  In positive control wells, tetracycline at 1 µg/ml is added and 
negative control wells did not receive any antibiotics.  Media along with freshly prepared 
antibiotics dilutions were replaced every 3 days.  The infectivity of the DH82 cells was also 
monitored at four time points (3, 7, 10 and 12 days) by microscopic evaluation of polychromatic 
stained cytospin culture slides.  The inhibitory effect of rifampin was assessed relative to the E. 
chaffeensis growth in control wells.  Average values of E. chaffeensis infected host cells were 
plotted on the Y-axis against the time point at which infectivity was monitored on the X-axis.  
The experiments were performed three independent times and the data were presented with 
error bars representing the standard deviation.  Gen, gentamicin; Rif, rifampin; spec, 
spectinomycin; Kan, kanamycin; Amp, ampicillin; Chl, chloramphenicol; Tet, tetracyline. (Figure 
continued into Pages 103-105) 
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chaffeensis growth by day 7 post antibiotic treatment.   Similarly, chloramphenicol at a 
concentration of 10 µg/ml is inhibitory to E. chaffeensis growth, as the number of infected cells 
decreased from 50% to about 15% by day 3 and none were detectable by day 7.  Ampicillin (at 
1 and 20 µg/ml) and kanamycin (at 1 and 10 µg/ml) were not inhibitory to E. chaffeensis growth 
as the proportion of infected cells increased in the same manner as in the untreated controls.  
The presence of tetracycline at 1 µg/ml inhibited E. chaffeensis growth as no organisms were 
detected by day 7 post antibiotic addition.  Although, we have initially identified spectinomycin to 
be inhibitory to E. chaffeensis, we have observed development of spontaneous resistance 
towards this antibiotic in the bacteria. 
 
Identification of suitable targets for homologous recombination:  Two genes, p28-Omp 15 
and Ech_0126 were selected for use in creating mutations in E. chaffeensis.  P28-Omp 15 was 
chosen for mutational analysis as our microarray data described in Chapter 3 suggested that 
transcripts from this gene was low in both tick cell and macrophage derived E. chaffeensis 
(Figure 3.8 of Chapter 3).  Earlier proteome analysis from our laboratory suggested that p28-
Omp 15 protein is not made in either tick or macrophage derived E. chaffeensis (115).  
Microarray analysis also suggested that Ech_0126 is a transcriptionally silent gene.  RT-PCR 
analysis was performed using primers specific for the coding region of the Ech_0126 gene to 
verify the lack of transcription in E. chaffeensis cultured in macrophages and tick cells (Figure 
4.7).  The RT-PCR analysis included a positive control using genomic DNA as the template and 
no template reaction to serve as the negative control.  The predicted size amplicons were 
detected only in the PCR products obtained from the reaction where genomic DNA is used as 
the template, but not in the reactions that contained E. chaffeensis RNA isolated from 
organisms cultured in tick cells and macrophages as the templates.  Similarly, the no template 
control had no detectable amplicons.  Ech_0126 is positioned in the negative strand of E. 
chaffeensis chromosome between a transcriptional  
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Figure 4.7  RT-PCR analysis of the ECH_0126 gene expression.   
 RNA isolated from E. chaffeensis grown in macrophage and tick cell backgrounds was 
used as templates in a RT-PCR reaction containing primers targeting a segment of the 
ECH_0126 gene. L, ladder; + reaction positive control with DNA as the template, -, 
reactive negative control; M, RNA from macrophage-grown E. chaffeensis; T, RNA from 
tick cell-derived E. chaffeensis. 
 
Figure 4.8.  E. chaffeensis genomic region spanning the Ech_0126 gene selected for 
creating deletion mutational analysis.   
The numbers above refer to the genomic coordinates of the protein coding regions of the genes.  
Active and silent refer to the presence or absence of mRNA transcripts in E. chaffeensis 
originating from macrophages or tick cells (as judged by the microarray analysis).  For the gene 
in purple color (selected for mutational analysis), lack of detectable mRNA expression was also 
verified by RT-PCR.  Arrowhead direction represents the orientation of each gene. 
L  M  T  +  -
Ech_0125 Ech_0126 Ech_0127
(Glutmate-cysteine ligase) (Hypothetical protein) (Lipoprotein releasing system
transmembraneprotein)
Active Silent Silent
113,261 114,493 114,297 115,931 116,375 117,607
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 active glutamate cysteine ligase gene (located on the positive strand) and a transcriptionally 
silent lipoprotein releasing system transmembrane gene (located on the negative stand) (Figure 
4.8). 
 
Identification of E. chaffeensis promoters useful in driving the expression from antibiotic 
selection marker genes:  To identify promoters that may be useful in driving the expression 
from antibiotic selection marker genes, we analyzed the transcriptionally active genes in E. 
chaffeensis.  Our microarray analysis aided in the identification of 263 genes that are 
constitutively expressed in E. chaffeensis cultivated in both host cell types.  While promoters 
from any one or more of these genes may be suitable, we selected tr and rpsL  gene promoters 
as our choice because promoters from these gene homologues in A. marginale and R. 
prowazeki have already been shown to be useful in mutational analysis (37,78).  To further 
verify the microarray results, RT-PCR analysis was performed by using RNA isolated from E. 
chaffeensis, grown in both host cell backgrounds, as templates and using primers designed to 
amplify segments of coding regions of the tr and rpsL  genes.  The RT-PCR analysis included a 
positive control using a genomic DNA as the template and no template reaction to serve as a 
negative control.  The predicted size amplicons were detected in the PCR products obtained 
from reactions that contained the E. chaffeensis RNAs as templates and also in reaction 
positive control but not in the negative control reaction (Figure 4.9). 
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Figure 4.9  RT-PCR analysis of the activity of the tr (A) and rpsl  (B) promoters.    
RNA isolated from E. chaffeensis grown in macrophage and tick cell backgrounds was used as 
templates in a RT-PCR reaction containing primers targeting to a segment of the tr or rpsl  
genes. L, ladder; + reaction positive control with DNA as the template, -, reactive negative 
control; M, RNA from macrophage-grown E. chaffeensis; T, RNA from tick cell-derived E. 
chaffeensis. 
L  +  - M  TA B L  M  T  +  -    -
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Construction of the plasmids for mutational analysis:  Several plasmid DNA constructs 
were prepared for creating mutations in the E. chaffeensis genome.  Initially three plasmids 
were constructed targeting gene 15 of the p28-Omp gene locus (Figure 4.2).  The plasmid 
BlueScript SK+ (pBS) was used as the base vector to insert the partial or complete gene 15 
coding sequences along with the 5’ and 3’ flanking sequences and also rifampin resistance 
gene driven by R. prowazekii rpsL promoter.  Two of the plasmids, termed pBS-15C-RP and 
pBS-15P-RP, are designed for use in homologous recombination experiments to create 
duplication of either a complete gene 15 or a partial gene 15 in E. chaffeensis genome (Figure 
4.10).  The third plasmid, pBS-15D-RP which contained the rifampin resistance cassette in the 
middle of gene 15 segment, was constructed for use in creating disruptions in the gene 15 of E. 
chaffeensis.  Similarly, three more plasmids were constructed for use in disrupting gene 15 but 
containing alternative selection markers (Figure 4.3).  These plasmids contained E. chaffeensis 
tr promoter driving the expression from gentamicin, chloramphenicol or spectinomycin 
resistance genes. 
 
We also generated plasmids targeting another gene, Ech_0126, in the E. chaffeensis 
genome.  These constructs were engineered to contain the E. chaffeensis rpsL gene promoter 
driving the chloramphenicol and rifampin resistance genes.  The 5’ and 3’ fragments of 
Ech_0126 gene were inserted such that they are flanking the resistance gene cassette.  These 
plasmids are designed for use in creating disruption mutations within the coding sequence of 
Ech_0126 gene (Figure 4.4).  The integrity of all eight plasmids, particularly the presence of 
inserts at appropriate locations and the presence of accurate sequences of promoters and 
antibiotic resistance genes was verified by employing restriction enzyme digestion and 
sequencing methods as described in Chapter 5. 
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Figure 4.10  A schematic representation of the possible homologous recombination 
events by insertion mutations and the resulting outcomes by using plasmids targeted to 
the p28-Omp 15 gene in the E. chaffeensis genome.   
If pBS-15C-RP recombines with the E. chaffeensis genome, it results in integration into the 
genome resulting in creation of a duplicate complete gene 15.  Similarly, pBS-15P-RP upon 
recombination results in a complete gene 15 and a partial gene 15. The plasmid pBS-15D-RP 
results upon recombination results in a partial gene 15 and a complete gene 15 disrupted by the 
rifampin resistance gene.  15C; p28-Omp 15 complete gene 15; 15P, p28-Omp 15 partial gene; 
14, p28-Omp 14 gene; 15, p28-Omp 15 gene; 16, p28-Omp 16 gene.
Homologous Recombination
Partial gene duplication Gene deletion
P28 Omp locus
14 15 16
Gene duplication
Gene duplication
Hind III
Sma I* pBS-15C-RP
Sma I*
pBS -15PD -RP
Hind IIIHind III
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Evaluation of electroporation conditions in internalization of recombinant plasmid DNAs into E. 
chaffeensis:  Establishment of methods for E. chaffeensis requires the identification of 
conditions that would permit the entry of extracellular DNA into the organism.  Different 
electroporation conditions were evaluated to identify the appropriate conditions to allow the 
internalization of the extracellular plasmid DNA.  Electroporation was chosen because of its 
efficiency and moreover, it has been successfully used in recent studies transforming other 
rickettsial pathogens (37,69,78,94,95).  The host cell-free E. chaffeensis organisms were 
prepared as described earlier (37,69,94).  Host cell-free E. chaffeensis was electroporated in 
the presence of plasmid DNA at various voltage settings and evaluated for the internalization of 
the plasmid DNA upon electroporation.  The viability of the host cell-free E. chaffeensis was 
initially examined for their ability to reinfect the host cells before or after subjecting to 
electroporation conditions.  The electroporated E. chaffeensis were able to infect naïve host 
cells suggesting that electroporation did not kill the organisms (data not shown).  internalized 
plasmid DNA in E. chaffeensis organisms was detected only in electroporated E. chaffeensis 
organisms at all voltage settings (Figure 4.11).  Internalized plasmid DNA was not detected in 
the E. chaffeensis that did not receive electroporation treatment but contained equal amounts of 
plasmid DNA.  Internalized plasmid DNA increased with increase in the amount of voltage used 
in subjecting E. chaffeensis to electric shock. 
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Figure 4.11 Southern blotting analysis to assess the internalization of plasmid DNA.  
Host cell-free E. chaffeensis was subjected to electroporation under different voltage settings in 
the presence of 1 µg of pBS-15C-RP plasmid DNA.  After electroporation, extracellulluar DNA 
residual plasmid DNA that did not internalize into Ehrlichia organisms was digested with DNAse.  
Subsequently, total DNA from the control and electroporated E. chaffeensis was isolated and 
subjected to EcoR I digestion.  EcoR I digested DNA is resolved on an agarose gel and probed 
with 32P labeled probes targeting the 16S rDNA gene of the E. chaffeensis and a rifampin gene 
segment.  0, no electroporation; 1000-2000, various voltage settings; G-DNA, 0.5 µg of EcoR I 
digested genomic DNA loaded as a control; B, blank well; P-DNA, 10 ng of EcoR I digested 
pBS-15C-RP plasmid DNA loaded as a control. 
O    1000   1200  1400  1600  1800  2000 G-DNA   B   P-DNA
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Transformation of E. chaffeensis using plasmids targeting gene 15 of the p28-Omp locus:  
To create mutations in the genome of E. chaffeensis, the plasmids designed for targeted 
mutagenesis of gene 15 in the p28-Omp locus were used in transformation experiments.  About 
one hundred experiments were performed using pBS-15C-RP and pBS-15P-RP plasmids in E. 
chaffeensis cultivated in macrophages or tick cells (Table 4.2).  About nine experiments were 
also performed using the plasmids pBS-15D-RP, pBS-15-CAT, pBS-15-GEN and pBS-15-SPEC 
(Table 4.3).  Most of the transformation experiments were performed using host cell-free purified 
E. chaffeensis.  A subset of experiments was also performed using E. chaffeensis infected 
macrophages or tick cells.  The control for these experiments included the host cell-free purified 
or unpurified E. chaffeensis organisms that did not receive electroporation and plasmid DNA 
and E. chaffeensis organism that received electric shock but in the absence of plasmid DNA.  
These control flasks along with the E. chaffeensis electroporated in the presence of plasmid 
were transferred to the flasks containing naïve host cells and monitored for their growth.  E. 
chaffeensis growth in host cells was detectable in the control flasks in the absence of antibiotic 
selection by day 3 or later.  However, inclusion of antibiotics in these flasks resulted in the 
complete inhibition of E. chaffeensis within one week.  The flasks that contained electroporated 
E. chaffeensis in the presence of plasmid DNA did not show any infectivity in the presence of 
antibiotic selection for up to two months post transformation.  The infectivity was also monitored 
by using molecular methods PCR and RT-PCR targeting to the 16S rRNA gene of E. 
chaffeensis.  Our analysis from two of the transformation experiments performed using pBS-
15P-RP plasmid DNA  
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Table 4.2  Transformation experiments performed by using pBS-15C-RP and pBS-15P-
RP plasmids designed to create mutations in the p28-Omp 15 gene locus in the  
E. chaffeensis genome.  The E. chaffeensis grown in the host cells were purified free of host 
cells or used along with the host cells.  The E. chaffeensis cultures were washed with and 
resuspended in 0.25 M sucrose or SPG buffer or 10% glycerol solution and subjected to 
electroporation in the presence of plasmid DNA.  Type I restriction inhibitor was added to some 
of the electroporation reactions.  The electroporated E. chaffeensis organisms were inoculated 
into a T25 flask containing a monolayer of naïve host cells.  Rifampin antibiotic at inhibitory 
concentrations were added after 1-3 days post transformation and media was replaced with 
fresh antibiotics once every three days for about two months.  The culture was monitored 
microscopically for the presence of infection once every 3 days. 
 
Conditions 
Date Culture No. of Expt. 
Resuspended in Electroporation Antibiotics Type1 
2005 
DH82 (whole 
cell) 
6 SPG buffer 2500 24 h no 
2005 
DH82 (purified 
by glass beads 
and 
centrifugation) 
19 
SPG buffer (2) 
10% glycerol (3) 
0.25 M sucrose (14) 
2500 (4)  
1700 (15) 
24 h 
No (2) 
Yes 
(17) 
2005 
ISE6 (purified by 
glass beads and 
centrifugation) 
1 0.25 M sucrose 1700 24 h Yes 
2006 
DH82 (whole 
cell) 
1 0.25 M sucrose 1700 24 h Yes 
2006 
DH82 (by glass 
beads and 
centrifugation) 
10 0.25 M sucrose 1700 24 h Yes 
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2006 
ISE6 (purified by 
glass beads and 
centrifugation) 
4 0.25 M sucrose 1700 
24 h (3) 
72 h (1) 
Yes 
2006 
AAE2 (whole 
cell) 
4 0.25 M sucrose 2500 
24 h (2) 
48 (1) 
72 (1) 
Yes 
2006 
AAE2 (purified 
by glass beads 
and 
centrifugation) 
4 0.25 M sucrose 1700 
24 h(3) 
48 (1) 
Yes 
2007 
DH82 (purified 
by needle) 
1 0.25 M sucrose 1200 
72 h (1) 
 
Yes 
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Table 4.3 Transformation experiments performed by using pBS-15PD-RP and pBS-
15D-AB plasmids designed to create gene disruptions in the p28-Omp 15 gene locus in 
the E. chaffeensis genome.  The transformation experiments were performed as described in 
Table 4.2, except that in some of the transformations the electroporated E. chaffeensis 
organisms were inoculated into flasks containing host cells and rocked once every 15 min for 
about 2 h. 
 
 
Conditions 
Date 
Culture 
No. of 
Expts Resuspended Electroporation Inoculation Antibiotics Type1 
2005 
DH82 (whole 
cell) 
1 SPG 2500 Straight 24 h no 
2005 
DH82 
(purified by 
glass beads 
and 
centrifugation) 
7 
0.25 M sucrose 
(4) 
SPG (1) 
10% glycerol (2) 
2500 (4) 
1700 (3) 
Straight 24 h 
No (2) 
Yes (5) 
2007 
DH82 
(purified by 
needle 
1 0.25 M sucrose 1200 
Rocking 
once every 
15 min for 2 
hours 
48 h Yes 
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showed positive results for 16S rDNA gene and the rifampin resistance gene by PCR starting 
day 7 post-transformation until day 25 (data not shown).  PCR analysis was performed to 
evaluate the homologous recombination in the genome.  The analysis suggested no evidence of 
a recombination in the E. chaffeensis genome (data not shown). 
 
Transformation of E. chaffeensis using plasmids targeting the ECH_0126 gene:  The 
plasmids designed for targeted mutagenesis of the Ech_0126 gene were also evalauted in 
transformation experiments similar to the p28-Omp 15 gene targeted plasmids described in the 
previous section.  About forty eight experiments were performed using pBS-126-CAT and pBS-
126-RIF plasmid constructs in purified host cell-free or unpurified E. chaffeensis organism 
cultivated in macrophage or tick cells (Table 4.4).  The experiments included controls as 
described in the previous section.  The electroporated E. chaffeensis cultures that received 
plasmid DNA were monitored for up to two months.  The control flasks showed the E. 
chaffeensis infectivity by day 3 or later post transformation.  However, the flasks inoculated with 
E. chaffeensis organisms that received electric shock in the presence of plasmid DNA did not 
show any infectivity for up to two months in the presence of appropriate antibiotic selection. 
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Table 4.4  Transformation experiments performed by using the plasmids designed to 
create gene disruption mutations in the Ech_0126 gene locus in the E. chaffeensis 
genome.   
The transformation experiments were performed as described in Table 4.2, except that all the 
reactions included type 1 restriction inhibitor and electroporation was performed at varying 
voltages in multiple experiments as shown in table.  In some transformation experiments, 
plasmid DNAs were added and no electroporation was performed to evaluate the utility of 
natural transformation mechanisms by E. chaffeensis.  In some transformation experiments, the 
plasmid DNA and the E. chaffeensis cultures were incubated for extended periods of time 
before electroporation. 
Conditions 
Date Culture 
No. of 
experiments Resuspended Electroporation Antibiotics 
Extra 
incubation 
2007 
DH82 
(whole ell) 
7 0.25 M sucrose 
1000 +1000 (2) 
1200 + 1200 (3) 
1200 (2) 
 
24 h 
1 min (1) 
5 min (2) 
30 min (4) 
 
2007 
DH82 
(purified 
by  
needle) 
5 0.25 M sucrose 
Phagocytosis (1) 
1000 + 1000 (1) 
1200 (3) 
 
72 (2) 
24 (3) 
1 min (4) 
5 min (1) 
2007 
AAE2 
(whole ell) 
5 0.25 M sucrose 
1000 + 1000 (1) 
1200 + 1200 (1) 
1000 (2) 
1200 (1) 
 
24 
5 min (2) 
30min (3) 
 
2007 
AAE2 
(purified 
by  
needle) 
7 0.25 M sucrose 
Phagocytosis (1) 
1000 + 1000 (1) 
1000 (1) 
1200 (4) 
 
24 (5) 
72 (2) 
1 min (5) 
5 min (2) 
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Discussion 
 In this study, we evaluated methods for establishing conditions for creating mutations in 
E. chaffeensis.  Standardization of many basic protocols is the first step towards establishing a 
mutational analysis system.  This is particularly important as there are no reports in the literature 
describing protocols for creating mutations in E. chaffeensis.  Likewise, methods are also not 
available for other closely related Ehrlichia pathogens.  We focused our efforts in standardizing 
several basic protocols which included optimizing methods for purifying viable E. chaffeensis for 
electroporation, identification of appropriate antibiotic selection markers, and the selection of 
targets in the genome for initial mutational analysis where creating mutations should not have 
any negative effect on bacterial growth.  We also identified constitutively expressed genes 
whose promoters can be used to drive the expression of appropriate antibiotic resistance genes.  
It is also important to identify appropriate antibiotics that are not used in controlling E. 
chaffeensis infections but are useful in selecting the transformed organisms.  All these protocols 
are the prior requirement in support of creating mutations in E. chaffeensis.   
 
 As a first step to identify the appropriate antibiotics, we evaluated chloramphenicol, 
rifampin, spectinomycin, gentamicin, ampicllin and kanamycin for their inhibitory effect on E. 
chaffeensis.  Gentamicin, rifampin spectinomycin and chloramphenicol were found to be 
inhibitory to E. chaffeensis growth.  Our analysis confirmed the earlier reports about the 
sensitivity of E. chaffeensis to rifampin, chloramphenicol and gentamicin (13).  In addition, we 
identified spectinomycin to be inhibiting the growth of E. chaffeensis.  Rifampin, gentamicin, 
specitnomycin and chloramphenicol were chosen as they are not routinely used in clinical 
setting to treat the HME infections and genes that confer the resistance to these antibiotics are 
available (33,87). 
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 Selecting an appropriate region(s) in the genome of E. chaffeensis to create initial 
mutations where there will be no detrimental effect caused by mutations is necessary to 
establish protocols for the introduction of genetic mutations in the organism.  Based on the 
careful analysis of transcriptome data and also taking into consideration the location of the 
genes in the genome, two genomic regions were selected for the initial mutational analysis 
experiments.  The region spanning the Ech_0126 is ideally suited for this kind of analysis as it 
met the criteria that we chose.  Similarly, p28-Omp 15 was selected as it is present in the 
genome locus coding for multiple paralogs that encode for differentially expressed outer 
membrane proteins.  Moreover, we were careful in designing mutational experiments that will 
retain the native structure of the p29-Omp 15 gene even after creating mutations by 
homologous recombination.   
 
 The third logical step in establishing the conditions for creating mutations is to select 
appropriate promoters that can be used to drive the expression of antibiotic selection marker 
genes.  Our transcriptome analysis identified several genes that are constitutively expressed in 
E. chaffeensis in both host cell backgrounds.  We focused our efforts in selecting the promoters 
of transcriptional regulator (tr) gene and ribosomal protein S12 gene (rpsL) as the homologues 
of these promoters were already used in demonstrating their utility in transformation studies in 
other rickettsiae and Anaplasma organisms (37,94). 
 
 Several constructs have been prepared by including DNA segments spanning the 
Ech_0126 and p28-Omp 15 genes.  Six plasmid constructs were made for the p28-Omp 15 
gene and two constructs were made for the Ech_0126 gene for use in mutational analysis 
experiments.  It is possible that creating mutations in the p28-Omp 15 region may have an 
impact on the growth of this bacterium as this gene is shown to be expressed in E. chaffeensis 
at low levels.  Therefore, a strategy was developed to create mutations that result in complete or 
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partial gene duplications rather than to create disruption mutations in this gene.  We also 
designed constructs for use in disruption mutations for p28-Omp 15 gene.  The constructs 
targeted to Ech_0126, an inactive gene, were designed to create gene disruption mutations. 
 
 The next important step in creating mutations is to have appropriate conditions for 
transformation where extracellular plasmid DNA can be introduced into the Ehrlichia cells.  We 
essentially followed the protocols described in the literature for our experiments, but made minor 
changes such as altering the voltage used for transformation.  The validity of the experimental 
protocols was tested by assessing the internalization of plasmid constructs into E. chaffeensis 
cell.  This experiment was performed after eliminating extracellular (non-internalized) DNA by 
enzymatic digestion and then checking the internalized plasmid DNA by Southern blot analysis 
probes specific for E. chaffeensis 16S rDNA gene and a segment of plasmid DNA.  The 
Southern blot analysis verified that we have appropriate conditions for transforming E. 
chaffeensis with recombinant plasmids.  We also demonstrated in our studies that 
electroporation conditions used in the transforming E. chaffeensis did not result in the complete 
loss of cultivable organisms. 
 
 About 109 independent transformation experiments were performed using plasmids 
targeting the p28-Omp 15 gene and about 48 experiments were performed using plasmids 
targeting to Ech_0126 gene. The transformation experiments were either performed at one set 
of conditions or by introducing minor modifications to the protocols.  This is to maximize the 
probability of creating targeted mutations in E. chaffeensis.  In each experiment, the 
electroporated bacteria were cultured in the presence or absence of appropriate antibiotic and 
the infectivity was monitored for up to 60 days.  In all the transformation experiments, E. 
chaffeensis infection of host cell cultures was detectable in control flasks.  However, none of the 
experiments resulted in the rescue of antibiotic resistant E. chaffeensis.  The only exception was 
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the two experiments where we detected rifampin resistant E. chaffeensis when plasmids 
designed for the gene duplication of the p28-Omp 15 gene were used.  However, careful 
evaluation of these two transformation experiments revealed no evidence for homologous 
recombination events in the genome.  Although studies led to the significant accomplishments in 
conducting the experiments, we were unsuccessful in identifying mutations by homologous 
recombination.   
 
Genetic manipulations have already been described for A. phagocytophilum, R. 
prowazekii and R. monacensis, however, they are based on transposon based mutagenesis 
approach (37,78,94).  Recent published reports by Rachek et al also described the targeting 
mutations in R. prowazeki (95,97).  Two reports of targeted mutagenesis in Anaplasmataceae 
bacteria have also been reported recently at two different scientific meetings (38,69).  In the 
absence of detailed description of these experiments from the Anaplasmataceae pathogens it is 
very difficult to conclude if targeted mutations is an achievable task or may need fine tuning of 
experiments.  Alternatively, despite the evaluation of about 150 transformation experiments, the 
failure to demonstrate targeted mutations may suggest that the pathogen does not support the 
replication of plasmids or integration of foreign DNA in its genome or has an efficient method to 
restore the integrity of the genome.  This hypothesis may be justified as E. chaffeensis and 
other closely related Anaplasmataceae organisms do not harbor plasmids (56).  The E. 
chaffeensis genome contains about eight genes that encode for recombinase like proteins (56), 
but our microarray data provides evidence for the expression of only two genes.  These data 
may further suggest that the E. chaffeensis genome does not support introduction of foreign 
DNA.  Nonetheless, this study is a significant step forward as it aided in carefully examining 
various protocols and methods required for creating mutations in E. chaffeensis. 
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CHAPTER 5 - General Molecular Methods 
 119 
Restriction enzyme digestions:  Typically, restriction enzyme digestions were performed in a 
20 µl reaction containing 0.5-1.0 µg of DNA, 1X concentration of appropriate buffer and 5-10 
units of restriction enzyme (Promega Corporation, Madison, WI).  The reaction was carried out 
by incubating at 37°C for 2 h.  For double digestion with two restriction enzymes, a buffer was 
chosen that was optimal for both the enzymes. 
Sequencing of PCR products or plasmid DNA:  The sequencing of plasmid DNA or PCR 
products was performed using the CEQ Genetic Analysis System following the manufacturer’s 
recommendation (Beckman & Coulter, Fullerton, CA).  PCR products were subjected to 
presequencing treatment prior to proceeding to sequencing.  Five l of PCR product were 
treated with Exo-I (10 units) and shrimp alkaline phosphotase (2 units) (USB Corporation, 
Cleveland, Ohio) and incubated at 37°C for 15 min to remove excess primers and nucleotides.  
The enzymes were inactivated by incubation at 80°C for 15 min.  After treatment, the DNA was 
purified by using a phenol purification method (72).  The integrity and concentration of the DNA 
was estimated by resolving the purified sample on an agarose gel and using nanodrop 
technique.  Plasmid DNA isolated by using boiling preparation method was purified free of 
contaminating proteins using phenol purification.  Later the integrity and concentration of the 
plasmid DNA was evaluated by resolving on an agarose gel and spectrophotometrically by 
using nanodrop instrument.  The purified PCR products/plasmid DNA were then used in 
sequencing reaction by using the DTCS sequencing kit following manufacturer’s protocols 
(Beckman & Coulter, Fullerton, CA).  The primers upstream or downstream to the insert 
sequences were used in the sequencing reaction of plasmid DNA.  The forward or reverse 
primers used in the PCR reaction are used in sequencing the DNA from PCR products.  The 
sequence generated from the above reaction was analyzed using the GCG program (142). 
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RNA isolation:  E. chaffeensis Arkansas strain were grown in host cells (dog macrophage cell 
line or tick cells) as described by Singu et al. (115).  RNA from cultures samples was isolated 
using Tri-reagent (Sigma Chemical Corporation, St. Louis, MO) as per manufacturer’s 
instructions.  Briefly, cells from 5 ml of culture were pelleted by centrifuging at 13,000 g for 15 
min at 4C and the pellet was dissolved in 1 ml of Tri-reagent solution, incubated at room 
temperature for 5 min after which 200 µl of CHCl3 was added, mixed and incubated at room 
temperature for 10 min.  Subsequently, the sample was centrifuged at 13,000 g for 15 min at 
4°C and the supernatant was transferred to a clean tube and an equal volume of ice cold 100% 
isoproponal was added. The sample was vortexed, incubated at room temperature for 10 min, 
and the centrifuged to pellet RNA.  The pellet was washed with 70% ethanol and the RNA 
dissolved in 100 µl of nuclease free water and stored at -70°C in the presence of 40 units of 
RNase inhibitor, RNasein (Ambion Corporation, Austin, TX). 
DNA isolation: Ehrlichia chaffeensis cultures also were used to isolate genomic DNA. Genomic 
DNA was isolated typically from 1-5 ml of Ehrlichia-infected DH82/ISE6/AAE2 cultures utilizing 
the sodium dodecyl sulfate-proteinase K, phenol, chloroform-isoamyl-alcohol method (72).  The 
final DNA pellet was dissolved in 100 µl of TE buffer. 
PCR:  PCR was performed in a 25 µl reaction at 1X PCR reaction buffer containing 10 pico 
moles of forward and reverse primers, 10 nmoles of each dNTP, 1 unit of Taq DNA polymerase 
(Invitrogen technologies, Carlsbad, CA), 75 nmoles of MgCl2, and about 50 ng of genomic DNA 
or 1 ng of plasmid DNA as template.  The thermal cycling conditions included an initial heating 
of 3 min at 95°C, followed by 45 cycles of 95°C denaturaion for 15 sec, 50°C of annealing for 30 
sec and 72°C extension for 60 sec (extension time is adjusted at the rate of 1 min per kb 
expected amplicon size).  For PCR reactions where proof reading is required, slight 
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modifications are made to the above conditions.  They are: 1) platinum Pfx DNA polymerase 
enzyme is added at 1 unit per 25 µl reaction containing 1X concentration of the Pfx reaction 
buffer (Invitrogen Technologies, Carlsbad, CA), 2) the concentration of dNTPs is changed to 5 
nmoles and 3) the extension temperature is decreased to 68°C.  The PCR products were 
resolved on an agarose gel to visualize the DNA bands. 
RT-PCR:  RT-PCR was performed in a 25 µl reaction at 1X reaction buffer containing 1 µl of 
SS-III and Taq mix (SuperScript-III, one step RT-PCR system with platinum Taq DNA 
polymerase, Invitrogen Technologies, Carlsbad,  CA), 10 pico moles of forward and reverse 
primers, 10 nmoles of each dNTP (Invitrogen technologies, Carlsbad, CA), 75 nmoles MgCl2 in 
a thermal cycler.  Thermal cycling conditions included an initial reverse transcription step at 
48°C for 30 min followed by an initial heating of 3 min at 95°C, followed by 45 cycles of 95°C 
denaturation for 15 sec, 50°C of annealing for 30 sec and 60°C extension for 60 sec.  The 
reaction products were resolved on an agarose gel to visualize the DNA bands. 
 
Real time RT-PCR: Taqman based Real-Time RT-PCR and PCR allows detection of amplified 
products in the reaction tube directly.  Real time RT-PCR was performed in a 25 µl reaction at 
1X reaction buffer containing 1 µl of SS-III and Taq mix (Super Script-III, one step RT-PCR 
system with platinum Taq DNA polymerase, Invitrogen Technologies, Carlsbad, CA), 10 pico 
moles of Ehrlichia-specific primers (116), 10 nmoles of each dNTP (invitrogen technologies, 
Carlsbad, CA), 40 nmoles MgCl2, 7.5 pmoles of E. chaffeensis-specific Taqman detection probe 
in the Smart Cycler. Thermal conditions include an initial reverse transcription step at 48°C for 
30 min and by an initial heating of 3 min at 95°C, followed by 45 cycles of 95°C denaturation for 
15 sec, 50°C of annealing for 30 sec and 60°C extension for 60 sec.  The fluorescence emitted 
is detected in the extension phase of the PCR cycles by turning on the optics built in the PCR 
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machine and the computer.  The threshold for detecting positive signal was set at 30 fluorescent 
units. 
Plasmid DNA isolation:  Plasmid DNA was isolated from E. coli cultures by boiling preparation 
method (72).  One and a half milliliters of culture was pelleted at 13,000 g for 5 min. The 
supernatant was carefully aspirated and the bacterial pellet suspended in 400 µl of plasmid lysis 
buffer (10mM Tris-HCl pH 8.0, 0.1 M NaCl, 1mM EDTA, 5% v/v Triton X-100) by agitating the 
pellet with a sterile toothpick.  To this, 25 µl of freshly prepared lysozyme (Lysozyme was 
dissolved in 10 mM Tris-HCl buffer pH 8.0 to get a final concentration of 10 mg/ml) was added.  
The samples were vortexed for 10 sec, boiled immediately in a boiling water bath for 40 sec and 
centrifuged for 15 min at 13,000 g.  The pellet was removed using a sterile toothpick.  To the 
solution, 420 µl of cold (-20°C) 100% isopropanol was added, mixed well, incubated at room 
temperature for 5 min and centrifuged at 13,000 g for 15 min to recover plasmid DNA.  The DNA 
pellet was washed with 70% ethanol, dried in a speed-vac system (Labconco Centrivap 
Concentrator, Kansas City, MO) and finally dissolved in 100 µl of TE buffer. To remove bacterial 
RNA, 1 µl of RNase A (1 mg/ml) was added and incubated at 37°C for 5 min. 
 
Transformation and selection of recombinant clones/plasmids: Ligated products were 
transformed into chemically competent XL1 Blue MRF’ strain E. coli cells by a chemical method.  
About 200 µl of competent cells are mixed with 50 µl of 100 ml CaCl2 and 49 µl of sterile water.  
To this suspension, 1 µl of ligation mixture is added, mixed well and incubated on ice for 15 min.  
The E. coli cells are heat shocked for 2 min at 42°C and incubated at room temperature for 10 
min.  One ml of SOC media is added to the tube and incubated at 37°C in a shaker incubator at 
200 rpm for 1 h.  Two hundred micro liters of the culture media were transferred to Luria-Bertani 
bacterial culture plates containing 4 µl of IPTG (200 mg/ml) and 40 µl of X-Gal (20 mg/ml) and 
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spread uniformly using a sterile bent glass rod to grow transformed E. coli.  The plates were 
incubated at 37°C for approximately 14 h.  Blue-white color selection resulting from the 
expression of the β-galactosidase gene was used to identify non recombinants from 
recombinants.  Recombinants will not produce β- galactosidase, thus forming white colonies.  
Several white colonies were selected to isolate plasmid DNA by growing in 3 ml of LB media 
containing appropriate antibiotic selection (72).  In the case of plasmids where blue/white 
selection cannot be employed, E. coli cells were plated onto LB plates with only antibiotics and 
several white colonies were selected to isolate plasmid DNA and further analysis. 
 
Ligation reactions:  About twenty five ng of a linearized plasmid was added to 3 molar excess 
concentration of the insert DNA segment and ligated using 5 units of T4 DNA ligase in a 20 µl 
reaction containing 1X concentration of ligation buffer (Promega Corporation, Madison, WI).  
The ligation reaction is typically carried out by incubating at 16°C for 16 h.  The ligated DNAs 
were purified by ethanol precipitation (72) and used in transformation experiments. 
Phenol purification of DNA:  DNA was purified free of proteins by using a phenol purification 
technique.  To the tube containing the DNA, 20 µl of 3 M sodium acetate was added and 
volume of the solution was adjusted to 200 µl by adding nuclease free water.  To this mixture, 
200 µl of phenol (pH=8.0) was added, vortexed and centrifuged at 15,000 g for 15 min.  
Supernatant was transferred to a new tube and 200 µl of freshly prepared 
phenol:chloroform:isoamylalcohol (25:24:1) mixture was added, vortexed and centrifuged at 
15,000g for 15 min.  The supernatant was transferred to a new tube and 200 µl of 
chloroform:isoamylalcohol (24:1) mixture is added, vortexed and centrifuged at 15,000 g for 10 
min.  The supernatant was transferred to a new tube and 500 µl of 100% alcohol was added 
and incubated at -20°C for 15 min and centrifuged at 15,000g for 15 min followed by 70% 
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ethanol wash.  The final DNA pellet was resuspended in 20 µl of nuclease free water or TE 
buffer and stored at -20°C until use. 
Agarose gel electrophoresis:  DNA was resolved on a 0.9% agarose gel by electrophoresis.  
The agarose gel was prepared by dissolving agarose powder in 1X TAE buffer containing 0.1 
µg/ml of ethidium bromide using heat.  About 5 µl of each of the plasmid DNA or PCR product 
or restriction digestion products were loaded onto the wells of a polymerized agarose gel.  
Appropriate DNA markers were also loaded onto the gel as a control.  The gel was subjected to 
electrophoresis at a voltage setting of 90 V for about 1 h in an electrophoresis chamber 
containing 1X TAE buffer containing 0.1 µg/ml of ethidium bromide.  The size and integrity of the 
resolved DNA was verified by visualizing the predicted size DNA bands under UV light and by 
comparing their migration patterns with the DNA markers. 
DNAse treatment of RNA samples:  RNA was treated with DNase to remove contaminating 
genomic DNA from the solution.  The reaction was typically performed in a 20 µl volume 
containing 5 µl of RNA sample, 1X concentration of RQ1DNase buffer and 1 µl of RQ1DNase 
(Promega Corporation, Madison, WI).  The reaction mixture was incubated at 37°C for 1 hour 
and later the enzyme was heat inactivated at 75°C for 10 min. 
Preparation of LB agar plates and liquid media:  The LB liquid medium is prepared by 
dissolving 15 g of Tryptone, 10 g of sodium chloride and 10 g of yeast extract in nanopure water 
to a final volume of 1 liter.  The pH is adjusted is 7.0 using 5N NaOH and the liquid medium is 
autoclaved on liquid cycle.  For preparing LB agar plates, the medium is prepared as described 
above but 15 g of agar powder was added before autoclaving.  After autoclaving when the 
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temperature of the agar media is about 60°C the agar media is pored into sterile plates and 
stored at 4°C.  
Competent cell preparation:  A colony of XL1Blue MRF’ strain of E. coli was grown in 3 ml of 
LB media containing tetracycline (50 µg/ml) overnight in 37°C incubator shaker.  The following 
morning, the liquid culture was inoculated into a 500 ml flask containing 100 ml of LB medium 
with tetracycline (50 µg/ml).  When the optical density measured at 660 nm reached between 
0.2-0.3, the culture was harvested by centrifugation at 2,500 g for 5 min.  The supernatant was 
discarded and the pellet suspended in 10 ml of Tris buffer and incubated on ice for 30 min.  The 
culture was centrifuged again at 2,500 g for 5 min and the pellet suspended in 2 ml of buffer and 
stored at 4°C. 
 
Filling-in reaction:  The PCR or restriction enzyme digestion products were made blunt ended 
by using T4 DNA polymerase enzyme.  Typically, eighty nanograms of DNA was treated with 10 
units of T4 DNA polymerase (Promega Corporation, Madison, WI,) for 5 min in the presence of 
0.2 mM dNTPs to create a blunt end.  The blunt ended products were purified by phenol-
chloroform, ethanol precipitated and suspended in 10 µl of TE buffer pH=8.0 (10 mM Tris-HCl 
and 1 mM EDTA). 
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